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     ABSTRACT 
BATCH AND CONTINUOUS PRODUCTION OF STABLE DENSE 
SUSPENSIONS OF DRUG NANOPARTICLES IN A WET STIRRED 
MEDIA MILL 
 
by 
Afolawemi Afolabi 
 
One way to improve the bioavailability of poorly water-soluble drugs is to reduce particle 
size of drug crystals down to nanoscale via wet stirred media milling. An increase in total 
surface area per mass loading of the drug and specific surface area as well as reduced 
external mass transfer resistance allow a faster dissolution of the poorly-water soluble 
drug from nanocrystals. To prevent aggregation of nanoparticles, polymers and 
surfactants are dissolved in water acting as stabilizers via adsorption onto the drug 
crystals.   
In the last two decades, ample experimental data were generated in the area of wet 
stirred media milling for the production of drug nanoparticle suspensions. However, a 
fundamental scientific/engineering understanding of various aspects of this process is still 
lacking. These challenges include elucidation of the governing mechanism(s) during 
nanoparticle formation and physical stabilization of the nanosuspension with the use of 
polymers and surfactants (formulation parameters), understanding the impact of process 
parameters in the context of first-principle-based models, and production of truly 
nanosized drug particles (10–100 nm) with acceptable physical stability and minimal 
contamination with the media. Recirculation mode of milling operation, where the drug 
suspension in a holding tank continuously circulates through the stirred media mill, has 
been commonly used in lab, pilot, and commercial scales. Although the recirculation is 
continuous, the recirculation operation mode is overall a batch operation, requiring 
significant number of batches for a large-volume pharmaceutical product. Hence, 
development and investigation of a truly continuous process should offer significant 
advantages. To explain the impact of some of the processing parameters, stress intensity 
and stress number concepts were widely used in literature, which do not account for the 
effect of suspension viscosity explicitly. The impact of the processing parameters has not 
been explained in a predictive and reliable manner.  
ii 
In this dissertation, a comprehensive investigation of the production of 
Griseofulvin nanosuspensions in a wet stirred media mill operating in both the 
recirculation and continuous modes has been conducted to address the aforementioned 
fundamental challenges. Griseofulvin has been selected as a model poorly water-soluble 
BCS Class II drug. Impact of various formulation parameters such as stabilizer type and 
loading as well as processing parameters such as rotor speed, bead loading, bead size, 
suspension flow rate and drug loading was studied. A major novelty of the present 
contribution is that the impact of processing and formulation parameters has been 
analyzed and interpreted using a combined experimental–theoretical 
(microhydrodynamic model) approach. Such a comprehensive approach allowed us to 
intensify the process for the production of sub-100 nm drug particles, which could not be 
produced with top-down approaches in the literature so far. In addition, a multi-pass 
mode of continuous operation was developed and the so-called “Rehbinder effect”, which 
has not been shown for the breakage of drug particles, was also elucidated. The 
dissertation work (1) indicated the need for a minimum polymeric stabilizer-to-drug ratio 
for proper stabilization of drug nanosuspensions as dictated by polymer adsorption and 
synergistic interactions between a polymeric stabilizer and a surfactant, (2) demonstrated 
the existence of an optimum polymer concentration from a breakage rate perspective in 
the presence of a surfactant, which results from the competing effects of viscous 
dampening and enhanced steric stabilization at higher polymer concentration, (3) 
developed fundamental understanding of the breakage dynamics–processing–formulation 
relationships and rationalized preparation of a single highly drug- loaded batch (20% or 
higher) instead of multiple dilute batches, (4) designed an intensified process for faster 
preparation of sub-100 nm particles with reduced specific energy consumption and media 
wear (i.e. minimal drug contamination), and (5) provided first evidence for the proof of 
Rehbinder effect during the milling of drugs. Not only do the polymers and surfactants 
allow proper physical stabilization of the nanoparticles in the suspensions, but they also 
do facilitate drug particle breakage. This dissertation also discusses applications of 
nanosuspensions and practical issues encountered during wet media milling.
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CHAPTER 1 
INTRODUCTION 
  
1.1 Background and Motivation  
Fast and efficient development of pharmaceutical formulations containing poorly water-
soluble drug particles is of great interest to the pharmaceutical industry (Date and 
Patravale, 2004). By some estimates, 60% of drug candidates currently under 
investigation can be classified as Biopharmaceutical Classification System (BCS) Class 
II, for which the bioavailability is limited by the dissolution rate. Recent advances in 
combinatorial chemistry aided the discovery of new drug molecules with such low 
solubility characteristics (Muller and Peters, 1998; Niwa et al., 2011). Few approaches 
that have been employed to improve drug solubility are the use of co-solvents or salt/pro-
drug formation (Merisko-Liversidge and Liversidge, 2011), reduction of particle size of 
the drugs (Merisko-Liversidge and Liversidge, 2011) and amorphous solid formation by 
methods such as hot melt extrusion (Leuner and Dressman, 2000), super cooling of the 
melt, rapid precipitation from solution (e.g., during freeze-drying or spray drying) 
(Hancock and Zografi, 1997). While amorphous solids have higher solubility and 
dissolution rates, they are generally less stable physically and chemically than their 
corresponding crystal forms.  
A popular approach for the bioavailability enhancement of poorly water-soluble 
drugs is particle size reduction. Reduction in particle size leads to an increase in the 
specific surface area of the drug particles which in turn improves the dissolution rate as 
per the modified version of Noyes-Whitney equation (Noyes and Whitney, 1897).  
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0 ( )S
dm
k A C C
dt
      (1.1) 
Here, k0 is the overall solute transfer coefficient defined by 1/k0= 1/ki + 1/kc, where ki and 
kc are the interface rearrangement constant and the external mass transfer coefficient 
respectively, Cs is the saturation solubility, C is the concentration in the bulk solution, A 
is the total surface area, and m is the amount dissolved at time t. Upon a decrease in 
particle size, the saturation solubility Cs increases according to the Ostwald-Freundlich 
equation and results in an increased dissolution rate in the nanoparticle size domain 
(Florence & Attwood, 1981). The increase in saturation solubility and surface area is 
important for dissolution of the nanoparticles (typically particles smaller than 1 m, 
prevalent within the pharmaceutical terminology); while the increase in surface area and 
decrease in the thickness of diffusion layer around the microparticles (Bisrat & Nystorm, 
1988) contribute to the higher dissolution rates of the microparticles (particles typically in 
the size range 1–10 μm).  
Ultrafine particles (or nanoparticles) can be produced either by the so-called top-
down approach, which includes jet milling (Chan et al., 2002), high pressure 
homogenization (Kamiya et al., 2009), and stirred media milling (Bilgili et al., 2004, 
2006); or by the bottom-up approach (Anais et al., 2009; Chiou et al., 2008) which 
involves building up particles by precipitation of dissolved molecules. Wet media milling 
has been the most popular approach of producing nanocrystals with four products 
Rapamune® (Wyeth), Emend® (Merck), Tricor® (Abbott), and Megace® (Par 
Pharmaceutical) currently on the market, which make use of Elan’s Nanocrystal 
Technology® (Liversidge et al., 1992). During wet stirred media milling, an aqueous 
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suspension containing drug particles and dissolved stabilizers (polymer and/or surfactant) 
as well as hard beads (media) is stirred at high speed by a rotor. Repeated stressing of the 
micron-sized drug particles that are captured between the colliding beads causes breakage 
and eventually production of nanoparticles provided that milling is continued for 
sufficient time. The milled particles in nanosuspensions (suspensions with median size 
typically less than a micron) interact significantly with the neighboring particles through 
van der Waals (interparticle) forces, hydrophobic forces, etc. due to their large surface 
area (Israelachvili, 1992). The attractive interparticle forces can ultimately result in 
particle aggregation if the suspensions are not properly stabilized. Stabilization can be 
achieved using polymers, surfactants or a combination of both; however, the particle 
growth can also occur in the suspension by Ostwald ripening during storage  (Wu et al., 
2011). Therefore, from a stability perspective as well as patient preference/compliance 
perspective, the general practice in pharmaceutical industry is to dry these suspensions 
into powders and incorporate them into solid dosage forms via standard pharmaceutical 
unit operations such as blending, milling, capsule filling, and tabletting. 
 
1.1.1 Physical Stability of Wet-Media Milled Suspensions  
In general, physical stabilization of suspensions can be achieved either by electrostatic, 
steric or electrosteric interactions (Kim, 2004; Napper, 1970). During electrostatic 
stabilization, the surface of the particles is equally charged (e.g. by the formation or 
adsorption of ions) so that repulsion forces emerge, which can overcome the attractive 
van der Waals forces between the particles. Steric stab ilization results from the 
adsorption of polymers or larger monomers onto the particles’ surface. If the adsorbed 
polymer contains charged groups, steric and electrostatic components act simultaneously, 
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which is typically described as electrosteric stabilization. To protect drug particles against 
aggregation, formulators commonly use stabilizers like polymer(s) and/or surfactant(s).  
A review by Van Eerdenbrugh et al. (2008) lists various polymers and surfactants 
and their concentrations used for the stabilization of drug nanoparticle suspensions. Few 
systematic studies on the stabilizing capability of adsorbed polymers suggest the 
importance of hydrophobicity of the polymers (Lee et al., 2005, 2008) and surface energy 
difference between drug particles and polymers (Choi et al., 2005; Lee et al., 2008). 
Investigation of the polymer adsorption on drug nanoparticles in aqueous suspensions has 
led to insight into the steric stabilization capability of the polymers and selection of 
optimum polymer concentration (Choi et al., 2008; Lee, 2003; Panmai and Deshpande, 
2003; Sepassi et al., 2007). Despite these advances, it is still not possible to predict, based 
solely on first principles and mechanistic understanding, an optimal stabilizer 
type/concentration for a given drug that ensures proper short- and long-term physical 
stability of the drug nanoparticle suspensions. This task is usually carried out by stabilizer 
screening studies at the bench-scale (Kesisoglou et al., 2007; Van Eerdenbrugh et al., 
2008), where milling dynamics, process cycle times, and scale-up effects are not of any 
concern.  
 
1.1.2 Breakage Dynamics and Microhydrodynamics  
Milling in a planetary mill (Van Eerdenbrugh et al., 2009) or in a ball mill (e.g. Lee, 
2003; Lee and Cheng, 2006; Liversidge and Cundy, 1995; Merisko-Liversidge et al., 
1996; Van Eerdenbrugh et al., 2007), both making use of vials containing drug 
suspensions with various stabilizers, has previously been described for their capability in 
obtaining nanoparticles. These mills are regarded as medium or low-energy mills; hence, 
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suspension flow and microhydrodynamics are quite different in these mills than in the 
wet stirred media mills. It is not surprising to see that the nanoparticles are produced after 
several hours to a few days of milling even at the bench scale with suspension quantities 
on the order of ~10 ml. In other screening studies, wet stirred media mills are used: e.g. 
the Nanomill® System (e.g. Kesisoglou et al., 2007). However, the impact of stabilizers 
on the microhydrodynamics has not been reported. More importantly, as pointed out by 
Bhakay et al. (2011), most wet media milling work in pharmaceutical literature either 
disregarded the breakage kinetics (rate) completely (as in Ain-Ai and Gupta, 2008; 
Cerdeira et al., 2010; Choi et al., 2005; Liversidge and Cundy, 1995; Tanaka et al., 2009;  
Van Eerdenbrugh et al., 2008, 2009) or did not characterize the breakage kinetics and its 
relationship to the stabilizers quantitatively (as in Lee, 2003; Lee et al., 2005, 2008; Choi 
et al., 2008; Deng et al., 2008). 
While scant information is available regarding the impact of stabilizers on the 
breakage rate during wet stirred media milling, the microhydrodynamics, which is the 
study of the fluctuating motion of the beads in sheared suspensions, has not been 
investigated at all. The milling process has been largely treated as a “black-box” in 
pharmaceutical literature. The recent advances in wet media milling of non-
pharmaceutical materials are summarized here. It is known that high solids loading 
results in high suspension viscosity, which could dampen the collision speed of the 
milling beads (viscous dampening) and reduce the breakage rate (Knieke et al., 2010; 
Mende et al., 2003). Knieke et al. (2010) provided a semi-theoretical model based on the 
kinematic equations describing the relative motion of undeformed spheres (beads). 
However, their model does not allow calculation of the bead oscillation velocity and 
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frequency (microhydrodynamic parameters), which fundamentally determine the 
breakage rate along with the material properties in a wet stirred media mill (Eskin et al., 
2005a, 2005b). Using the well-known kinetic theory of granular flows and the 
fundamental granular energy balance (Gidaspow et al., 1994), Eskin et al. (2005a, 2005b) 
developed a microhydrodynamic model on the basis that the power spent on stirring the 
mill rotor dissipates through bead–suspension viscous friction, lubrication, and partially 
inelastic collisions of the beads. This model was used to study the effects of stirring 
speed, beads loading, and bead size on the microhydrodynamic parameters in a mixing 
tank with Rushton type paddles, which provided significant insight into the 
experimentally observed impact of these process parameters on the bead collision 
dynamics. However, this model has not been applied to the wet stirred media milling of 
drug suspensions with the objective of elucidating the impact of stabilizers such as 
viscous dampening of the polymers on the breakage rate.   
 
1.1.3 Impact of Wet Milling Process Parameters  
Although ample experimental data exists on pharmaceutical nanoparticles production and 
their stabilization via wet media milling, the impact of process parameters on the 
breakage kinetics and its relation to the microhydrodynamics has not been reported. 
Considering that the breakage kinetics determines the process cycle times and production 
rate for a desired fineness of the nanosuspension, it is fair to remark that a significant gap 
exists in the pharmaceutical engineering literature regarding the dynamics of the wet 
media milling process. As wet media milling process is time-consuming, costly, and 
energy-intensive (Kawatra, 2006) and the breakage kinetics determines the cycle time 
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and production rate for a desired fineness, milling process design and optimization entails 
a good understanding of the breakage kinetics and its controlling process parameters.  
 Process parameters such as stirrer speed, bead loading, and drug loading can 
significantly affect the breakage rate and milling time required in a wet stirred media 
milling process. In a recent review paper, Peltonen and Hirvonen (2010) summarized 
various process parameters and their ranges investigated in wet media milling processes. 
While Peltonen and Hirvonen (2010) and the references cited therein provide great 
understanding of the impact of stabilization and formulation, little fundamental 
understanding of the impact of process parameters is available at the beads scale 
(microhydrodynamics). In a more recent work, Ghosh et al. (2012) present the effects of 
stirrer speed, bead size, and drug content on the final milled suspension; however, the 
impact of these parameters on the breakage kinetics was not investigated. Singare et al. 
(2010) and Singh et al. (2011) used a statistical design of experiments with a response 
surface methodology (RSM) with the goal of optimizing the process parameters including 
milling speed and time. However, no information regarding the breakage kinetics was 
presented explicitly. In general, the statistically-based designs of experiments such as 
those in Singare et al. (2010) and Singh et al. (2011) do not provide significant physical 
insight at the beads scale as to how the process parameters affect the breakage kinetics.  
 
1.1.4 Preparation of Sub-100 nm Drug Particles with Minimal Contamination 
It is understood that faster particle breakage reduces the milling time required for desired 
particle fineness and energy consumption, and can be achieved by the right selection of 
mill process parameters such as bead size, bead load, stirrer speed, and suspension flow 
rate. Influence of these operating parameters on the specific energy consumption and 
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product fineness has been studied previously through experiments and empirical models 
(Fadhel and Frances, 2001; Stehr, 1984; Tüzün et al., 1995). However, the combined 
effect of these parameters on breakage kinetics leading to the preparation of fine drug 
nanoparticles at a shorter time is not addressed. Therefore, a detailed strategy or 
methodology for combining different mill process parameters has to be developed which 
could lead to an intensified process for the faster production of fine drug nanoparticles 
with reduced specific energy consumption.  
In pharmaceutical applications, the demand for using fine drug nanoparticles with 
size as low as possible is increasing steadily, as fine drug nanoparticles offers a much 
faster dissolution rate, and also result in rapid onset of therapeutic action (Muller et al., 
2006). Most importantly, drug nanoparticles with size < 100 nm renders feasible and 
efficient sterile filtration of aqueous drug nanosuspensions, and allows higher loading for 
reduced injection volume in parenteral dosage forms (Baert et al., 2009; Xiong et al., 
2008). In addition to the nanosuspension dosage form, nanocomposite microparticles 
made of very small size drug nanoparticles offer rapid redispersion of particles at an 
increase drug loading in a given mass of dosage (Bhakay et al., 2013). Therefore, it is 
important to prepare drug nanosuspensions with size as small as possible (< 100 nm) to 
achieve enhanced efficacy in various pharmaceutical applications. By varying the process 
parameters, several researchers have prepared inorganic nanoparticles in the size range of 
10–100 nm using WSSM technique. For example, 20–50 nm Magenta pigment (Bilgili et 
al., 2004, 2006), 50 nm Al2O3 (Stenger et al., 2005), 50 nm BaSO4 (Patel et al., 2012), 
and 30–40 nm quartz, calcite and dolomite (Wang et al., 2006) have been prepared. 
However, an investigation on the effect of process parameters for the preparation of drug 
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nanoparticles having < 100 nm has not been attempted so far. From the current search in 
literature, only using smaller initial drug particle size and at low batch volume, the drug 
nanoparticles with a typical median size of 136 nm and above have been produced via 
WSMM. It is to be noted that the preparation of drug particles with < 100 nm size is a 
challenging task, especially if the mill is desired to operate with the large initial particle 
size, high batch volume (> 200 ml at the bench scale), and high drug load > 10 % (w/w).  
Despite the fact that drug nanoparticles with size as small as possible is of great 
interest in pharmaceutical application, drug product contamination introduced by typical 
bead wear (for example, e.g., yttrium stabilized zirconia) at intensified process conditions 
is a major concern and is yet to be investigated. Due to the high turbulence during the wet 
stirred media milling process, wear is generated, between grinding beads and grind ing 
bead/milling chamber and transferred into the related drug products as undesirable 
contamination (Juhnke et al., 2012; Peltonen and Hirvonen, 2010). In general, toxicity 
data and contamination levels from ceramics is unknown and needs to be quantified 
according to the current regulatory concepts and permitted daily exposures for oral, 
parenteral, pulmonary and topical administration (Juhnke et al., 2012).  
A literature review by Juhnke et al. (2012) lists several earlier publications that 
explored the generation of wear from grinding beads. Few systematic studies on the 
generation of grinding bead wear was investigated via the wet milling of alumina 
particles with yttrium stabilized beads along with fused corundum beads (Mende and 
Schwedes, 2006; Breitung-Faes and Kwade, 2008). The generation of wear was 
characterized by a gravimetric method, including washing, drying and weighing of the 
grinding media to determine the overall weight loss. Adam et al. (2008) investigated the 
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wet media of zirconia with grinding beads made from zircon silicate as well as a grinding 
chamber and a stirrer made from zirconia. The generation of wear from grinding beads 
was characterized by determining elemental silicium using inductively coupled plasma 
atomic emission spectrometry. Ohnishi et al. (2010) investigated the use of grinding 
beads made from silica doped and undoped yttrium stabilized zirconia during wet milling 
of barium titanate. The doped silica had a lower wear as compared to the un-doped 
grinding media. Several material combinations of grinding beads and milling chamber 
with respect to the overall generated wear during the production of fenofibrate 
nanosuspensions by wet media milling has also been investigated (Stein et al., 2010). 
Stein et al. (2010) investigated the use of various grinding beads made from glass, 
polyamide, polycarbonate, polystyrene, stainless steel and zirconia as well as milling 
chambers made from polyamide, polyurethane, stainless steel and zirconia. Wear 
generated by the grinding beads was characterized by a gravimetric method. Despite 
these advances, for a given drug, it is still not possible to predict drug contaminations 
levels, based solely on the mill process parameters such as bead size, bead load, stirrer 
speed, and suspension flow rate.  
 
1.1.5 Continuous Production of Drug Nanoparticles and Rehbinder Effect 
In all major chemical industries, continuous processing is widely used for large-scale 
production. There is a growing interest in moving all pharmaceutical unit operations in 
drug product manufacture from batch processes to continuous processes. Recent 
publications on continuous mixing have made the case for the feasibility of continuous 
drug product manufacture (see e.g. Berthiaux et al., 2008; Vanarase et al., 2010a, 2010b). 
This manufacturing strategy could bring the pharmaceutical industry advantages such as 
 
 
 
  11 
 
consistent and improved product quality, reduced waste, lower inventory and equipment 
costs, easy scale-up, flexibility, and short cycle times. Pharmaceutical unit operations 
such as tabletting, roller compaction, and capsule filling are already performed semi-
continuously; whereas mixing; wet milling, most granulations, drying, and tablet coating 
are usually performed in the batch/recirculation mode. Although ample experimental 
studies of batch and recirculation mode of wet media milling exist in literature, little 
effort has been devoted to the cascade or multi-pass continuous modes. In the area of 
continuous wet stirred media milling of drugs, there are only a couple of patents available 
(Holland et al., 2006; Verhoff et al., 2003). Feasibility of nanomilling Fenofibrate using a 
wet stirred media mill operating in single-pass mode was presented (Verhoff et al., 2003); 
however, the figures and examples provided only described recirculation milling. 
Another patent (Holland et al., 2006) presents what is believed to be the first 
documentation of cascade continuous mode of wet media milling of drugs, where 
Nabumetone nanoparticles were produced using five media mills in series. In both cases, 
only the final median particle size was provided; procedural details were missing, and the 
breakage dynamics was not studied.  
During wet media milling of materials, stabilizers such as polymer(s) and/or 
surfactant(s), also known as grinding aids, can affect or play a major role in three 
phenomena: stabilization of the suspension and proper dispersion of the product particles, 
microhydrodynamics during media milling as affected by suspension rheology, and 
particle strength. However, it is interesting to note that most pharmaceuticals literature on 
wet media milling focused on the first phenomena, i.e., stabilization and proper 
dispersion of the particles, thus largely neglecting the impact of the stabilizers on the 
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microhydrodynamics and the particle strength (associated with the Rehbinder effect). 
Rehbinder effect is described as the facilitation of crystal cleavage and decrease in 
hardness of crystals caused by surfactant solutions, and can be explained by the 
weakening of bonds in the crystal surface layer due to adsorption and lowering of the 
specific surface free energy (Rehbinder and Shchukin, 1972; Shchukin, 1999, 2006).  
Rehbinder effect manifests itself as facilitated breakage of crystals and enhanced 
breakage rate in the presence of surface-active agents (El-Shall and Somasundaran, 
1984). There exists no prior work as to whether Rehbinder effect arises during the wet 
media milling of drugs owing to the use of such agents as stabilizers.    
 
1.2 Objectives and Major Research Tasks 
Nanoparticle suspensions (nanosuspensions) of poorly water-soluble drugs are prepared 
with the ultimate goal of increasing the dissolution rate and bioavailability of such drugs.  
This dissertation work aims to achieve the following objectives: (1) develop a 
fundamental understanding of the impact of various stabilizers, i.e., polymers and 
surfactants,  on the breakage kinetics, microhydrodynamics, and suspension 
rheology/stability; (2) investigate the impact of various milling parameters on the 
breakage kinetics and explain the findings from a microhydrodynamic perspective;  (3) 
design an intensified process for faster preparation of sub-100 nm particles with reduced 
specific energy consumption and media wear (i.e. minimal drug contamination); (4) 
develop a continuous milling methodology that can mimick true cascade continuos 
milling operation; and (5) explore if Rehbinder effect plays any role during the milling of 
drugs. 
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In this dissertation, a comprehensive investigation of the production of 
Griseofulvin nanosuspensions in a wet stirred media mill operating in both the 
recirculation and continuous modes has been conducted to achieve the afore-mentioned 
objectives. Griseofulvin was selected as a model poorly water-soluble BCS Class II drug. 
Impact of various formulation parameters such as stabilizer type and loading as well as  
processing parameters such as rotor speed, bead loading, bead size, suspension flow rate 
and drug loading were studied. A major novelty of the present contribution is that the 
impact of processing and formulation parameters has been analyzed and interpreted using 
a combined experimental–theoretical (microhydrodynamic model) approach. Such a 
comprehensive approach allowed us to intensify the process for the production of sub-
100 nm drug particles, which could not be produced with top-down approaches in the 
literature so far. In addition, a multi-pass mode of continuous operation was developed 
and the so-called “Rehbinder effect”, which has not been shown for the breakage of drug 
particles, was also investigated. The five major objectives stated above have been divided 
into four Chapters and are discussed in the dissertation outline.  
 
1.3 Dissertation Outline 
The dissertation work is presented in seven chapters. Chapter 1 begins with a review of 
what has been done in literature followed by the objectives and outline of the dissertation. 
Chapter 2 discusses the theoretical framework used in the current work. Chapter 3 
explores the roles of various stabilizers such as polymers and surfactants during the wet 
milling of drugs. Chapter 4 investigates the impact of processing parameters on the 
breakage kinetics using a combined experimental–microhydrodynamic model approach. 
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Chapter 5 presents an intensified process for the production of sub-100 nm particles and 
how such a process is designed in view of the microhydrodynamic model. The 
contamination of the drug product during milling was also investigated in Chapter 5. In 
Chapter 6, the continuous production of drug nanoparticles suspension was investigated 
with a fresh look at the Rehbinder effect. Chapter 7 gives an overall summary and 
conclusion of the current work. Potential future work is discussed in Chapter 8.  
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CHAPTER 2 
THEORETICAL BACKGROUND 
 
2.1 Fundamentals of Interparticle Interactions and  
Stabilization of Drug Particles against Aggregation 
 
2.1.1 Fundamentals of Interparticle Interactions 
 
Several interparticle forces or interactions come into play when two colloidal particles 
approach one another. The extent of interaction between two colloidal particles is 
determined by how rapidly the approach occurs. The colloidal behavior which is 
dependent on the surface properties of the particles affects both the state of aggregation 
along with the suspension rheology.  
 2.1.1.1 van der Waals Interactions. The most attractive van der Waals forces is 
the interaction between induced dipoles, which arise due to orientation effects between 
molecules with permanent dipoles or induction effects in neutral particles (Hunter, 1986). 
Particle stressing and/or deformation as a result of two colliding beads can lead to 
aggregation of particles during milling. The attractive van der Waals interaction energy, 
Va is given by (Russel et al., 1987). 
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where kB is Boltzmann’s constant, T is absolute temperature, 
Aeff  is the effective Hamaker 
constant, d1 
and d2 are the core diameters  of  the two particles, which can be of different 
(2.1) 
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size, and r is the center to center distance between the particles. Whenever an aggregate 
of two or more particles is formed, the resultant aggregate is considered to be a spherical 
particle of volume equal to the sum of the constituents (Kumar et al., 2010).  
2.1.1.2 Electrostatic Interactions. Electrostatic repulsion energy (
eV ) between two 
particles is calculated using the expression below. (Hunter, 1987; Lee et al., 1998; 
Ohshima, 1995) 
 
 
 
 
 
                                                                                                                   
where                                                                               
 
where subscript i indicates 1, 2; e is elementary charge,   is the dielectric constant of the 
medium (water),   
is the permittivity of free space,   is the surface potential and  is 
Debye length. The surface potential   can be approximated by measuring values of the 
 - potential.  
In general, the repulsion potential during electrostatic interactions is generated 
from electrical double layer (EDL) (see schematic in Appendix A (Figure A.1)). The 
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(2) 
EDL is sensitive to the ion concentration in the system (i.e. the ions move freely under 
the influence of electrical and thermal forces in the so called diffuse layer). Upon an 
increase in the ion strength, the thickness of the EDL decreases due to screening of the 
surface charge (Kim, 2004). This effect leads to a decrease in the repulsion potential and 
an increase in the attractive potential (van der Waals interaction) (i.e. the vulnerability of 
dispersed particles to form aggregates). Zeta () potential is the electric potential at the 
shear plane and is the representative of the surface charge (see schematic in Appendix A 
(Figure A.2)).  
2.1.1.3 Steric Interactions. Attractive van der Waals and electrostatic interactions often 
fail to describe the all interactions; steric repulsion energy between polymer coated 
spherical nanoparticles is given by (Rosensweig, 1985) 
 
                                                                                                                                                                                                                                                                                                             
                                                                                                                                 
                                     
 
 
where g is the grafting density (i.e. the number of stabilizing groups bound to the particle 
surface), s  is the surface to surface separation distance,   is the thickness of the polymer 
chain (shell) and d  is the average core diameter of the two solid particles (see schematic 
in Appendix A (Figure A.3). Steric interaction between two particles of diameters 1d  and 
2d  can be calculated using average core diameter 
 1 2 / 2d d d   (Castro et al., 2008). 
In addition, 2 /l s d  and 2 /t d  have been defined (see schematic in Appendix A 
(Figure A.3)).  
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The net interaction potential energy (Vtotal) can be calculated by summing all the 
above individual interaction potentials. This is governed by van der Waals (Va), steric 
(Vs), and electrostatic (Ve) interactions and is discussed next further in the next section by 
the DLVO theory. 
 
2.1.2 Stabilization of Drug Particles against Aggregation 
The physical stability of poorly water-soluble drug nanosuspensions produced by wet 
media milling must be preserved against aggregation and ripening during the production 
and storage. Milled drug particles with mean sizes below 1 m show a strong tendency to 
aggregate due to a high number concentration (given solid loading), small interparticle 
distances, enhanced Brownian motion, and relatively high surface energy (Bruno et al., 
1996; Knieke et al., 2009; Lee, 2003; Sommer et al., 2006). During milling, repeated 
stressing of the micron-sized drug particles that are captured between the colliding beads 
increases the turbulent shear, which can cause a high collision rate among the particles 
and in turn high aggregation rate (Barthelmes et al., 2003; Peukert et al., 2005; Su et al., 
2004). The physical stability during the storage of the nanosuspensions is affected by the 
sedimentation (gravity), Ostwald ripening, Brownian motion, along with van der Waals 
interactions (see section 2.1.1.1). Based on the physical stability of the suspension, it is 
known that drug particles below 1 m can be stabilized electrostatically due to unipolar 
charging of particles; sterically by the adsorption of polymers on the particle surface; or 
electrosterically by a combination of both electrostatic and steric mechanism (see 
schematic of various forms of stabilization in Appendix A (Figure A.4)). 
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2.1.2.1 Electrostatic Stabilization. The DLVO-Theory: The net interaction potential 
(Vtotal) between particles is the result of repulsion forces (Vrepulsive) due to the electric 
double layer (electrostatic interaction) and attraction due to the van der Waals interaction 
(Vattractive). The superposition of the van der Waals interaction and electrostatic repulsion 
can be traced back to the independent research of Derjaguin and Landau (1941) as well as 
Verwey and Overbeek (1948) and is known as DLVO theory (see schematic in Appendix 
A (Figure A.5)). Mostly the repulsive steric interaction is also included so that the net 
interaction energy consists out of: 
stericattractiverepulsivetotal VVVV                 (2.6) 
The probability of a particle to overcome the energy barrier leads to more aggregation 
due to the attractive interaction (see schematic in appendx A (Figure A.5)). For this case, 
attraction is very strong and redispersion of the particles is almost impossible (i.e. strong 
aggregate formation). If repulsive forces are large enough, the suspension can remain 
well dispersed.  
2.1.2.2 Steric Stabilization. Unlike electrostatic stabilization, the influence of steric 
stabilization on the energy barrier is complex to interpret. However, it can be understood 
mainly through the adsorption or chemisorption of polymer chains on the surface of the 
particles (Napper, 1977). If the concentration of the polymer is high (i.e. increase in the 
polymer layer thickness), the attractive forces will be suppressed and the surface 
coverage of the polymer on the particle will be high (Fleer et al., 1938). When two 
particles coated with polymer approach each other, one can distinguish them by three 
distance regimes (Davies and Binner, 2000). At large distances between the particles, no 
overlap of the polymer is observed. For this case, no repulsive forces are acting. At a 
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close distance, an overlap of the polymer chains is observed, for solvents, a densification 
of the polymer chains is detected and solvent molecules are depleted out of the overlap 
area into the solvent (Wu et al. 2011). In a good solvent, the entanglement of polymer 
chains is unfavorable, strong enthalpic interaction (good solvation) between the solvent 
and the stabilizing segment of the stabilizer is the key factor to achieve steric stabilization 
and prevent particles from aggregation in the medium (Kim, 2004; Nutan and Reddy, 
2009). The chemical potential of the solvent molecules is higher than in the bulk solvent, 
resulting in an increase of the osmotic pressure and yielding a positive contribution to the 
net interaction potential (Vtotal) (i.e. the reason for the repulsion). For the third case, 
particles approach each other closer to the compressed polymer layer. The compression 
forces in addition to the osmotic forces have to be considered.  
2.1.2.3 Electrosteric Stabilization. Electrosteric stabilization occurs, if the adsorbed 
polymer contains charged groups, steric and electrostatic components act simultaneously. 
Basically, the development of a double layer is formed when the non-polar ends of the 
polymers adsorb favorably on hydrophobic particles in polar surroundings, while the 
polar ends reach into the polar solvent (Klimpel, 1999). Consequently, the concentration 
of the ionic charge should be optimal to avoid suppression of the double layer. The 
stabilization is strengthened by the polymer layer due to the steric effect suggesting that 
the principle of the DLVO theory can be applied.  
 
2.1.3 Comparison: Steric Stabilization vs. Electrostatic Stabilization 
Steric stabilization offers several distinct advantages over electrostatic stabilization.  
 Steric stabilization is comparatively insensitive to the presence of electrolytes because 
the dimensions of non- ionic chains vary relatively little with the electrolyte 
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concentration. This contrasts sharply with the electrical double layers, which are 
strongly dependent upon the ionic strength (Hunter, 1986). This accounts for the 
coagulation of electrostatically stabilized dispersions on the addition of electrolyte.  
 Steric stabilization is equally effective in both aqueous and non-aqueous dispersion 
media. This contrasts with electrostatic stabilization, which is relatively ineffective in 
non-polar dispersion media. 
 Steric stabilization is equally effective at both high and low volume 
fractions/concentrations of the dispersed phase, the high volume fraction dispersions 
displaying relatively low viscosities. 
 Sterically stabilized suspensions can be often be flocculated reversibly whereas this is 
less common with electrostatically stabilized suspensions.  
 Sterically stabilized suspensions frequently display good freeze-thaw stability, which 
can be a desirable attribute in some practical application (e.g. paint system).  
Despite all these advantages, there exist several significant disadvantages for the 
application in wet stirred media milling. High molecular weight polymers affect the 
suspension rheology during the milling process which could dampen the collision speed 
of the milling beads (viscous dampening), resulting in a reduced breakage rate. 
Moreover, the adsorbed polymers can be desorbed from the particle surface by the high 
shear forces during milling. However, the most critical issue and disadvantage is due to 
the unknown adsorption kinetics for high molecular weight molecules.  
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2.2 Impact of Apparent Shear Viscosity on  
Suspension Rheology in Wet Stirred Media Mills  
It is known that both a high solids loading and particle–particle interactions results in 
high suspension viscosity. High solids loading could dampen the collision speed of the 
milling beads (viscous dampening), resulting in a reduced breakage rate (Knieke et al., 
2010; Mende et al., 2003) while particle-particle interactions can increase the rate of 
aggregation. Suspension viscosity affects the microhydrodynamics, which is the study of 
the fluctuating motion of the beads during the media milling process. It is therefore 
necessary to measure the rheological properties of the milled suspension.  
The rheological behavior of suspensions is determined by the shear stress function 
τ(γ*) or alternatively the shear viscosity function ηapp(*) which has to be measured in 
stationary shear experiments. The two functions are connected by a constitutive equation 
for the shear stress (Hunter, 1986). Here, * is the shear rate, which is applied by the 
rheometer, and ηapp(*) a characteristic material function which describes the flow 
behavior of the fluid. The typical flow characteristic of suspensions is further explained 
in Appendix B. 
 
2.3 Analysis of the Breakage Kinetics 
When particle breakage governs the dynamics of a wet media milling process as opposed 
to particle growth/aggregation in a properly stabilized suspension, the median particle 
size d50 decreases in time t monotonically and approaches/attains a limiting value 
provided milling is continued for a prolonged time. The evolution can be described by a 
first-order exponential decay function as follows (Bilgili et al., 2008; Strazisar and 
Runovc, 1996; Varinot et al., 1999):  
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  )/exp()0()( plim50lim50 tdddtd                      (2.7) 
where dlim is the limiting median particle size, τp is a characteristic time constant of the 
process, and d50(0) is the initial median particle size. A lower τp corresponds to faster 
breakage of the particles and a higher overall apparent breakage rate, which will be 
shortly referred to as the breakage rate throughout the rest of this dissertation. To 
estimate dlim and τp, Eq. (2.7) was fitted to the measured median size data via 
minimization of the following sum of squared residuals (SSR):  
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where the superscripts ‘exp’ and ‘mod’ refer to experiment and model, respectively.  The 
median sizes at different time points were indexed by i (i = 1, 2, …, n). SigmaPlot’s 
(Version 11) nonlinear regression wizard, which has a built- in Marquardt-Levenberg 
algorithm, was used for the minimization. Preliminary analysis indicated that large 
particles with as-received median particle size broke faster initially (within first minute) 
than the particles produced after one minute or first turnover or pass. Therefore, Eq. (2.7) 
with a single time constant τp was not able to fit the whole experimental data governed by 
two or potentially more characteristic time constants (Cho et al., 1996). Hence, initial 
median particle size at 0th min was discarded, thus making the 1st min median size the 
initial size for better fitting capability, which is in line with prior studies (Varinot et al., 
1999; Bilgili and Afolabi, 2012).  
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2.4 Microhydrodynamic Analysis 
Based on the kinetic theory of granular flows and the fundamental granular energy 
balance (Gidaspow et al., 1994), Eskin et al. (2005a and 2005b) developed a model to 
calculate the mean velocity of the milling bead oscillations (fluctuations) in a well-mixed 
slurry. The salient features of this model are presented here and readers are referred to 
Eskin et al. (2005a) for the full set of assumptions and the development of their model. It 
is assumed that the power input by the mill rotor in a wet stirred media mill is uniformly 
applied throughout the whole volume of the slurry and equals the total energy dissipation 
rate. The power input dissipates through fluctuating motions of the beads and liquid–
beads viscous friction at the micro-scale; hence, the total energy dissipation rate (ε tot) is 
given by  
collviscwtot P              (2.9) 
where Pw is the power applied by the rotor per unit volume, εvisc is the energy dissipation 
rate due to both the liquid–beads viscous friction and lubrication, and εcoll 
is the energy 
dissipation rate due to partially inelastic bead–bead collisions. Numerical simulations 
performed by Eskin et al. (2005a, 2005b) and Bilgili’s research group (not shown here for 
brevity) indicate that εvisc is much greater than εcoll, making the viscous friction–
lubrication the main energy dissipation mechanism.  
In its current form, Eq. (2.9) can be used for a suspension undergoing turbulent 
motion, which is characterized by the stirrer Reynolds number (Re = ND2L/L) greater 
than 35000 (Kawatra, 2006). Re value between 120 and 35000 describes a laminar–
turbulent transition region and a Re value less than 120 describes a laminar region. In Re  
definition, N is the rotor speed, D is the rotor’s tip diameter, L is the density of the 
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equivalent liquid, and L is the apparent shear viscosity of the equivalent fluid. Eskin et 
al. (2005a, 2005b) considered the equivalent liquid to be water (~1 cP); therefore, their 
numerical simulations considered the turbulent motion. On the other hand, most drug 
suspensions with polymeric stabilizers have orders of magnitude higher viscosity than 
water and can exhibit a flow behavior in the transition region. As co mmonly assumed in 
the wet stirred media milling literature (refer to Kawatra, 2006), the equivalent liquid was 
taken as the milled suspension. The shear viscosity obtained at a shear rate of 1000 1/s 
was taken as the L value. Although the shear rate in media mills could exceed this value, 
earlier work (Bernhardt et al., 1999; Knieke et al., 2010) considered 1000 1/s to be a 
representative value because the shear viscosity did not change drastically above 1000 1/s 
and it can be reliably measured by most rheometers. Re values were calculated with the 
equivalent liquid properties of the milled suspensions. In this dissertation, unless 
otherwise indicated, Re typically ranged from 1000–35000; thus, the flow was in the 
transition region in most runs. 
Since Eq. (2.9) does not consider the energy dissipation due to friction between 
“liquid layers”, which becomes more pertinent in the transition region, a new term should 
be added to the right-hand-side. Eskin and Miller (2008) included such a term εht in the 
granular energy balance for a slurry flow in fractures. εht is defined as the power spent on 
shearing equivalent fluid of the slurry (beads–drug suspension here) at the same shear 
rate but calculated or measured as if no particles (beads here) were present in the slurry. 
Then, following Eskin et al. (2005a, 2008), Eq. (2.9) can be modified as  
htcollviscwP            (2.10) 
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where c is the beads volumetric concentration, Rdiss is the dissipation or effective drag 
coefficient, db 
is the average bead size (taken as the median size of the bead), b is the 
density of the beads (measured to be ~6000 kg/m3), k is the restitution coefficient for the 
bead–bead collisions (taken from Tatsumi et al., 2009), and  is the granular temperature 
defined as the bead–liquid relative mean-square velocity. The dissipation coefficient Rdiss 
is given by Wylie et al. (2003) as 
L
21
Lb0dissdiss )()( dcKcRR                     (2.12) 
L is the density of the equivalent liquid, K is a coefficient expressed as an empirical 
correlation of bead concentration c expressed as  
  454.4212.0 )1(142.0096.0)( cccK                    (2.13) 
Rdiss0 is the dissipation coefficient taking into account squeezing in the equivalent liquid 
film between two approaching beads and is expressed as follows: 
m210diss ln)()()( ckckcR                     (2.14) 
In Eq. (2.14), εm is the non-dimensional bead–bead gap thickness at which the lubrication 
force stops increasing and becomes a constant. According to Sangani et al. (1996), εm can 
be taken as 0.003. k1 and k2 in Eq. (2.14) are computed using 
  )77.2157.161.51(26.11ln64135231)( 321 cccccccck          (2.15) 
  32 )1(5.01)( cccck                      (2.16)   
Using the equivalent liquid properties (L and µL), power input values in the presence and 
absence of the beads (Pw and εht), and the aforementioned bead parameters, Eq. (2.11) is 
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solved for the granular temperature () using MATLAB’s fsolve function. The average 
bead oscillation velocity (ub) and the frequency of single-bead oscillation () are 
determined using the calculated  value from 
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The microhydrodynamic parameters (, ub, and ) determine the intensity and frequency 
of the bead–bead collisions, and thus the number of compression events and compression 
forces to which the drug particles are subjected during the milling. At the micro-scale 
(beads scale), these parameters are good predictors of the breakage rate for a given 
material (Eskin et al. 2005b).   
Eskin et al. (2005b) advanced the earlier microhydrodynamic model (Eskin et al. 
2005a) by considering the elastic contact deformation of the beads along with the elastic–
perfectly plastic deformation of the particles caught between the beads. While the beads 
frequently collide due to their fluctuating motions in a slurry, which are characterized by 
, ub, and , the beads capture and compress (deform) the particles to be milled. Based on 
Hertzian theory of elastic impact, the average maximum normal force Fb
n during collision 
of two identical elastic beads, the radius of the contact circle formed at the contact of two 
beads αb, and the maximum contact pressure at the center of the contact circle σb
max (see 
schematic of bead–bead interaction in Appendix A (Figure A.6)) were calculated using 
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where Yb, and b are the Young’s modulus and Poisson’s ratio of the bead material. 
(yttrium stabilized zirconia here), and were taken from the literature as 200 GPa and 0.2, 
respectively (Ashby, 1999; Srikar et al., 2004); Rb is the bead radius and was taken as half 
of db. The probability p of a single particle with radius Rp being caught between beads 
was estimated as the ratio of the volume containing the caught particles to the volume of 
milled drug suspension falling on a pair of the milling beads and is expressed as  
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The average frequency of drug particle compressions a was estimated using Eq. (2.22) 
below as the product of this probability p and the frequency of single-bead oscillations   
pa             (2.22) 
The energy dissipation rate resulting from the deformation of the drug particles per unit 
volume Π characterizes the grinding intensity and is expressed as follows: 
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where ε, Y*, Yp, b, σy, Rp, and Rb respectively denote volumetric drug loading in the 
milled suspension, reduced elastic modulus of the bead–drug particle contact, elastic 
modulus of the drug particles, Poisson’s ratio of the beads, contact pressure in a drug 
particle captured when the fully plastic condition is obtained, radius of the drug particle, 
and radius of the bead.  
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To calculate Π using the expressions derived by Eskin et al. (2005b) (Eq. (2.23)), 
one must either find the mechanical properties of the drug particles (Yp, p, σy) from the 
literature or measure them. First, it is difficult to find reliable mechanical properties of 
the drug particles or to measure them. Second, the objective of this dissertation is to gain 
fundamental insight into the impact of the process parameters on the breakage kinetics. 
While the potential influence of different bead materials and drugs are of interest, it is not 
considered here. Therefore, multiplicative decomposition or factorization of Π into a 
material-dependent factor  and a process-dependent factor, F, which is referred to as the 
milling intensity factor, yields: Π  = F, where functional forms of and F will be 
specifically introduced in Chapter 4 and Chapter 5. 
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CHAPTER 3 
A COMBINED MICROHYDRODYNAMICS–POLYMER ADSORPTION 
ANALYSIS FOR ELUCIDATION OF THE ROLES OF STABILIZERS IN WET 
STIRRED MEDIA MILLING 
 
3.1 Introduction 
About 40% of active substances identified through combinatorial screening programs in 
pharmaceutical industry are poorly water-soluble (Lipinski, 2002). Size reduction of drug 
crystals increases the specific surface area, which can improve the dissolution rate of 
drugs according to the Noyes–Whitney equation (Noyes et al., 1897). Wet stirred media 
milling has found common use as a robust process to reduce micron-sized drug particles 
to nanoparticles, i.e., particles less than 1 μm (Bruno et al., 1996; Merisko-Liversidge et 
al., 2003). In this process, an aqueous suspension containing drug particles and dissolved 
stabilizers (polymer and/or surfactant) as well as hard beads is stirred at high speed by a 
rotor. Stabilizers are added to prevent the aggregation of milled drug particles and to 
inhibit particle growth (ripening) during milling/storage. An optimal stabilizer 
type/concentration, which ensures proper short- and long-term physical stability of a drug 
nanoparticle suspension, is usually obtained by stabilizer screening studies at the bench-
scale (Kesisoglou et al., 2007; Van Eerdenbrugh et al., 2008), where milling dynamics, 
process cycle times, and scale-up effects are not of major concern. To this end, milling in 
a planetary mill (Van Eerdenbrugh et al., 2009) or in a ball mill (e.g. Lee and Cheng, 
2006; Van Eerdenbrugh et al., 2007), both making use of vials containing drug 
suspensions with various stabilizers, has previously been described for their capability in 
obtaining nanoparticles. These mills are regarded as medium or low-energy mills; hence, 
suspension flow and microhydrodynamics are quite different in these mills than in the 
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wet stirred media mills. It is not surprising to see that the nanoparticles are produced after 
several hours to a few days of milling even at the bench scale with suspension quantities 
on the order of ~10 ml. In other screening studies, wet stirred media mills have been 
used: e.g. the Nanomill® System (e.g. Kesisoglou et al., 2007). However, the impact of 
stabilizers on the microhydrodynamics has not been reported. More importantly, as 
pointed out by Bhakay et al. (2011), most wet media milling work in pharmaceutical 
literature disregarded the breakage kinetics completely (e.g. Ain-Ai and Gupta, 2008; 
Tanaka et al., 2009). Other studies (Choi et al., 2008; Deng et al., 2008; Lee et al., 2008) 
did not characterize the breakage kinetics and its relationship to the stabilizers 
quantitatively.  
While scant information is available regarding the impact of stabilizers on the 
breakage rate during wet stirred media milling, the microhydrodynamics, which is the 
study of the fluctuating motion of the beads in sheared suspensions, has not been 
investigated at all. The wet media milling has been largely treated as a “black-box” in 
pharmaceutical literature. It is known that high solids loading results in high suspension 
viscosity, which could dampen the collision of the milling beads, resulting in a reduced 
breakage rate (Knieke et al., 2010; Mende et al., 2003). Knieke et al. (2010) provided a 
semi-theoretical model based on the kinematic equations describing the relative motion 
of undeformed spheres (beads). However, their model does not allow calculation of the 
bead oscillation velocity and frequency, which fundamentally determine the breakage 
rate along with the material properties in a wet stirred media mill. Eskin et al. (2005a) 
developed a microhydrodynamic model to study the effects of stirring speed and bead 
size on the microhydrodynamics in a mixing tank with Rushton type paddles, which 
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provided significant insight into the experimentally observed impact of these process 
parameters on the breakage rate. However, this model has not been applied to the wet 
milling of drug suspensions with the goal of elucidating the impact of stabilizers such as 
viscous dampening of the polymers.   
This chapter is a first attempt to develop a fundamental understanding of the roles 
of a cellulosic polymer (hydroxypropyl cellulose, HPC) on the apparent breakage rate of 
griseofulvin (GF), a model poorly water-soluble drug, in the presence–absence of an 
anionic surfactant (sodium dodecyl sulfate, SDS) during wet stirred media milling. The 
major novelty here is the use of a combined microhydrodynamics–polymer adsorption 
analysis. To this end, temporal evolution of the particle size during milling was 
investigated as a function of HPC concentration, in the presence and absence of SDS. The 
particle size data were analyzed via an empirical rate model to quantify the overall 
apparent breakage rate. Particle sizing via laser diffraction, scanning electron microscopy 
(SEM), and rheometry were used to characterize the milled suspensions. Another novelty 
is that unlike most wet media milling studies that solely relied on particle sizing. This 
chapter examined the aggregation state of the milled suspensions via both laser 
diffraction and rheometry. HPC adsorption on GF particles was determined using a 
thermo-gravimetric method. The viscosity of the milled suspensions was measured and 
used in the microhydrodynamic model. In the absence of SDS, an increase in HPC 
concentration reduced the extent/rate of particle aggregation leading to faster apparent 
breakage. On the other hand, due to a synergistic stabilizing action of HPC with SDS, 
lower HPC concentration was needed to stabilize the suspensions, and an optimum HPC 
concentration for the fastest apparent breakage was found. The microhydrodynamic 
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analysis quantified the viscous dampening effect of HPC, while only the combined 
analysis could explain the experimentally observed optimum.  
 
 3.2 Experimental 
 
3.2.1 Materials 
Griseofulvin (GF, Cat# 606440, US Pharmacopeia, Letco Medical, Livonia, MI, USA) 
was used as a model BCS Class II drug because of its low solubility in water: 7.7 µg/ml 
(Merisko-Liversidge and Liversidge, 2011). A non- ionic cellulosic polymer, 
hydroxypropyl cellulose (HPC, Klucel® SL, Lot# NOH-4811, Nisso America Inc, New 
York, NY, USA) and an anionic surfactant, sodium dodecyl sulfate (SDS, 99% ACS 
reagent, Cas# 436143-100G, Sigma Aldrich, Bellefonte, PA, USA) were acquired due to 
their common use in wet media milling (Kesisoglou et al., 2007). Wear-resistant yttrium 
stabilized zirconia beads (Zirmil Y, Saint Gobain ZirPro, Mountainside, NJ, USA) with a 
median size of 430 µm were used as the media in the milling.  
 
3.2.2 Methods  
3.2.2.1 Preparation of GF Suspensions. Table 3.1 presents the suspension 
formulations used in this chapter. Throughout the chapter, all percentages (%) refer to 
w/w with respect to de- ionized (DI) water; suspension refers to drug particles with the 
stabilizer solution; and slurry refers to a combination of the beads and the drug 
suspension. The drug (GF) loading was 20 g GF per 200 g DI water (10%). Feed GF 
suspensions were prepared using a shear mixer (Cat#. 14–503 Fisher Scientific 
Pittsburgh, PA, USA) running at a fixed speed of 300 rpm. The required amount of 
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stabilizer(s) was dissolved in DI water for 60 min followed by dispersion of the GF 
powder in the stabilizer(s) solution for 30 min (except Run 1). The GF powder was 
dispersed in DI water for 30 min in Run 1.  
The wet stirred media mill used in this chapter was manufactured by Netzsch Fine 
Particle Technology, LLC. (Model: Microcer) (Exton, PA, USA). The schematic of the 
mill is shown in Figure 3.1. The milling chamber has a volume of 80 ml and is lined with 
zirconia. During the milling, a peristaltic pump recirculated the suspension between the 
holding tank and the milling chamber, while a 200 m screen kept the zirconia beads in 
the milling chamber allowing the passage of the drug suspension. Process parameters 
were selected based on previous work on the wet media milling of GF (Bhakay et a l., 
2012). The feed suspensions prepared using the shear mixer were poured into the holding 
tank and milled under the same conditions: bead loading of 50 ml (bulk), suspension flow 
rate of 126 ml/min, and stirrer (rotor) speed of 3200 rpm corresponding to a tip speed of 
11.7 m/s. Both the milling chamber and the holding tank were equipped with a cooling 
system (model number M1-.25A-11HFX, Advantage Engineering, Greenwood, IN, USA) 
to keep the suspension in the holding tank below 35 oC. Due to the relatively high HPC 
concentration, the heat dissipation rate in Runs 8, 9, 15, and 16 was high. To keep the 
temperature below 35 oC, the rotor was stopped twice in Runs 8 and 15 and several times 
in Runs 9 and 16 while the suspension continued to recirculate under cooling for few 
minutes. The experiments were resumed once the temperature in the holding tank reached 
~25 oC.  
Samples at several milling times were taken at the outlet of the milling chamber 
for particle sizing. The final suspensions (after 64 min milling) were tested for density 
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and shear viscosity, and they were refrigerated at 8 oC for a period of 7 days. Particle 
sizes right after milling and after 7 days of storage were compared to assess the physical 
stability of the suspensions.  
Table 3.1 Formulation used in the Wet Stirred Media Milling Experiments 
Run 
No. 
Drug 
Loading 
(% w/w)a 
HPC 
Concentration 
(% w/w)a 
SDS 
Concentration 
(% w/w)a 
1 10 — — 
2 10 — 0.5 
3 10 0.1 — 
4 10 0.5 — 
5 10 1 — 
6 10 2.5 — 
7 10 5 — 
8 10 10 — 
9 10 15 — 
10 10 0.1 0.5 
11 10 0.5 0.5 
12 10 1 0.5 
13 10 2.5 0.5 
14 10 5 0.5 
15 10 7.5 0.5 
16 10 10 0.5 
 17b 10 3 — 
 18b 10 3 0.5 
a % w/w with respect to de-ionized water. 
 b Runs 17–18 were performed as part of the adsorption study.  
 
3.2.2.2 Measurement of Power Input for the Microhydrodynamic Analysis. The 
power input per unit volume of the slurry, i.e., Pw, was measured during a milling 
experiment (Runs 5–9 and Runs 12–16), and an average value was reported. In the 
absence of the milling beads, the power input per unit volume of the suspension, i.e., εht, 
was also measured while each stabilizer solution with 10% GF particles was stirred at 
3200 rpm. In both cases, the no- load power value obtained from a dry run of the mill 
rotor at 3200 rpm was subtracted from the power values in the calculation of Pw and εht.  
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Figure 3.1 Schematic of the Netzsch stirred media mill (Model: Microcer) operating in 
the recirculation mode. P and T stand for pressure gauge and thermocouple, respectively.  
 
3.2.2.3 Particle Sizing. Particle size distributions were measured with the laser 
diffraction device LS 13 320 (Coulter Beckman, Brea, CA). A polarized intensity 
differential scattering (PIDS) obscuration water optical model was employed. The PIDS 
was maintained between 40% and 50% while the obscuration was maintained below 8% 
for all particle size measurements. Particle size distribution was computed by the 
software using the Mie scattering theory. A refractive index (RI) value of 1.65 for the GF 
particles (Watanabe, 2002) and 1.33 for the measurement medium (DI water) were used. 
Prior to the size measurement, milled suspension samples (~2 ml) were diluted with 10 
ml of DI water or solution of HPC, SDS, or HPC–SDS depending on the stabilizer(s) 
used in the milling experiment. The refrigerated suspension samples after 7-day storage 
were mixed with the shear mixer running at 300 rpm for 5 min. Then, ~2 ml samples 
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were taken and diluted for particle size measurement using the pertinent stabilizer 
solution. 
3.2.2.4 Scanning Electron Microscopy (SEM). SEM imaging was used to examine 
the morphology of the as-received and milled particles and to determine the primary 
particle sizes of the GF nanoparticles. Suspension samples were mounted on a silicon 
chip (Ted Pella, Inc., Redding, CA, USA), placed on top of carbon specimen holders, and 
dried in a desiccator. The samples were then sputter coated with carbon and observed 
under a LEO 1530 SVMP (Carl Zeiss, Inc., Peabody, MA, USA).  
3.2.2.5 Apparent Shear Viscosity and Density of the Milled Suspensions. The 
apparent shear viscosity of the milled suspensions (Runs 5–9 and Runs 12–16) and the 
stabilizer(s) solutions was measured using an R/S plus rheometer (Brookfield 
Engineering, Middleboro, MA, USA) with a water jacket assembly Lauda Eco (Lauda-
Brinkmann LP, Delran, NJ, USA). A coaxial cylinder (CC40) was used to impart 
controlled shear rate on the samples from 0 to 1000 1/s in 60 s. The temperature of the 
jacket was kept constant at 25 ± 0.5 oC. The raw data were analyzed using the Rheo 3000 
software (Brookfield Engineering, Middleboro, MA, USA) of the R/S plus rheometer to 
obtain the apparent shear viscosity as a function of the shear rate. The suspensions with 
very low HPC concentration (< 1%) (Runs 3–4; 10–11) could not be tested precisely by 
this rheometer set-up since the viscosity was very low (< 4 cP). The density of the milled 
suspensions (Runs 5–9; Runs 12–16) were experimentally determined using a 60 ml glass 
cylinder (Cat#. 08-559D Fisher Scientific, Pittsburgh, PA, USA) for volume 
measurements and a digital scale balance Adventurer-Pro (Ohaus Corporation, 
Parsippany, NJ, USA) to obtain the weights. The weight was divided by the volume to 
 
 
 
  38 
 
obtain the density. Average value of three measurements on each suspension was 
reported.  
3.2.2.6 Differential Scanning Calorimetry (DSC). The melting point and heat of fusion 
of the as-received GF powders and dried GF suspension (Run 1) were determined using a 
Mettler-Toledo POLYDSC (Mettler Toledo Inc., Columbus, OH, USA). A sample of 9–
10 mg powder was placed in a sealed perforated aluminum pan. The samples were heated 
under nitrogen flow from 25 °C to 300 °C with a rate of 10 °C/min.  
3.2.2.7 Determination of the Polymer Adsorption on Milled GF Particles. Fresh 
GF suspensions with 0.1–10% HPC concentration in the absence and presence of 0.5% 
SDS (Runs 3–8 and 10–16, respectively) were prepared by milling with similar 
conditions to those described in Section 3.2.1. A 10 min milling yielded Sauter-mean 
diameter values in the range of ~0.4–1.0 m, which allowed easier separation of these 
particles from the suspensions during the centrifugation step. Two additional suspensions 
with 3% HPC were produced similarly: one without SDS and the other one with 0.5% 
SDS (Runs 17 and 18). The adsorption isotherms were determined using a thermo-
gravimetric technique (Lee, 2003; Panmai and Deshpande, 2003). Each suspension was 
centrifuged (Sorvall RS-28S, DuPont Company, Wilmington, Delaware, USA) at 20,000 
rpm for about 6 h. The supernatant solution was assayed for stabilizer content using a 
thermogravimetric analyzer (TGA): Mettler-Toledo TGA/DSC1/SF, Stare system 
(Mettler Toledo Inc., Columbus, OH, USA). A sample (30–80 mg) taken from the 
supernatant solution was heated to 200 °C under nitrogen environment with a heating rate 
of 10 °C/min to remove the water and determine the residual weight. The stabilizer 
concentration in the supernatant solution was determined using the initial weight and the 
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residual weight. The amount of stabilizer adsorbed per mass of the GF particles was 
back-calculated by subtracting the stabilizer concentration in the supernatant solution 
from the total stabilizer concentration in the suspension sample. Assuming sphericity of 
the GF particles, the external specific surface area (S) was calculated from S = 6/(pdsm), 
where p is the true density of GF (1.45 g/cm
3) and dsm is the Sauter-mean diameter of the 
milled particles, which was obtained from the laser diffraction measurement. The S value 
was used to express the amount of HPC adsorbed per GF surface area.    
 
3.3 Results and Discussion 
 
3.3.1 Main Role of Polymers and Surfactants: Stabilization/Dispersion 
Polymers and surfactants play a major role in two phenomena that determine the apparent 
breakage rate during wet media milling: stabilization/dispersion of the milled drug 
particles (Kim, 2004; Kissa, 1999) and microhydrodynamics of the milling beads (Eskin 
et al., 2005a) as affected by the suspension rheology. To elucidate the main role of the 
stabilizers, milling was performed in the absence (Run 1)/presence (Runs 2, 6, and 13) of 
stabilizers. Figure 3.2a shows the evolution of the GF particle size distribution (PSD) 
during milling as measured by the laser diffraction method when stabilizers were not 
used. The GF particles exhibited a bimodal PSD after milling; the shoulder in the 100–
400 nm region suggests the existence of primary nanoparticles and some small aggregates 
of few primary particles. Although the fraction of particles in this region increased 
slightly upon prolonged milling, overall the PSD did not seem to change after 4 min 
milling.  
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Figure 3.2 (a) Evolution of the cumulative particle size distribution of GF suspension 
milled in the absence of stabilizers (Run 1), (b) cumulative particle size distribution o f 
the unmilled GF suspension without stabilizers and various 64 min milled       
suspensions: without HPC or SDS (Run 1), with 2.5% HPC (Run 6), with 0.5% SDS 
(Run 2), and with 2.5% HPC and 0.5% SDS (Run 13). 
 
SEM images of the unmilled and milled GF particles in Figure 3.3a–c confirm the 
breakage of the GF particles and formation of 50–250 nm primary particles. A 
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comparison of LD results and SEM images suggests that GF nanoparticles were formed 
by breakage; however, they aggregated fast via attractive interparticle forces (van der 
Waals) in the absence of stabilizers. Hence, it can be noted that GF nanoparticles can 
form even in the absence of stabilizers; however, the so-produced nanoparticles cannot be 
preserved against aggregation.  
 
Figure 3.3 SEM image of (a) the as-received GF particles (marker size: 20 m,1 kX 
magnification), (b) the GF particles milled for 64 min without stabilizers (Run 1, marker 
size: 1 m, 46 kX magnification), (c) the GF particles milled for 64 min without 
stabilizers at a higher magnification (Run 1, marker size: 200  nm, 131 kX magnification) 
, (d) the GF particles milled for 64 min with 2.5% HPC and 0.5% SDS (Run 13, marker 
size: 200 nm, 131 kX magnification).  
 
In general, polymers and surfactants adsorb on particle surfaces, providing a steric 
or electrostatic barrier (Merisko-Liversidge et al., 2003; Ploehn and Russel, 1990). In 
addition, they allow proper wetting of the hydrophobic drug surfaces, which can help to 
disperse aggregates formed during the milling process (Kissa, 1999). Various 
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concentrations of stabilizers (0.5% SDS (Run 2), 2.5% HPC (Run 6), and 2.5% 
HPC/0.5% SDS (Run 13)) were used to elucidate their stabilizing roles. Figure 3.2b 
illustrates that finer GF particles were obtained after 64 min milling when the stabilizers 
were used. In view of the median size of Run 1 suspension (4.725 m), the addition of 
2.5% HPC alone (Run 6) improved the dispersion of the nanoparticles, leading to a 
smaller median size (1.599 m). HPC, an electrically neutral polymer, stabilizes particles 
by steric forces that are created by the long-tail interference of adsorbed protruding large 
chains onto the particle surfaces (Stuart, 1991). The median particle size of GF was 
reduced to 0.273 m in the presence of SDS alone (Run 2). SDS (an anionic surfactant) 
appears to disperse the nanoparticles more effectively than HPC (a non- ionic cellulosic 
polymer). SDS has a smaller molecular weight than HPC and thus diffuses and adsorbs to 
the drug particle surfaces faster. In addition, being an anionic surfactant, SDS can make 
the GF particles negatively charged after adsorption and increase the electrostatic 
repulsion among the GF particles, thereby preventing the aggregation. 
Figure 3.2b also shows that a combination of HPC–SDS (2.5% HPC and 0.5% 
SDS, Run 13) led to the narrowest PSD and smallest d50 and d90 values (0.163 and 0.211 
m). HPC–SDS mixtures are known to have synergistic effects in the stabilization of 
drug suspensions (Basa et al., 2008; Lee et al., 2008; Ryde and Ruddy, 2002). HPC and 
SDS interact, forming aggregates or micelle-like SDS clusters bound to HPC (Winnik 
and Winnik, 1990). These clusters can co-adsorb on surfaces (Berglund et al., 2003a, 
2003b; Evertsson and Nilsson, 1997), potentially facilitating adsorption of HPC (Cerdeira 
et al., 2010) and enabling electrosteric stabilization. The SEM image (Figure 3.3d) shows 
the primary GF nanoparticles in the size range of 50–250 nm. Along with the LD results, 
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where the d50 and d90 sizes after 64 min milling were 0.163 and 0.211 m (Figure 3.2b, 
Run 13), the SEM image suggests that the HPC–SDS stabilized suspension had relatively 
small extent of aggregation. GF primary particle sizes in the absence or presence of 
stabilizers was in the range of 50–250 nm, as seen in the SEM images (Figures 3.3c and 
3.3d, respectively), which suggest that stabilizer(s) are needed to disperse the 
nanoparticle aggregates. A combination of stabilizers (HPC–SDS) can help to disperse 
the aggregated nanoparticles effectively. On the other hand, a slight reduction in the 
fraction of GF nanoparticles in the <100 nm size range when SDS was used at 0.5%, 
above the critical micelle concentration (CMC) of 0.23%, either alone or along with HPC 
is observed. The aqueous solubility of GF increases above the CMC of SDS (Rao et al., 
1997), which may cause preferential loss of <100 nm particles due to enhanced 
dissolution or aggregation. 
The reproducibility of the wet media milling process was checked by repeat 
experiments of Run 2 (0.5% SDS), Run 6 (2.5% HPC), and Run 13 (0.5% SDS/2.5% 
HPC). The d50 and d90 values of the repeat experiments were 0.289 and 0.532 m, 1.765 
and 3.182 m, and 0.163 and 0.207 m, respectively. The (absolute) percent deviations 
from the d50 and d90 values were all less than 10%: 5.86 and 5.51%, 10.4 and 6.89%, and 
0.0 and 1.90%, respectively. Hence, the particle size statistics were fa irly reproducible. In 
general, the reproducibility was better for the suspensions with a smaller extent of 
aggregation (Runs 2 and 13 vs. Run 6). Excellent reproducibility observed for the 
suspension with HPC–SDS combination and higher variability observed  for the 
suspension with HPC alone agree with the recent work on the wet media milling of 
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griseofulvin, naproxen, and azodicarbonamide suspensions containing HPC or HPMC in 
the presence/absence of SDS (Bhakay et al., 2011, 2013; Monteiro et al., 2013).  
The DSC thermograms of the as-received GF particles and milled GF particles 
exhibited a sharp endothermic peak associated with the melting of the crystalline GF 
(Figure 3.4). The peak melting temperature decreased slightly from 219.3 oC (as-received 
GF powder) to 217.5 oC after milling (Run 1), while the heat of fusion did not change 
much: 115 J/g to 113 J/g. These results indicate that a significant change to the 
crystallinity of GF did not occur during the wet milling. Readers are referred to Monteiro 
et al. (2013) for a more detailed characterization using powder-XRD and Raman 
spectroscopy on milled GF particles, which supported the above finding.  
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Figure 3.4 DSC thermograms of the as-received GF particles and 64 min milled GF 
particles in the absence of stabilizers (Run 1).  
 
3.3.2 Analysis of the Apparent Breakage Kinetics 
To investigate the role of HPC in the apparent breakage rate, a wide range of HPC 
concentrations was considered in the absence/presence of SDS. Figures 3.5a and 3.5b 
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illustrate the evolution of the median particle size (d50) and the 90% passing size (d90) as 
a function of HPC concentration: 0.1–2.5% (Runs 3–6) and 2.5–15% (Runs 6–9), 
respectively, in the absence of SDS. Figures 3.6a and 3.6b present the same information 
as a function of HPC concentration: 0.1–2.5% (Runs 10–13) and 2.5–10% (Runs 13–16), 
respectively, in the presence of 0.5% SDS. Table 3.2 presents the particle size statistics 
for the suspensions that were milled for 16 min and 64 min.  
3.3.2.1 Effects of HPC in the Absence of SDS. Both d50 and d90 decreased fast 
within the first 4 min as the large micron-sized GF particles were easier to break (Figure 
3.5). As milling continued, the apparent breakage rate decreased, and the particle size  
exhibited either a clear minimum followed by an increase or varied about a plateau size. 
This non-monotonic evolution of the particle size cannot be explained by pure breakage 
of the particles. The GF suspensions with HPC as the sole stabilizer, even after prolonged 
milling (64 min), did not have d90 less than 1 µm. Moreover, the suspensions with 0.1–
2.5% HPC had median sizes greater than 1 µm. Both d50 and d90 after 16 min and 64 min 
milling were smaller at higher HPC concentration (Table 3.2, Runs 3–9), which suggests 
that the overall apparent breakage rate increased with an increase in the HPC 
concentration. Considering that 50–250 nm primary GF nanoparticles were produced 
even in the absence of stabilizers (Figure 3.3c), the findings here imply the significant 
impact of the particle aggregation in the apparent breakage rate and the particle size of 
the final milled suspension.   
During wet stirred media milling, two particle change mechanisms act 
simultaneously: breakage of as-received particles, fragments of already broken particles 
as well as aggregates (also known as deaggregation) and aggregation of the particles 
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(Bilgili et al., 2004; Sommer et al., 2006). The particle size distribution at a given time 
reflects the net effect of the competing breakage and aggregation mechanisms (Monteiro 
et al., 2013). During the course of milling (Runs 3–9), the particle size decreased initially 
within the first 4 min and increased/decreased instantaneously thereafter and seemed to 
approach or varied around a large plateau size because the aggregation rate of the 
produced fine particles equaled or exceeded the rate at which the particles and aggregates  
broke upon prolonged milling. Initially, the breakage was faster than the aggregation due 
to the presence of relatively large (micron-sized), weaker GF particles.  
As milling progressed, the aggregation rate increased upon production of finer 
(colloidal) drug particles because steric stabilization imparted by HPC alone was not 
sufficient to keep the freshly formed nanoparticles discrete. Moreover, as the drug 
particle size decreased, particle number concentration in the suspension increased and the 
interparticle distance decreased, leading to more frequent collisions and potentially 
higher aggregation rate (Sommer et al., 2006). An increase in HPC concentration reduced 
the extent and rate of the aggregation, which resulted in finer particles and a higher 
apparent breakage rate.  
3.3.2.2 Effects of HPC in the Presence of SDS. Unlike the evolution of d50 and d90 in 
the absence of SDS (Figure 3.5), the evolution of both d50 and d90 exhibited a monotonic 
decrease in the presence of SDS (Figure 3.6). For the formulations with SDS (Runs 10–
16), Table 3.2 shows that the suspensions with an HPC concentration greater than 0.5% 
reached identical particle size after 64 min (within experimental accuracy), and all 
suspensions reached ~160 nm median size after 64 min milling (except Run 10, with the 
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lowest HPC concentration). All of the suspensions had d50 and d90 values less than 1 m 
after 64 min. 
Table 3.2 Effects of the HPC Concentration on the Median Size (d50) and 90% Passing 
Size (d90) of the GF Suspensions for Runs 1–9 (without SDS) and Runs 10–16 (with 
0.5% SDS) After 16 and 64 min Milling and After 7 Day Storage 
Run 
No. 
HPC 
Concentration 
(% w/w) 
Milled (16 min) 
d50 (µm), d90 (µm) 
Milled (64 min) 
d50 (µm), d90 (µm) 
7 day storage 
d50 (µm), d90 (µm) 
1 — 4.586, 7.995 4.725, 9.023 4.416, 7.568 
  2a — 0.648, 1.723 0.273, 0.563 0.279, 0.543 
3 0.1 2.976, 5.295 2.895, 5.173 2.318, 4.265 
4 0.5 2.334, 4.855 2.189, 4.362 2.173, 4.127 
5 1 2.001, 3.932 2.030, 3.721 NMb 
6 2.5 1.588, 2.894 1.599, 2.977 1.684, 3.709 
7 5 1.117, 2.176 0.473, 1.762 1.178, 2.327 
8 10 0.559, 2.022 0.358, 1.425 0.390, 1.725 
9 15 0.426, 1.460 0.300, 1.125 0.332, 1.176 
10 0.1 0.419, 1.442 0.274, 0.469 0.257, 0.510 
11 0.5 0.450, 1.470 0.165, 0.394 0.197, 0.442 
12 1 0.441, 1.483 0.154, 0.238 0.158, 0.258 
13 2.5 0.256, 0.476 0.163, 0.211 0.164, 0.214 
14 5 0.315, 0.577 0.162, 0.221 0.161, 0.228 
15 7.5 0.367, 0.670 0.165, 0.235 0.173, 0.250 
16 10 0.399, 1.170 0.161, 0.237 0.190, 0.314 
aThis run has 0.5% SDS and included here for comparative purpose.  
bNM: not measured.                         
 
In view of the 50–250 nm primary particles produced in Run 13 (Figure 3.3d) and the 
above information, the extent of aggregation in the 64 min milled suspensions was low, 
and the breakage mechanism dominated over the aggregation mechanism when SDS was 
used in combination with HPC. Moreover, the presence of SDS allowed a much lower 
concentration of HPC (as low as 1%) that can ensure the formation of a stable GF 
nanosuspension. This finding can be explained by the aforementioned synergistic 
stabilizing action of the HPC–SDS combination (Section 3.4.1). 
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Figure 3.5 Effects of the HPC concentration on the evolution of d50 and d90 during the milling of the GF particles in the absence of 
SDS: (a) 0.1–2.5% HPC (Runs 3–6), (b) 2.5–15% HPC (Runs 6–9).  
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The particle size decreased fast within the first 8 min (Figure 3.6). The apparent 
breakage rate decreased with further milling and the particle size approached or reached a 
plateau size: d50 value of ~160 nm and d90 value of ~220 nm for HPC concentration 
greater than 0.5%. The monotonic decrease of the particle size and tendency toward a 
plateau size signify the dominance or higher extent of particle breakage over particle 
aggregation for these relatively stable suspensions. For prolonged milling, a plateau size 
is theoretically expected for two reasons: a dynamic equilibrium between the particle 
breakage and aggregation can be established (Bhakay et al., 2011) and the true breakage 
rate decreases upon generation of finer particles, especially nanoparticles, which are more 
difficult to break stemming from their high strength (Lee, 2003; Bilgili et al., 2006). 
Since a plateau size was approached after 64 min milling, the apparent breakage rate may 
be conveniently assessed considering the particle size at an earlier time point, e.g., 16 min 
of milling in Table 3.2 and Figure 3.6. Within the HPC range studied, an optimum HPC 
concentration of 2.5% was identified, which yielded the smallest d50 and d90 at 16 min. 
The larger values of d50 and d90 for the other HPC concentration values can be explained 
as follows: below 2.5% HPC, the particle aggregation might have occurred to a larger 
extent leading to slower apparent breakage, whereas the viscous dampening effect might 
have reduced the true breakage rate and led to the formation of coarser particles for the 
relatively more stable suspensions with an HPC concentration above 2.5%. These aspects 
will be elucidated in Section 3.4.7 using the combined microhydrodynamics–polymer 
adsorption analysis. The result suggests that 2.5% is the optimal HPC concentration in 
view of the HPC concentrations studied. Finding a more accurate and precise value of the 
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optimum polymer concentration entails additional milling experiments with many more 
HPC concentrations within the 1–5% range. However, since an emphasis is on the 
qualitative nature of this optimum, this aspect will not be studied.     
To confirm the optimality of 2.5% HPC in the presence of SDS, a quantitative 
analysis of the breakage rate, which considers all milling time points including 16 min, 
was performed using the two-parameter empirical model (Section 3.1). The evolution of 
the median size in Runs 12–16 (1–10% HPC), excluding runs with 0.1 and 0.5% HPC, 
was fitted to minimize the confounding effect of the particle aggregation and to improve 
the goodness-of- fit and statistical significance of the parameters. Table 3.3 presents the 
values of the parameters dlim and τp (see Chapter 2.3) and the coefficient of determination 
(R2). For all fits, R2 value was greater than 0.90 and the empirical model was statistically 
significant (p-value < 0.05). In addition, all p-values for the parameters estimated were 
found to be less than 0.005, proving the statistical significance of the parameter estimates. 
The process time constant τp correlates negatively with the overall apparent breakage 
rate: a larger τp indicates a slower apparent breakage during the milling.      
Table 3.3 confirms the aforementioned result obtained from the analysis of 16 
min milling data: 2.5% HPC concentration led to the fastest apparent breakage. The 
monotonic increase of τp with an increase in HPC concentration from 2.5% to 10% could 
be attributed to greater viscous dampening of the beads and resultant slower particle 
breakage. The estimated dlim values were about 200 nm (Table 3.3) and slightly greater 
than the experimental d50 values obtained after 64 min milling (Table 3.2), suggesting a 
limitation of the simple empirical model expressed by Eq. (2.7). 
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Figure 3.6 Effects of the HPC concentration on the evolution of d50 and d90 of the GF particles in the presence of 0.5% SDS: (a) 0.1–
2.5% HPC (Runs 10–13), (b) 2.5–10% HPC (Runs 13–16).  
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This deviation is the largest for Run 12 (1% HPC) among Runs 12–16, which may 
suggest that the deviation can be partly explained by the presence of particle aggregation. 
Experimental errors may also partly explain the deviation: experimental d50 values (64 
min) were still within 2 standard deviations of the estimated dlim, which were quantified 
by the coefficient of variation (COV) values.  
Table 3.3 Fit of the Empirical Model (Eq. (2.7)) to the Evolution of the Median Particle 
Size in Runs 12–16 (with 0.5% SDS) 
Run 
No. 
HPC 
Concentration 
(% w/w) 
dlim, COV% 
(µm), (–) 
τp, COV% 
(min), (–) 
R2 
(–) 
12 1 0.239 (20.7) 4.33 (23.6) 0.919 
13 2.5 0.194 (14.4) 2.22 (15.7) 0.960 
14 5 0.202 (20.0) 2.45 (18.4) 0.940 
15 7.5 0.218 (14.5) 3.90 (15.9) 0.962 
16 10 0.209 (16.4) 5.40 (16.6) 0.961 
 
3.3.3 Physical Stability of the Milled Suspensions  
Milled GF suspensions were refrigerated at 8 oC for a period of 7 days to examine the 
aging effects. In the absence of SDS, the size-dependence of the aged particles on the 
HPC concentration followed the same trend as that for 64 min milled suspensions: 
smaller particle size at higher HPC concentration (Table 3.2). Interestingly, upon storage, 
the particle size increased for the milled suspensions with an HPC concentration greater 
than 1% (Runs 6–9), while it decreased for the milled suspensions with 0%, 0.1%, and 
0.5% HPC (Runs 1, 3, and 4). It must be noted that the latter group of suspensions had 
such a low viscosity (less than 4 cP) that could not be measured reliably with the current 
rheometer set-up. After refrigerated storage for 7 days, the suspensions were mixed using 
a shear mixer for 5 min at 300 rpm to obtain a homogeneous sample for particle sizing. 
Due to the very low viscosity and presence of a appreciable fraction of large and weak 
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aggregates (>3–4 m after milling and storage), Runs 1, 3, and 4 suspensions were 
subjected to higher shear, leading to the breakage of the large aggregates and reduction in 
d50 and d90. On the other hand, Runs 6–9 suspensions were more viscous and subjected to 
lower shear rate at the same rotation rate (300 rpm). Since they had a much smaller 
fraction of large aggregates after milling, the low shear did not lead to significa nt 
breakage; hence, an increase in d50 and d90 was observed possibly due to Brownian 
aggregation during the storage. It should be noted that this shear rate dependence of the 
particle size of 7-day stored GF suspensions was mainly a consequence of the high extent 
of aggregation in these relatively less stable suspensions with HPC as the sole stabilizer 
and the relatively high speed of the mixer.   
In the presence of SDS, the particle size of the milled suspensions increased 
slightly after 7-day storage (Table 3.2) because of the synergistic stabilizing action of the 
HPC–SDS combination, except at the very low HPC concentrations (0.1% and 0.5%). 
The particle sizes (d50 and d90) measured by the laser diffraction were similar to the 
primary nanoparticle size range of 50–250 nm observed in Figure 3.3d, suggesting 
minimal or limited extent of aggregation in these suspensions. It appears that Ostwald 
ripening was not a serious issue during the 7-day refrigerated storage of these 
suspensions. Long-term stability of these suspensions was not investigated here as they 
were intended to be dried shortly after the milling (Bhakay et al., 2013; Sievens-Figueroa 
et al., 2012). 
 
 
 
 
 
 
  54 
 
3.3.4 Polymer Adsorption on Milled GF Particles 
To gain a deeper understanding of the steric stabilization imparted by HPC, HPC 
adsorption on the milled GF particles was studied in the absence/presence of SDS. HPC 
concentration in the GF suspension determines the maximum amount of HPC that can 
possibly adsorb on the GF particles and the thickness of the HPC layer. A thicker layer of 
the adsorbed polymer and strong adsorption are desirable for good steric stability (Lee, 
2003). In the absence of SDS, the amount of HPC adsorbed per surface area of the GF 
particles increased with an increase in the total HPC concentration from 0.1% to 0.5% 
(Figure 3.7). It continued to increase and appeared to reach a plateau at about 2.5–3% 
HPC. Beyond 3%, the adsorption resumed to increase. One explanation may be that 
mono-layer adsorption occurred up to 3% HPC (mono-layer saturation) followed by 
multilayer adsorption. Similar observations were made about the HPC adsorption onto 
ibuprofen particles (Law and Kayes, 1983). The monotonic increase in the amount of 
HPC adsorbed with an increase in HPC concentration means a monotonic increase in the 
adsorbed HPC layer thickness and thus better steric stability. This enhanced steric 
stability at higher HPC concentration reduced the aggregation probability of the colliding 
GF particles, leading to the monotonic decrease in d50 and d90 (Table 3.2). In addition, an 
increase in HPC concentration led to a higher suspension viscosity (Section 3.4.5), which 
can reduce the collision rate among the GF particles and thus the aggregation rate 
(Sommer et al., 2006). In spite of all the positive effects associated with the use of a 
higher HPC concentration, the particle aggregation was not completely suppressed with 
the use of HPC even at the highest concentration (15%). An insufficient layer thickness 
on the GF particle surfaces, slow adsorption of large HPC molecules during milling, and 
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small repulsive forces stemming from the non- ionic nature of HPC and small surface 
charge of GF particles in aqueous cellulosic suspensions (Meng et al., 2011) could 
explain the inadequacy of HPC.  
Adsorption of HPC on GF particles in the presence of 0.5% SDS was also studied 
to explain the synergistic effects observed during the milling (Figure 3.7). The amount of 
stabilizers (mostly HPC) adsorbed on the hydrophobic surfaces of the GF particles 
monotonically increased with an increase in the HPC concentration. The amount 
adsorbed was much higher in the presence of SDS potentially due to the co-adsorption of 
SDS with HPC and the facilitation of HPC adsorption by SDS, which was suggested 
earlier by Cerdeira et al. (2010) for HPC adsorption on miconazole particles in the 
presence of SDS. The co-adsorbed layers can impart electrosteric stabilization to the GF 
particles. Strictly speaking, the amount of stabilizers adsorbed reflects the contributions 
from both HPC and SDS. On the other hand, since SDS concentration was kept constant 
at 0.5%, the dramatic increase of the amount adsorbed above 0.5% HPC can only be 
explained by the enhanced adsorption of HPC and the amount adsorbed is mainly 
contributed by HPC. Regardless of the underlying mechanisms for the observed 
enhancement in the adsorption, the presence of SDS could allow formation of a thicker 
HPC–SDS layer at higher HPC concentration, leading to enhanced electrosteric 
stabilization.  
The adsorption isotherms presented in Figure 3.7 explain the synergistic effects of 
the HPC–SDS combination, the larger d50 and d90 values of the milled suspensions with 
HPC concentration less than 1% and the large τp value of Run 12 as well as the relatively 
good physical stability of the suspensions with >1% HPC. At higher HPC concentrations, 
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the shear viscosity of the suspensions were higher (see below), which could reduce the 
collision rate of the GF particles, leading to a reduced aggregation rate besides the lower 
aggregation probability (thicker HPC–SDS layer). Interestingly, since the adsorption 
isotherm is a monotonically increasing function of the HPC concentration when 0.5% 
SDS is present, the optimal HPC concentration (2.5%) cannot be explained by the 
isotherm alone.    
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Figure 3.7 Adsorption of HPC on milled GF particles in the absence (Runs 3–8 and 17) 
and presence (Runs 10–16 and 18) of 0.5% SDS. 
 
3.3.5 Suspension Rheology and Assessment of the Aggregation State 
The apparent shear viscosities of aqueous HPC solutions (without GF) and 64 min milled 
GF suspensions (Runs 5–9) without SDS were measured as a function of shear rate at 
various HPC concentrations and presented in Figures 3.8a and 3.8b, respectively. An 
increase in HPC concentration significantly increased the viscosity in the absence or 
presence of the milled GF particles. In general, as the shear rate was increased, the 
viscosity of the HPC solutions decreased significantly (shear-thinning behavior) and 
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tended to an asymptotic value (Newtonian fluid behavior) above a shear rate of 500 1/s 
(Figure 3.8a). A slight increase in the viscosity was observed for the 1% HPC solution 
above 400 1/s shear rate. The milled suspensions had higher viscosity and exhibited 
stronger shear-thinning behavior that was prevalent up to 1000 1/s as compared with the 
HPC solutions. The approach to an asymptotic viscosity was delayed, and the decrease of 
viscosity above 500 1/s was still notable. These findings accord well with other studies in 
literature and could be attributed to the higher extent of aggregate breakage 
(deaggregation) at higher shear rates (Barthelmes et al., 2003; Bernhardt et al., 1999). 
Presence of aggregates, which can occlude liquid in their void space, increases the 
effective volume fraction of the solid in a suspension with fixed solids loading. Hence, in 
general, an aggregated suspension has a higher shear viscosity than a fully-dispersed 
suspension consisting of discrete primary particles. Since the GF aggregates broke more 
extensively at higher shear rates, the apparent shear viscosity decreased with an increase 
in the shear rate. As a crude measure of shear-thinning, the ratio of shear viscosity at a 
low shear rate (s) to that at a high shear rate (1000 1/s), i.e., L0/L, was calculated. 
The ratio decreased from 8.2 (1% HPC) to 1.6 (15% HPC) monotonically, which 
suggests a less pronounced shear-thinning behavior, thus signifying a less aggregated 
state of the GF suspensions at higher HPC concentrations. The same behavior can be seen 
from the absolute value of the slope of the viscosity curve on semi- log axes (Figure 3.8b): 
as the HPC concentration was increased, the absolute value of the slope decreased at a 
given shear rate (e.g. 250 1/s). The viscosity measurements independently confirmed the 
aggregation state of the milled suspensions, agreeing well with the laser diffraction data 
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(Table 3.2). Both methods suggest that the extent of aggregation decreased monotonically 
when the milled suspension had a higher HPC concentration.  
In order to investigate the impact of HPC–SDS combination on the suspension 
rheology, the apparent shear viscosity was obtained as a function of shear rate in the 
absence (solution) and presence of GF (milled suspension) (see Figures 3.8c and 3.8d, 
respectively). An increase in HPC concentration increased the viscosity significantly in 
the absence or presence of the milled GF particles. A comparison of Figures 3.8a and 
3.8c shows that addition of SDS to an HPC solution increased the viscosity significantly, 
which can be attributed to the formation of HPC–SDS aggregates or micelle- like SDS 
clusters bound to the polymer (Berglund et al., 2003a; Evertsson and Nilsson, 1997; 
Winnik and Winnik, 1990). 
Unlike the viscosity profiles presented in Figures 3.8a and 3.8b (no SDS), the 
viscosity of a milled suspension was lower than that of the HPC–SDS solution (Figures 
3.8c and 3.8d). This finding can be explained by the relatively well-dispersed nature of 
the GF suspensions with HPC–SDS (less number of smaller aggregates) and the reduced 
concentration of HPC–SDS in the bulk solution of the GF suspensions due to enhanced 
HPC adsorption, as mentioned above. Moreover, a comparison of the absolute value of 
the slope of the viscosity curves in Figures 3.8b and 3.8d suggests that at the same HPC 
concentration, the shear thinning behavior was weaker (flatter curves) in the presence of 
SDS. Figure 3.8d also illustrates that the apparent viscosity of the milled suspensions 
tends to plateau at low shear rates, exhibiting a near-Newtonian behavior. Similarly, the 
shear viscosity ratioL0/L) was lower (0.9–1.8) in the presence of SDS than in its 
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absence (1.6–8.2). These results agree with the laser diffraction results in that the milled 
suspensions with HPC–SDS were better dispersed and more stable.  
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Figure 3.8 Effects of the HPC concentration on the apparent shear viscosity as a function 
of the shear rate for (a) the HPC solutions without SDS, (b) 64 min milled GF 
suspensions without SDS (Runs 5–9), (c) the HPC solutions with 0.5% SDS, (d) 64 min 
milled GF suspensions with 0.5% SDS (Runs 12–16). 
 
3.3.6 Microhydrodynamic Analysis of the Wet Stirred Media Milling Process 
A microhydrodynamic analysis was performed to further elucidate the impact of the HPC 
concentration and absence (Runs 5–9)/presence (Runs 12–16) of SDS. Table 3.4 presents 
the power input (Pw and εht), density and shear viscosity of the milled suspensions (L and 
µL), and the microhydrodynamic parameters (, , and ub) (see Chapter 2.4). The power 
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applied by the rotor in the presence of the beads (Pw) and in the absence of the beads (εht) 
monotonically increased with an increase in the HPC concentration, which can be 
explained by a corresponding increase in the suspension viscosity. On the other hand, for 
the same reason, the granular temperature (), average bead oscillation velocity (ub), and 
the single bead frequency () monotonically decreased. Hence, the microhydrodynamic 
analysis has enabled the quantification of the viscous dampening effect of HPC during 
the wet media milling of drugs for the first time. The decrease in the values of  , , and 
ub at higher HPC concentration correlates to a reduction in the number and intensity of 
the bead–bead collisions, which implies a smaller number of less intense compression 
events during which the GF particles are deformed and/or broken by the colliding beads 
during milling. The general trends for the effects of HPC concentration on the power 
input and the microhydrodynamic parameters were similar regardless of the 
absence/presence of 0.5% SDS. However, the use of SDS in addition to HPC has a 
negative effect on the microhydrodynamic parameters, as suggested by the lower  , , 
and ub values (except at 1% HPC). The higher viscosity of the milled suspensions with 
HPC–SDS can explain this negative effect even though Pw values were also higher in the 
presence of SDS.  
Although the decrease in  , , and ub values at higher HPC concentration 
(viscous dampening) suggests a decrease in the breakage rate of the GF particles, the 
overall apparent breakage rate presented in Table 3.2 and Figure 3.5 suggests otherwise 
(Section 3.3.2.1). Hence, in the absence of SDS, the apparent breakage kinetics and final 
particle size distribution of the milled GF suspensions, with HPC as the steric stabilizer, 
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are affected more by the rate–extent of the particle aggregation than the viscous 
dampening observed at the higher HPC concentration.  
 
3.3.7 Combined Microhydrodynamics–Polymer Adsorption Analysis 
Figure 3.9 summarizes the effects of HPC concentration, in the presence of SDS, on the 
median size after 16 min milling, the characteristic process time constant estimated by the 
empirical model, the adsorption isotherm, and the granular temperature. Both the median 
size and the process time constant showed a minimum at 2.5% HPC (most favorable 
condition from a processing and physical stability perspective). The same optimum, even 
more pronounced, could be identified if the 90% passing size instead of the median size 
was plotted in Figure 3.9. The granular temperature was a monotonically decreasing 
function of the HPC concentration (viscous dampening), whereas the adsorption isotherm 
was a monotonically increasing function. Therefore, neither the granular temperature nor 
the adsorption isotherm alone can explain the observed optimum at 2.5% HPC: both of 
these values should be sufficiently high to ensure the highest apparent breakage rate. 
Below 2.5% HPC, the particle aggregation was more pronounced due to the relatively 
small thickness of the adsorbed HPC layer and higher GF particle collision frequency at 
the low viscosity of the milled suspensions. Above 2.5%, the viscous dampening effect 
becomes pronounced for the stable suspensions with the lower extent of aggregation.  
 
3.3.8 Correlating the Microhydrodynamics with Equipment-Scale Hydrodynamic 
Behavior 
The stirrer (rotor) Reynolds number (Re) and the stirrer (rotor) Euler number (Eu), also 
known as the power number, are widely used to assess the overall flow behavior of the 
suspensions and to relate the power consumption to the operating parameters, equipment 
 
 
 
  62 
 
parameters, and the fluid properties (Kawatra, 2006; Mannheim, 2011). In the absence or 
presence of SDS, Re decreased and Eu increased with an increase in the HPC 
concentration (Figure 3.10). For scale-up purposes, one can relate Eu to Re (Manneheim, 
2011), which is beyond the scope of this work.  
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Figure 3.9 Effects of the HPC concentration, in the presence of 0.5% SDS, on (a) the 
median size of the GF particles after 16 min milling and the characteristic time constant 
(Runs 12–16), (b) the granular temperature (Runs 12–16) and the amount of HPC 
adsorbed on the GF particles (Runs 10–16). 
 
Eu exhibited a continuous increase with HPC concentration in the presence of SDS 
(Figure 3.10b), whereas it had a smaller slope and tend to plateau at higher HPC 
concentration in the absence of SDS (Figure 3.10a). In both cases, the granular 
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temperature () monotonically decreased and exhibited a profile similar to that of Re, 
suggesting a correlation.  
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Figure 3.10 Effects of the HPC concentration on the stirrer Reynolds number, the stirrer 
Euler number, and the granular temperature: (a) in the absence of SDS (Runs 5–9), (b) in 
the presence of 0.5% SDS (Runs 12–16). 
 
Figure 3.11 presents a statistically significant correlation between the fundamental 
microhydrodynamic parameter  and macro-scale (equipment/stirrer scale) flow 
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parameter Re in the form of a simple logarithmic function, which was built on both HPC 
formulations and HPC–SDS formulations.  
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Figure 3.11 A correlation between the granular temperature and the stirrer Reynolds 
number for the formulations without SDS (Runs 5–9) and with 0.5% SDS (Runs 12–16). 
 
3.4 Summary and Conclusions 
Impact of polymers and surfactants on the wet stirred media milling of poorly water-
soluble drugs is commonly examined within the context of their stabilizing action. Hence, 
a significant gap exists in terms of a fundamental engineering understanding of their roles 
in breakage kinetics, which determine the cycle times and production rate–volume for a 
desired fineness of the drug suspension. With the goal of developing such an 
understanding, for the first time, used a combined microhydrodynamics–adsorption 
analysis and elucidated the impact of a non- ionic cellulosic polymer (HPC), in the 
absence/presence of an anionic surfactant (SDS), on the apparent breakage kinetics of 
griseofulvin (GF) during wet stirred media milling. The aggregation state of the milled 
suspensions was examined by both particle sizing and rheometry.  
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Table 3.4 Effects of the HPC Concentration on the Parameters Measured (Pw, εht, L, and µL) and the  
Microhydrodynamic Parameters ( , , and ub) for Runs 5–9 (without SDS) and Runs 12–16 (with 0.5% SDS) 
Run 
No. 
HPC 
Concentration 
(% w/w) 
Pw 
(W/m3) 
 εht 
(W/m3) 
µL 
(cP) 
ρL 
(kg/m3) 
 
(m2/s2) 
ub 
(m/s) 
ν 
(1/s) 
5 1 6.88105  0
a 11 1084 2.2510–2 2.3910–1 6.42103 
6 2.5 8.13105  0
a 17 1161 2.1210–2 2.3210–1 6.24103 
7 5 1.00106  0
a 40 1178 1.5610–2 2.0010–1 5.35103 
8 10 1.28106  5.74104 135 1266 7.1010–3 1.3510–1 3.61103 
9 15 1.31106  2.11105 346 1366 2.6010–3 8.1810–2 2.20103 
12 1 7.50105  0
a 5 1024 2.9310–2 2.7310–1 7.33103 
13 2.5 9.69105  5.74104 25 1037 1.9810–2 2.2410–1 6.02103 
14 5 1.41106  7.66104 93 1067 1.0810–2 1.6610–1 4.45103 
15 7.5 1.53106  1.15105 180 1077 6.3010–3 1.2710–1 3.41103 
16 10 1.97106  1.91105 270 1100 5.4010–3 1.1710–1 3.14103 
                aToo small to be measured accurately.                                
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Due to the non- ionic nature of the HPC and low inherent charge of GF in aqueous 
suspensions, HPC, even at high concentrations, was not able to fully stabilize the milled 
suspensions: the milled GF particles were highly aggregated in the absence of SDS, 
which was confirmed by laser diffraction and rheometry. The suspensions exhibited 
strong shear-thinning behavior that spanned the whole shear rate range investigated in 
this chapter. Although an increase in HPC concentration caused a reduction in the 
granular temperature (viscous dampening), the particle size decreased monotonically due 
to a decrease in the extent of particle aggregation, which was facilitated by the lower 
collision frequency (higher suspension viscosity) and lower aggregation probability 
(greater thickness of the adsorbed HPC layer). The inclusion of SDS during milling 
enhanced the HPC adsorption (thicker adsorption layer), allowing a synergistic 
electrosteric stabilizing action. Less HPC was needed to reduce the aggregation tendency 
in the presence of SDS. Similarly, these milled suspensions showed a weaker shear-
thinning behavior and exhibited a lower extent of particle aggregation. Since they were 
physically more stable, the viscous dampening effect associated with high HPC 
concentration (above 1% HPC) was dominant in determining the apparent breakage 
kinetics. The combined microhydrodynamics–adsorption analysis aided the explaination 
of not only the viscous dampening effect of HPC, but also the optimum HPC 
concentration (2.5%) in the presence of SDS. The apparent breakage rate was the fastest 
at 2.5% HPC because both the granular temperature and the HPC adsorbed per unit 
surface area of the GF particles were relatively high. A simple logarithmic correlation 
between the granular temperature and the stirrer Reynolds number connected the 
intensity of the bead–bead collisions at the microscopic (bead) scale to the flow behavior 
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of the suspensions at the macroscopic (stirrer) scale. This correlation expresses the 
impact of suspension formulation parameters on the granular temperature for a given 
scale and operating conditions of the mill. The combined microhydrodynamics–polymer 
adsorption analysis has opened a new path to the work of the wet media milling process 
in terms of microhydrodynamic parameters as they are affected by formulation–design–
operating parameters. It will potentially help formulators and engineers to design the 
nanosuspension formulations, to select the operating mill parameters, and to scale-up 
milling processes. Future work will involve the analysis of the impact of other commonly 
used polymers such as HPMC and PVP with/without SDS on the apparent breakage rate.    
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CHAPTER 4 
IMPACT OF PROCESS PARAMETERS ON THE BREAKAGE KINETICS OF 
POORLY WATER-SOLUBLE DRUGS DURING WET STIRRED MEDIA 
MILLING: A MICROHYDRODYNAMIC VIEW 
 
4.1 Introduction 
Size reduction of drug crystals is known to be a feasible approach for improving the 
dissolution rate and bioavailability of poorly water-soluble drugs (Muller and Peters, 
1998). Among all size reduction techniques, wet stirred media milling has proved to be a 
robust top-down process for producing drug nanoparticles (Bhakay et al., 2011; Bruno et 
al., 1996; Merisko-Liversidge et al., 2003). In this technique, micron-sized drug particles 
and media (beads) in an aqueous solution of stabilizers, usually polymers and/or 
surfactants are mixed by a stirrer at very high speeds. Repeated stressing of the micron-
sized drug particles that are captured between the colliding beads causes size reduction 
down to the nanometer size range provided milling is continued for a sufficient time. 
Stabilizers are usually added to prevent the aggregation of the milled drug particles, while 
some polymeric stabilizers can also inhibit particle growth (ripening) during 
milling/storage (Ghosh et al., 2011; Kesisoglou et al., 2007).  
Finding an optimal stabilizer type/concentration is an important aspect of drug 
nanoparticle formulation development because short or long-term physical stability of a 
drug nanoparticle suspension must be ensured for the intended end use of the suspension 
in a desired dosage form. Therefore, a great majority of the wet media milling studies 
have focused on the physical stability of the milled drug suspensions that are formulated 
with various stabilizers (Kesisoglou et al., 2007; Van Eerdenbrugh et al., 2008). For 
example, milling in a planetary mill (Van Eerdenbrugh et al., 2009) or in a ball mill (Lee 
 
 
 
  69 
 
and Cheng, 2006; Van Eerdenbrugh et al., 2007), both making use of vials containing 
drug suspensions with various stabilizers, has previously been described for their 
capability in obtaining nanoparticles. These mills are regarded as medium or low-energy 
mills. Hence, the suspension flow and microhydrodynamics, which is the fluctuating 
motion of the beads in suspensions, are quite different in these mills than in the wet 
stirred media mills. It is not surprising to see that nanoparticles are produced after several 
hours to a few days of milling, even at the bench scale, for suspension quantities on the 
order of ~10 g. In other studies (e.g. Cerdeira et al., 2010; Merisko-Liversidge et al., 
2003), wet stirred media mills have been used; however, the impact of process 
parameters on the breakage kinetics and microhydrodynamics has not been reported. It is 
clear that milling dynamics, breakage kinetics, process cycle times, and scale-up effects 
have not been of major concern in these formulation studies. Bhakay et al. (2011) points 
out that most wet media milling studies in pharmaceutical literature (e.g. Ain-Ai and 
Gupta, 2008; Tanaka et al., 2009) did not consider the breakage kinetics explicitly and 
focused mainly on the physical stability of the final milled suspensions, which were 
produced upon prolonged milling. Other studies (Choi et al., 2008; Deng et al., 2008; Lee 
et al., 2008) reported limited analysis of the effects of milling time, with little to no 
quantification of the breakage kinetics and its relation to the microhydrodynamics.   
As wet media milling process is time-consuming, costly, and energy- intensive 
(Kawatra, 2006) and the breakage kinetics determines the cycle time and production rate 
for a desired fineness, milling process design and optimization entails a good 
understanding of the breakage kinetics and its controlling process parameters. Process 
parameters such as stirrer speed, bead loading, and drug loading can significantly affect 
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the breakage rate and milling time required in a wet stirred media milling process. In a 
recent review paper, Peltonen and Hirvonen (2010) summarized various process 
parameters and their ranges investigated in wet media milling processes. While Peltonen 
and Hirvonen (2010) and the references cited therein provide great understanding of the 
impact of stabilization and formulation, little fundamental understanding of the impact of 
process parameters is available at the beads scale (microhydrodynamics). In a more 
recent work, Ghosh et al. (2012) present the effects of stirrer speed, bead size, and drug 
content on the final milled suspension; however, the impact of these parameters on the 
breakage kinetics was not investigated. Singare et al. (2010) and Singh et al. (2011) used 
a statistical design of experiments with a response surface methodology (RSM) with the 
goal of optimizing the process parameters including milling speed and time. However, no 
information regarding the breakage kinetics was presented explicitly. In general, the 
statistically-based designs of experiments such as those in Singare et al. (2010) and Singh 
et al. (2011) may not provide significant physical insight at the beads scale as to how the 
process parameters affect the breakage kinetics.  
While valuable and sizeable body of work exists in pharmaceutical literature 
regarding the impact of processing parameters on the particle size of milled suspensions, 
as mentioned above, the breakage kinetics and its relation to the microhydrodynamics has 
not been investigated. To a certain extent, wet media milling has been treated as a “black-
box”. In a separate field, Eskin et al. (2005a, 2005b) developed a model to study the 
microhydrodynamics in a mixing tank filled with beads that are stirred with a pair of 
Rushton type paddles. The impact of bead size, stirrer speed, and bead concentration was 
simulated for a mixing tank with water as the medium. Bilgili and Afolabi (2012) have 
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applied this model (see Chapter 3) to the wet media milling of drug suspensions with 
polymer–surfactant and elucidated/quantified the viscous dampening effect of the 
stabilizers. While the excellent work by Eskin et al. (2005a, 2005b) built the theoretical 
foundation for analysis of the microhydrodynamics, developing a fundamental 
understanding of the impact of milling process parameters on the breakage rate of drug 
nanoparticle suspensions entails a combined analysis of the microhydrodynamics and 
breakage kinetics.  
The preceding chapter investigates the impact of formulation parameters; the key 
results suggest a minimum stabilizer-to-drug ratio, synergistic stabilizing effect of a 
hydrophilic polymer and surfactant, and a dampening effect of the polymer on the 
breakage kinetics above an optimum loading level. The major objective of this chapter is 
to elucidate the impact of stirrer speed, bead concentration, and drug loading on the 
breakage kinetics during the wet stirred media milling of griseofulvin (GF), a model 
poorly water-soluble drug, via a microhydrodynamic model of the milling process. GF 
particles were wet-milled in the presence of two stabilizers, hydroxypropyl cellulose 
(HPC) and sodium dodecyl sulfate (SDS), to prepare stable GF suspensions under various 
processing conditions. Laser diffraction, scanning electron microscopy, and rheometry 
were used to characterize the suspensions. The evolution of the median particle size was 
measured and fitted by a well-established empirical model (Strazisar and Runovc, 1996), 
yielding a characteristic time constant of the process as a measure of the breakage 
kinetics. The impact of the process parameters on the breakage kinetics was explained in 
terms of various microhydrodynamic parameters, including the newly defined milling 
intensity factor. Besides providing physical insight and guiding process optimization, the 
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theoretical analysis also rationalizes preparation of a single highly drug- loaded batch 
(20% or higher) instead of multiple dilute batches.  
 
4.2 Experimental 
 
4.2.1 Materials 
Griseofulvin (GF, Cat# 606440, BP/EP micronized grade of GF was purchased from 
Letco Medical, Decatur, AL, USA) was used as a model BCS Class II drug. 
Hydroxypropyl cellulose (HPC) and sodium dodecyl sulfate (SDS) were used as 
stabilizers as reported in Chapter 3.  
 
4.2.2 Methods  
4.2.2.1 Preparation of GF Suspensions. Feed suspensions to be milled were prepared 
in a shear mixer (Cat#. 14–503 Fisher Scientific Pittsburgh, PA, USA). Based on a 
previous formulation study (see Chapter 3) with GF (Bilgili and Afolabi, 2012), a 2.5% 
HPC–0.5% SDS aqueous solution was prepared with 200 g deionized water so as to 
properly stabilize GF suspensions during milling and after storage. Note that all 
percentages (%) refer to w/w with respect to deionized water unless otherwise specified. 
SDS was added to deionized water in a beaker gradually for 15 min while the mixer ran 
at a fixed speed of 300 rpm. Then, HPC was added to the SDS solution gradually for 30 
min. The final HPC–SDS solution was further mixed for 15 min to ensure proper 
dissolution of HPC and SDS particles. Desired amount of GF powder was weighed and 
added to this solution gradually for 30 min while mixing continued.  
 
 
 
  73 
 
The feed suspensions were milled in a Microcer wet stirred media mill (Netzsch 
Fine Particle Technology, LLC. Exton, PA, USA), whose schematic is shown in Figure 
3.1. Table 4.1 presents the process parameters examined in this chapter, while other 
parameters were kept constant. Run 1 was regarded as the base-case as its process 
parameters were selected based on prior formulation study (see Chapter 3) (Bilgili and 
Afolabi, 2012).  
Table 4.1 Processing Parameters used in the Wet Milling Experiments 
Run 
No. 
Drug 
Loading 
(% w/w)a 
Stirrer Speed  
(rpm, m/s) 
Bead Load, 
Concentration 
 (ml), (c) 
1 10 3200, 11.7 50, 0.388 
2 10 1600, 5.86 50, 0.388 
3 10 2400, 8.80 50, 0.388 
4 10 4000, 14.7 50, 0.388 
5 10 3200, 11.7 14, 0.107 
6 10 3200, 11.7 32, 0.244 
7 10 3200, 11.7 75, 0.572 
8 5 3200, 11.7 50, 0.388 
9 20 3200, 11.7 50, 0.388 
10 30 3200, 11.7 50, 0.388 
   a % w/w with respect to de-ionized water. 
 
In Runs 2–10, stirrer speed, bead concentration, and drug loading were 
systematically studied by varying only one variable at a time and keeping the other 
variables constant. The suspensions were milled for 96 min, which allowed sufficient 
time for preparation of GF nanoparticles (d90 < 1000 nm) under all processing conditions. 
The maximum stirrer speed allowed per mill design is 4200 rpm; hence, 4000 rpm was 
studied as the highest value (Run 4). The milling chamber is lined with zirconia and has a 
volume Vm of 80 ml. To minimize potential pressure build-up and fast temperature rise, 
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the mill was loaded with a maximum of 75 ml of zirconia beads (bulk volume) in Run 7. 
Also, a maximum of 30% drug loading was used to conserve the drug (Run 10).  
The milling procedure was followed as in section 3.2.2.1 at a constant volumetric 
flow rate Q of about 126 ml/min by a peristaltic pump (Figure 3.1). In Runs 4 and 7, the 
stirrer was stopped occasionally when the temperature reached 35 oC due to high heat 
generation rate. Samples were taken from the outlet of the milling chamber at several 
intervals of milling and the particle size distribution was measured. The final milled 
suspensions were stored in a refrigerator at 8 oC after density and shear viscosity 
measurements. 
4.2.2.2 Measurement of Power Consumption for the Microhydrodynamic Analysis .  
The power applied by the mill motor P was measured during 96 min milling. The stirrer 
power per unit volume of the slurry in the milling chamber (shortly will be referred to as 
the stirrer power), i.e., Pw = P/Vm was calculated and an average value was reported. The 
power input per unit volume of the milled suspension in the absence of the beads i.e., Pht, 
was also measured. Its value was multiplied by the equivalent liquid (drug suspension) 
volume fraction to obtain εht, which will be used in the microhydrodynamic analysis 
along with Pw (Section 2.4). The no-load power values obtained from dry runs of the mill 
stirrer running at 1600, 2400, 3200, and 4000 rpm were subtracted from the measured 
power values in the calculation of Pw and Pht. 
4.2.2.3 Particle Sizing and Scanning Electron Microscopy (SEM). Particle size 
analysis was followed as in section 3.2.2.3. Prior to the size measurement, milled 
suspension samples (~2 ml) were diluted in a vial with 10 ml of HPC–SDS solution by 
using a vortex mixer (Fisher Scientific Digital vortex mixer, Model No: 945415, NH, 
 
 
 
  75 
 
USA), which rotated at 1500 rpm for 1 min. The PSD of the milled suspension samples 
was also measured after 7 day storage at 8 oC to assess the physical stability. SEM 
imaging was carried out as in section 3.2.2.3 to examine the morphology of the milled 
particles and to determine the primary particle size of the GF.  
4.2.2.4 Apparent Shear Viscosity and Density of the Milled Suspensions. The 
apparent shear viscosity of the milled suspensions (Runs 1–10) was measured using an 
R/S plus rheometer (Brookfield Engineering, Middleboro, MA, USA) as reported in 
section 3.2.2.5. The suspension densities were determined by weighing the suspension 
filled in a 60 ml glass cylinder. The weight of the suspension was divided by the volume 
to obtain the density. Average value of three measurements on each suspension was 
reported in Table 4.4. 
4.2.2.5 Milling Intensity Factor. Recall the energy dissipation rate Π can be 
decomposed into a material-dependent factor  and a process-dependent factor, F, which 
is referred to as the milling intensity factor, as follows:  
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Where F represents the milling intensity factor with the use of the same drug, same bead 
material, and the same bead size. Upon a change in each process parameter, a possible 
increase/decrease in F corresponds to a proportional increase/decrease in Π in some time- 
and space-averaged sense because well-mixedness and average power consumption 
during the milling are considered, and  is taken as a constant for a given pair of drug–
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bead materials. One can then refer to either F or Π while reporting the impact of the 
process parameters. All microhydrodynamic parameters calculated are presented in Table 
4.4. 
 
4.3 Results and Discussion 
 
4.3.1 Preparation of Stable GF Suspensions 
As the major objective of this chapter is to elucidate the impact of processing parameters 
on the breakage kinetics, potential confounding effects that may arise from particle 
aggregation should be minimized via proper stabilization of the GF nanoparticle 
suspensions. Based on a previous formulation study (Bilgili and Afolabi, 2012), a 2.5% 
HPC–0.5% SDS stabilizer combination was selected here for proper stabilization. Figure 
4.1a shows the evolution of the GF particle size distribution (PSD) during milling (Run 1, 
base-case) as measured by the laser diffraction method. Upon further milling, the PSD 
shifted toward finer particles monotonically. At 96 min, GF particles had d50 and d90 
values of 0.149 and 0.180 m, respectively. The SEM image (Figure 4.1b) shows the 
primary GF nanoparticles in the size range of 50–200 nm, similar to the range observed 
in Figure 4.1a. Hence, both the laser diffraction and the SEM imaging suggest that the 
HPC–SDS stabilized suspension had relatively small extent of aggregation and the 
dominant mechanism during the milling was breakage and not aggregation. The 
combination of HPC and SDS is known to have a synergistic effect in the stabilization of 
drug suspensions (Basa et al., 2008; Lee et al., 2008). HPC and SDS interact, forming 
aggregates or micelle- like SDS clusters bound to HPC (Winnik and Winnik, 1990). These 
clusters can co-adsorb on surfaces (Berglund et al., 2003; Evertsson and Nilsson, 1997), 
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facilitating adsorption of HPC on drug particles (Cerdeira et al., 2010) and enabling 
electrosteric stabilization.  
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Figure 4.1 Wet media milling of GF particles in the presence of stabilizers (Run 1): (a) 
evolution of the cumulative particle size distribution, (b) SEM image of the GF particles 
milled for 96 min (marker size: 200 nm, 27 kX magnification).  
 
To establish the reproducibility of the milling process, the milling experiment 
(Run 1) was repeated. The d50 and d90 values of the repeat experiment were 0.151 and 
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small: 1.34% and 3.33%, respectively. Hence, both the process and the particle size 
measurements were fairly reproducible. Good reproducibility has also been established in 
recent work on the wet stirred media milling of several poorly water-soluble drugs such 
as azodicarbonamide, fenofibrate, griseofulvin, and naproxen with HPC or HPMC 
(hydroxypropyl methyl cellulose) in the presence of SDS (Bhakay et al., 2013; Bilgili and 
Afolabi, 2012; Knieke et al., 2013; Monteiro et al., 2013).  
Table 4.2 The Median Size d50 and 90% Passing Size d90 of the GF Suspensions 
 After 96 min Milling and After 7 Day Storage 
Run 
No. 
Milled (96 min) 
d50 (µm), d90 (µm) 
7 day storage 
d50 (µm), d90 (µm) 
1 0.149, 0.180 0.152, 0.185 
2 0.228, 0.393 0.230, 0.401 
3 0.167, 0.212 0.164, 0.218 
4 0.148, 0.178 0.152, 0.187 
5 0.292, 0.497 0.311, 0.516 
6 0.167, 0.218 0.165, 0.221 
7 0.132, 0.160 0.140, 0.171 
8 0.139, 0.170 0.139, 0.169 
9 0.161, 0.208 0.161, 0.209 
10 0.156, 0.220 0.158, 0.220 
 
Short-term physical stability of the milled suspensions prepared in Runs 1–10 
were assessed by comparing the particle size after milling and after 7 day storage (see 
Table 4.2). Long-term stability of these suspensions was not investigated here as they 
were intended to be dried shortly after the milling via various drying methods (as in 
Bhakay et al., 2013; Sievens-Figueroa et al., 2012). After 7 day storage, d50 and d90 of the 
milled suspensions did not change significantly; the suspensions were physically stable 
and remained colloidal mainly due to the synergistic stabilizing action of the HPC–SDS 
combination. In view of the effectiveness of the 2.5% HPC–0.5% SDS stabilizer 
combination and reproducibility of the milling process, the differences in d50 and d90 
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values during 96 min milling can be mainly attributed to the changes in the process 
parameters. 
 
4.3.2 Impact of Process Parameters on the Breakage Kinetics and  
Microhydrodynamics  
The impact of stirrer tip speed, beads loading, and drug loading on the breakage kinetics 
was investigated and the effects were elucidated via the microhydrodynamic model in the 
present chapter. The overall apparent breakage rate or shortly the breakage rate was 
quantitatively assessed by two separate measures: the median size at 4 min and the 
characteristic time constant p of the process, which was obtained by fitting Eq. (2.7) to 
the evolution of the median size. The breakage rate can be described mathema tically by 
1/p. Albeit chosen somewhat arbitrarily, 4 min was long enough for the effects of 
different process parameters to develop, yet was still shorter than what a dynamic 
equilibrium would entail. Table 4.3 presents the values of the parameters dlim and p 
estimated (see Chapter 2.3), their coefficient of variation COV, and the coefficient of 
determination R2. Considering the simplicity of the model, the fits were fairly good: R2 
values were greater than 0.90, COV values were less than about 20%, and the parameters 
were all statistically significant (p-value < 0.05). The estimated dlim values were slightly 
greater than the experimental median particle sizes obtained after 96 min milling (Table 
4.2), except for Runs 2 and 5, which entail further milling to approach a dynamic 
equilibrium. The differences are mostly small and within 1–2 standard deviation of the 
dlim estimated and can be explained by experimental variability in d50 measured, 
insufficient number of time samples in the fitting, presence of low extent of aggregation 
that was not considered by the simple two-parameter model. Overall, the fit statistics 
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suggest that the use of p to assess the impact of process parameters on the breakage 
kinetics. 
Table 4.3 Parameters and Their Statistics Estimated From the Empirical Model 
(Eq. (2.7)) Fit to the Evolution of the Median Particle Size 
Run 
No. 
dlim, COV% 
(µm), (–) 
τp, COV% 
(min), (–) 
R2 
(–) 
1 0.160 (3.78) 2.56 (7.07) 0.99 
2 0.269 (8.94) 9.77 (8.95) 0.98 
3 0.184 (8.18) 3.57 (12.7) 0.97 
4 0.165 (8.62) 1.97 (20.8) 0.91 
5 0.404 (13.6) 7.06 (12.5) 0.95 
6 0.190 (7.97) 3.78 (13.0) 0.97 
7 0.144 (2.60) 1.91 (11.6) 0.97 
8 0.163 (7.56) 1.50 (17.2) 0.94 
9 0.171 (7.10) 3.14 (13.0) 0.97 
10 0.173 (8.17) 4.46 (1.31) 0.96 
 
4.3.2.1 Impact of Stirrer (Rotor) Tip Speed. Figure 4.2a shows the temporal 
evolution of d50 and d90 for angular speeds of 1600–4000 rpm or equivalent tip speeds of 
5.86–14.7 m/s (Runs 1–4). For proper scaling and good discrimination of the impact of 
various tip speeds, the median size was plotted in log-scale and the initial size was not 
shown (d50 = 19.65 ± 1.17 m and d90 = 50.88 ± 6.33 m at t = 0 min). Both d50 and d90 
decreased monotonically upon an increase in milling time, and no size increase was 
observed. This finding suggests that breakage was the dominant mechanism and 
aggregation of the particles probably occurred at a much smaller rate than the breakage in 
the presence of HPC–SDS. In general, the rate of decrease in d50 and d90 decreased with 
time, suggesting a slowing-down of the breakage. Hence, a dynamic equilibrium 
(plateau) in d50 was approached or practically attained, except at the tip speed of 5.86 
m/s, for which the overall breakage rate appeared to be the lowest and d50 continued to 
decrease for the whole 96 min.  In general, the dynamic equilibrium was approached or 
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attained earlier with an increase in the tip speed. Since d90 heavily weighs the 
contribution from the coarser particles, whose breakage into smaller particles of desired 
fineness will take more time, d90 continued to decrease up to 96 min. The slowing-down 
of the breakage and approach to a dynamic equilibrium can be explained as follows: 
while milling progressed, finer particles were produced, which are more difficult to 
capture between the beads and are harder to break. Finer particles, especially 
nanoparticles, are mechanically stronger and have a much smaller breakage probability 
than coarser particles (Bilgili et al., 2006). Theoretical work from Bilgili’s research group  
using population balance models, even without any aggregation terms, were able to 
capture the sharp decrease in the breakage rate (Bilgili et al., 2006; Bilgili and Capece, 
2011).  
The particle breakage appears to get faster with an increase in the stirrer speed, as 
shown by the smaller median size at any given time point (Figure 4.2a). At the lowest 
speed of 5.86 m/s (Run 2), the breakage rate was so low that d50 and d90 continued to 
decrease significantly up to and including 96 min; much more time would be needed to 
reach a dynamic equilibrium. The breakage rate increased monotonically with an increase 
in the stirrer speed as indicated by the monotonic decrease in both d50 at 4 min and τp 
(Figure 4.2b), while dlim decreased with an increase in the tip speed (Table 4.3). These 
effects got weaker at higher speeds (especially >11.7 m/s).  
To explain the aforementioned effects of the stirrer speed at the beads scale, the 
microhydrodynamic parameters (see Chapter 2.4) granular temperature , the average 
bead oscillation velocity ub, the frequency of single-bead oscillations , the maximum 
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contact pressure compressions b
max,  the milling intensity factor F, and the average 
frequency of drug particle a were calculated (Figures 4.3a and 4.3b). 
Experimentally, upon an increase in the tip speed, the stirrer power increased and 
the viscosity of the milled suspension decreased due to the presence of finer particles 
(both reported in Table 4.4).  Since more mechanical energy was imparted on the slurry 
and the beads, all microhydrodynamic parameters increased monotonically, as one would 
expect intuitively. Upon an increase in the stirrer speed, the fluctuating motion of the 
beads became more vigorous (higher  There were more frequent bead oscillations 
(higher ), which led to a more frequent compression of the drug particles (higher a), i.e., 
a greater number of stressing events.  
The beads had higher fluctuating velocity (higher ub) and fluctuating momentum, 
which led to more impactful bead collisions and development of higher compressive 
stresses (higher b
max), i.e., a greater stress intensity. For the griseofulvin (drug)–zirconia 
beads (milling media) pair, the energy dissipation rate attributed to the deformation of the 
drug particles per unit volume can be expressed in terms of a milling intensity factor F, 
which captures all of the above effects of the stirrer speed on the number/intensity of the 
stressing events through a lumped microhydrodynamic parameter. The increase in the 
overall breakage rate upon an increase in the stirrer speed (Figure 4.2b) can be simply 
explained by more bead collisions with greater stressing intensity (Figures 4.3a and 4.3b). 
In summary, a decrease in τp resulted from an increase in the stirrer speed through an 
increase in F. Despite the rapid rise of F especially above 11.7 m/s, τp decreased more 
gradually, implying that the impact of the milling intensity factor on the breakage rate 
begins to saturate above a certain value.       
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Figure 4.2 Effects of the stirrer speed on (a) the time-wise variation of the characteristic 
sizes of GF particles, (b) the median size of GF particles after milling for 4 min and the 
characteristic time constant (Runs 1–4). At t = 0 min, the GF particles have d50 = 19.65 ± 
1.17 m and d90 = 50.88 ± 6.33 m. 
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Figure 4.3 Effects of the stirrer speed on (a) the granular temperature, the average bead 
oscillation velocity, and the frequency of single-bead oscillations, (b) the maximum 
contact pressure, the milling intensity factor, and the average frequency of drug particle 
compressions (Runs 1–4). 
 
4.3.2.2 Impact of Bead Concentration. The temporal evolution of d50 and d90 is 
illustrated in Figure 4.4a for bead concentrations of 0.107–0.572, which were described 
in terms of volume fraction c (Runs 5–7 and 1). In general, the evolution of d50 and d90 
followed similar patterns as discussed in Section 4.2.1: both d50 and d90 decreased 
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monotonically with milling time. The absolute value of the slope of the d50 and d90 
profiles decreased with time, suggesting a decrease in the breakage rate as milling 
progressed. Although d90 was evolving very slowly even up to 96 min of milling; a 
dynamic equilibrium (plateau) in d50 was approached or attained, except at a bead volume 
fraction of 0.107, for which the overall breakage rate was the lowest. The dynamic 
equilibrium was approached or attained earlier with an increase in the beads loading. The 
breakage rate appears to increase with an increase in the bead concentration, as shown by 
the smaller median particle size at a given time (Figure 4.4a). This finding was further 
reflected by the monotonic decrease in p (Figure 4.4b) and decrease in dlim (Table 4.3) 
upon an increase in the bead concentration. Interestingly, Figures 4.5a and 4.5b exhibit 
two counteracting effects of an increase in the bead concentration: , ub, and b
max 
decreased while , a, and F increased. In other words, the number of stressing events 
dramatically increased, but their intensity decreased (less impactful collisions and particle 
compressions). The increase in , a, and F seems to be more drastic than the decrease in 
ub, and b
max in relative terms. Upon an increase in the bead concentration, the number 
of the beads increased and the clearance between the beads decreased, leading to a 
dramatic increase in the bead–bead collisions and the average number of drug particle 
compressions per unit time ( and a). 
On the other hand, despite the increase in the stirrer power and the decrease in the 
suspension viscosity at the higher bead loading (Table 4.4), higher number of inelastic 
bead–bead collisions and liquid-film squeezing events coupled with an increase in the 
effective drag coefficient Rdiss led to greater energy dissipation.  
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Figure 4.4 Effects of the bead concentration on (a) the time-wise variation of the 
characteristic sizes of GF particles, (b) the median size of GF particles after milling for 4 
min and the characteristic time constant (Runs 5–7 and Run 1). At t = 0 min, the GF 
particles have d50 = 19.65 ± 1.17 m and d90 = 50.88 ± 6.33 m. 
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Table 4.4 Power Values (Pw and εht) and Properties of the Milled Drug Suspensions (µL and L) Measured as Well  
as the Microhydrodynamic Parameters ( , ub, , b
max, a, and F) Calculated 
Run 
No. 
Pw  
(W/m3) 
εht  
(W/m3) 
µL  
(cP) 
ρL  
(kg/m3) 
  
(m2/s2) 
ub  
(m/s) 
ν  
(KHz) 
b
max  
(GPa) 
a  
(mHz) 
F 
(m2.6/s2.6) 
1 5.23105 0 17 1029 1.5310–2 1.9710–1 5.29 2.03 2.0410–1 6.6710–2 
2 1.70105 7.66104 31 1024 2.2010–3 7.5010–2 2.01 1.38 5.4610–2 5.3610–3 
3 2.95105 0 24 1022 7.7010–3 1.4010–1 3.76 1.77 1.2310–1 2.7310–2 
4 9.55105 0 10 1023 2.9910–2 2.7610–1 7.40 2.32 3.7010–1 1.5910–1 
5 2.50105 2.03104 37 1021 5.3310–2 3.6810–1 1.03 2.60 2.4210–2 9.7110–3 
6 3.64105 0 22 1024 2.8410–2 2.6910–1 2.63 2.30 7.4110–2 3.4210–2 
7 1.32106 0 6 1028 1.1110–2 1.6810–1 17.3 1.90 1.09 2.4810–1 
8 5.00105 0 13 1006 1.6710–2 2.0610–1 5.53 2.06 2.0610–1 1.5010–1 
9 6.02105 0 26 1039 1.3610–2 1.8610–1 5.00 1.98 1.9810–1 2.8610–2 
 10 6.20105 0 34 1070 1.1710–2 1.7310–1 4.63 1.92 1.6810–1 1.5710–2 
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Consequently, the fluctuating motion of the beads was less vigorous (smaller  and ub), 
which in turn led to smaller bead compression stresses (smaller b
max). It is worth-
mentioning that even a decrease in  could not prevent the drastic increase in  and a 
because the impact of more beads and reduced clearance between them upon an increase 
in the bead loading was stronger.  
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Figure 4.5 Effects of the bead concentration on (a) the granular temperature, the average 
bead oscillation velocity, and the frequency of single-bead oscillations, (b) the maximum 
contact pressure, the milling intensity factor, and the average frequency of drug particle 
compressions (Runs 5–7 and Run 1). 
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It is of fundamental importance to determine which of the aforementioned two effects 
will be dominant in explaining the observed increase in the breakage rate upon an 
increase in the bead concentration. A comparison of the trends in Figure 4.4b and Figures 
4.5a and 4.5b suggests that upon an increase in the bead loading, the dramatic rise in a 
was more prevalent than the decrease in b
max, leading to an increase in the milling 
intensity factor F, which explains the decrease in τp. Despite the rapid rise of F especially 
above a bead concentration of 0.388 in Figure 4.5b, the breakage rate did not change 
significantly (Figure 4.4b), implying that the impact of the milling intensity factor on the 
breakage rate begins to saturate above a certain value (similar to the impact of the tip 
speed).    
4.3.2.3 Impact of Drug Loading. The temporal evolution of d50 and d90 is illustrated 
in Figure 4.6a for 5%, 10%, 20%, and 30% drug loadings (Runs 8–10, and Run 1). The 
evolution of d50 and d90 followed similar patterns as discussed in the previous sections; 
hence, this aspect will not be elaborated. In comparison with the impact of the stirrer 
speed and the beads loading, the impact of the drug loading appears to be weaker, within 
the parameter space investigated. A slight difference worth mentioning is the attainment 
of similar median size values after 96 min for all drug loadings. Figure 4.6 suggests that 
the overall breakage rate slightly decreased with an increase in the drug loading. Table 
4.3 presents dlim values that are slightly greater than the median size values at 96 min 
(Table 4.2).  
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Figure 4.6 Effects of the drug loading on a) the time-wise variation of the characteristic 
sizes of GF particles and b) the median size of GF particles after milling for 4 min and 
the characteristic time constant (Runs 8–10 and Run 1). At t = 0 min, the GF particles 
have d50 = 19.65 ± 1.17 m and d90 = 50.88 ± 6.33 m. 
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Figure 4.7 Effects of the drug loading on (a) the granular temperature, the average bead 
oscillation velocity, and the frequency of single-bead oscillations, (b) the maximum 
contact pressure, the milling intensity factor, and the average frequency of drug particle 
compressions (Runs 8–10 and Run 1). 
 
An increase in the drug loading from 5% to 30% led to a slight, almost linear 
decrease in all microhydrodynamic parameters except the milling intensity factor F (see 
Figure 4.7), which exhibited a sharper decrease. While b
max did not decrease 
significantly upon an increase in drug loading, the increase in the number of drug 
particles that are captured by the colliding beads caused a decrease in the compressive 
force applied on each drug particle, which in turn led to a stronger decrease in F. It is 
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worth noting that both the stirrer power and the suspension viscosity increased (Table 
4.4), due to the presence of larger number of drug particles in the milled suspension. 
However, these changes counteracted each other and led only to a slight reduction in 
most hydrodynamic parameters except the milling intensity factor.  
 
4.3.3 A Unified Correlation for the Breakage Kinetics–Microhydrodynamics  
It is important to determine if a single microhydrodynamic parameter can explain the  
impact of all process parameters on the overall breakage rate, which is quantified by the 
characteristic time constant τp. The specific energy Ps is defined as the mechanical energy 
spent per unit mass of the drug particles and used in the milling literature for process 
design and scale-up purposes (Kawatra, 2006):  
pmws QVPP          (4.3)  
As a fundamental microhydrodynamic parameter, the milling intensity factor F appears to 
explain the impact of individual process parameters on the breakage rate directly. In 
addition, Pw was considered to determine if the stirrer power plays a direct role in the 
breakage kinetics.  
Figure 4.8 exhibits considerable scatter when τp is plotted against Ps and 
especially Pw. As a result, it was not possible to correlate τp to Ps or Pw using any of the 
linear or nonlinear regression models in SigmaPlot’s (Version 11) comprehensive library 
of models. To be precise, a statistically significant model with statistically significant 
parameters could not be generated; R2 was less than 0.80 and p-values were greater than 
0.05 in all cases. On the other hand, the plot of τp vs. F showed relatively small scatter 
and the three-parameter exponential decay model  
 FAAA 321p exp                               (4.4) 
 
 
 
  93 
 
fitted the data very well, as indicated by R2 = 0.96, SSR = 2.387 min2, and a standard 
error of the estimate of 0.584 min.  
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Figure 4.8 Scatter plots for the characteristic time constant versus the specific energy, the 
milling intensity factor, and the stirrer power per unit volume. Fit: an exponential decay 
correlation. 
 
Both the model and its parameters were statistically significant with p-values < 0.05; the 
model parameters exhibited acceptably low COV values: 13.2%, 12.2%, and 18.1% for 
A1, A2, and A3, respectively. The empirical model approaches a plateau above an F value 
of about 0.07 m2.6/s2.6, confirming that above a certain milling intensity, the breakage rate 
will not be affected significantly by F, which has already been elaborated in Sections 
4.3.2.1 and 4.3.2.2. A caveat to the correlation in Figure 4.8 is strictly valid for 
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griseofulvin particles milled with 430 m zirconia beads, signifying its descriptive 
nature. 
Nonetheless, to the best knowledge of the author, no such simple three-parameter 
correlation, which connects breakage kinetics to a single microhydrodynamic parameter 
(F here) lumping three different process parameters, exists in the literature. It is expected 
that use of different drugs and beads could lead to a similar type of correlation with 
different A1, A2, and A3. To develop relationships between the breakage kinetics of 
different drugs and their mechanical properties, it would be best to work with  instead 
of F in Eq. (4.4). These aspects will be considered in a future study.  
 
4.3.4 Implications for Process Design and Optimization 
The effects of the process parameters on the specific energy Ps, the milling intensity 
factor F, and the stirrer power per unit volume Pw were illustrated in Figure 4.9. An 
increase in either the stirrer tip speed or the bead concentration led to an increase in Ps, F, 
and Pw, whereas an increase in the drug loading led to a decrease in Ps and F but an 
increase in Pw. The analysis of the data illustrated in Figures 4.9 and 4.10 suggests that a 
wet media milling process should operate at the highest F, which will increase the 
breakage rate and minimize the milling time required for desired product fineness (d50 or 
d90). For the range of processing parameters considered, the mill should be operated at the 
highest possible stirrer tip speed (14.7 m/s) and the highest beads loading (0.572 or 93.8 
vol.% of the milling chamber) provided that the product contamination due to bead wear 
is acceptably low (not studied here) and the heat dissipation can be controlled via 
effective cooling. Owing to the plateau observed for the region F ≥ 0.07 in Figure 4.8, the 
mill could be operated at a lower tip speed (11.7 m/s) and bead loading (0.388) than the 
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above-mentioned values to minimize potential media contamination and to control the 
temperature rise reliably, while still ensuring fast particle breakage.  
For a given batch size and desired end point particle size, selecting a drug loading 
level that minimizes the overall process cycle time seems to be a complex task. On one 
hand, Figure 4.6b suggests that the mill should be loaded with 5% drug to ensure the 
highest breakage rate (lowest τp) and shortest milling time as compared with 10%, 20%, 
and 30% drug loading cases. On the other hand, engineers/formulators must consider the 
fact that the negative effect of an increase in τp can be compensated by the positive 
impact of having more drug processed per batch at higher drug loadings: e.g. twice at 
10% as compared with 5%. Note that τp increased with an in drug loading: 1.50 min, 2.56 
min, 3.14 min, and 4.46 min for the 5%, 10%, 20%, and 30% drug loadings, respectively. 
Similarly, the times to produce suspensions with a median size of 400 nm and 300 nm, 
which are some potential end points in industrial scale milling operations, were 
calculated by Hermite interpolation of the data in Figure 4.6a. They were 3.19 min and 
7.74 min, 5.98 min and 8.41 min, 7.70 min and 13.7 min, and 10.6 min and 18.7 min for 
the 5%, 10%, 20%, and 30% drug loadings, respectively.  
A conjecture from these three different measures can be made that although the 
breakage kinetics slowed down or τp increased upon an increase in the drug loading, the 
time it takes to mill per mass of the drug for a desired median size decreased even more 
significantly, signifying enhanced operational efficiency and a decrease in the overall 
process cycle time. Hence, for a given mass of drug particles to be milled, engineers 
should prefer a single milling batch with 20% or 30% drug loading as opposed to two or 
three batches at 10% drug loading. 
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Figure 4.9 The specific energy, the milling intensity factor, and the stirrer power per unit 
volume at various (a) stirrer speeds (Runs 1–4), (b) bead concentrations (Runs 5–7 and 
Run 1), (c) drug loadings (Runs 8–10 and Run 1). 
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Considering the suspension preparation/unloading/cleaning times in-between the multiple 
batches with 10% drug loading along with the above breakage kinetics arguments, 
milling at a higher drug loading appears to be operationally more efficient, with 
appreciable reduction in the overall process cycle time. Depending on the final 
application of the milled suspension and its properties (viscosity, physical stability, etc.), 
the high drug- loaded suspensions may either be diluted or used as- is. 
It is important to investigate if the milling intensity factor can be correlated to the 
energy consumption. Figure 4.10 presents scatter plots for the milling intensity factor 
versus the specific energy, and the stirrer power per unit volume. A statistically 
significant correlation between the milling intensity factor F  and specific energy Ps in the 
form of a linear function is found. Considerable scatter is also seen when F is plotted 
against Pw. Therefore, it was not possible to correlate F to Pw using any of the linear or 
nonlinear regression models in SigmaPlot’s (Version 11) comprehensive library of 
models. Despite the correlation between F and Pw, Ps was not able to predict the breakage 
rate (Figure 4.8) due to scatter in both the time constant and spec ific energy 
measurements. Moreover, F is a fundamental microhydrodynamic parameter which 
accounts for the physics of bead-bead collisions, whereas Ps cannot yield such 
fundamental information. 
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Figure 4.10 Scatter plots for the milling intensity factor versus the specific energy, and 
the stirrer power per unit volume. Fit: a linear correlation. 
 
4.4 Summary and Conclusions 
Significant advances have been made, for about two decades, in preparation and 
stabilization of drug nanoparticle suspensions via wet stirred media milling. Nevertheless, 
a fundamental understanding of the impact of process parameters on the breakage 
kinetics in terms of the underlying microhydrodynamics in the mills has not been 
developed. Considering the importance of nanoparticle production for the enhancement 
of dissolution rate/bioavailability and the relatively expensive and energy- intensive 
nature of the wet stirred media milling, it is of utmost importance to study the breakage 
kinetics, which determines the process cycle time and production rates for a desired 
fineness of the drug product. With the goal of developing a fundamental understanding 
and gaining physical insight, in this chapter, an elucidation of the impact of the stirrer 
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speed, the bead concentration, and the drug loading on the breakage rate of griseofulvin 
(GF) via a combined microhydrodynamics–breakage kinetics analysis was performed. 
The experiments have shown that an increase in either the stirrer speed or the 
bead concentration led to an increase in the specific energy and the milling intensity 
factor, consequently faster breakage; whereas an increase in the drug loading led to a 
decrease in these parameters and consequently slower breakage. All microhydrodynamic 
parameters provided significant physical insight while only the milling intensity factor 
was capable of explaining the influence of all parameters uniquely through its strong 
correlation with the process time constant. Besides guiding process optimization and 
providing fundamental physical insight, the theoretical analysis has also rationalized the 
use of a single highly drug-loaded batch (20% or higher) over multiple dilute batches. 
This study has opened a new path to the investigation/design/optimization of the wet 
media milling process in terms of microhydrodynamic parameters as they are affected by 
the formulation–design–operating parameters. It will help formulators/engineers to 
streamline the development of nanosuspension formulations and to select the operating 
mill parameters in the context of a theoretical framework. Future studies will focus on the 
influence of bead size/type, suspension flow rate, batch size, and mechanical properties 
of different drugs and beads on the breakage kinetics and microhydrodynamics.  
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CHAPTER 5 
FAST PRODUCTION OF DENSE, STABLE DRUG SUSPENSIONS WITH SUB - 
100 NM PARTICLES AND MININMAL MEDIA CONTAMINATION VIA 
INTENSIFIED WET STIRRED MEDIA MILLING 
 
5.1 Introduction 
In recent years, wet stirred media milling (WSMM) technique has received much 
attention in producing fine drug particles in suspension form, because of its capability in 
producing a narrow particle size distribution, high drug loading, organic solvent- free 
processing, batch and continuous operation capability, and ease of scale up (Bilgili and 
Afolabi, 2012; Bruno et al., 1996; Merisko-Liversidge et al., 2003). In this method of 
preparing the drug nanoparticles, micron-sized drug particles and media (beads) in an 
aqueous solution of stabilizers is fed into the mill at a control flow rate, mixed by a rotor 
(mill stirrer) at very high speeds. Repeated stressing of the micron-sized drug particles 
that are captured between the colliding beads causes size reduction down to the 
nanometer size range provided milling is continued for a sufficient time (Ghosh et al., 
2011; Verma et al., 2009). 
  
Although several commercial nanoparticulate oral and parenteral drug products 
are being produced via WSSM, the technique is generally considered as time-consuming, 
costly, and energy-intensive (Kawatra, 2006). Even at the bench scale milling operations, 
drug nanoparticle suspension quantities in the order of ~10 g are produced after several 
hours to a few days of milling, leading to increased energy consumption. Perhaps the lack 
of fundamental understanding of the impact of process parameters and/or  heavy reliance 
on purely empirical approaches make the process energy intensive and time consuming 
(Afolabi et al., 2013). In fact, the majority of the wet media milling studies have focused 
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mainly on optimization of various stabilizers, and physical stability of the milled drug 
suspensions (Kesisoglou et al., 2007; Lee et al., 2008; Peltonen and Hirvonen, 2008; Van 
Eerdenbrugh, 2008), and no explicit information on reducing the mill time, energy 
consumption, and bead wear is given. It is known that faster particle breakage rate leads 
to reduction in both milling time and energy consumption, and can be achieved by right 
selection of mill operating parameters such as bead size, bead load, rotor speed, and 
suspension flow rate. Influence of these parameters on final drug particle size has been 
studied previously through experiments (Cerdeira et al., 2011a; Ghosh et al., 2011, 2013) 
and statistical based approach (Singare et al., 2010; Singh et al., 2011). However, the 
influence of these parameters at intense conditions on breakage kinetics leading to the 
faster preparation of fine drug nanoparticles is not addressed. Therefore, a detailed 
strategy or methodology for combining different mill process parameters has to be 
developed which could lead to an intensified process for the faster production of fine 
drug nanoparticles with reduced specific energy consumption and bead wear.  
In pharmaceutical applications, the demand for using drug nanoparticles with size 
as low as possible is increasing steadily, as fine drug nanoparticles offers a much faster 
dissolution rate due to their high surface area to volume ratio, and also result in rapid 
onset of therapeutic action (Merisko-Liversidge et al., 2011; Müller and Peters, 1998; 
Shegokar and Müller, 2008). Most importantly, drug nanoparticles with size < 100 nm 
renders feasible and efficient sterile filtration of aqueous drug nanosuspensions, and 
allows higher loading for reduced injection volume in parenteral dosage forms (Baert et 
al., 2009; Xiong et al., 2008). In addition to the nanosuspension dosage form, 
nanocomposite microparticles made of very small size drug nanoparticles offer rapid 
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redispersion of particles at an increase drug loading in a given mass of dosage (Bhakay et 
al., 2013). Therefore, it is important to prepare drug nanosuspensions with size as small 
as possible (< 100 nm) to achieve enhanced efficacy in various pharmaceutical 
applications. By varying the process parameters, several researchers have prepared 
inorganic nanoparticles in the size range of 10–100 nm using WSSM technique (Patel et 
al., 2012; Stenger et al., 2005; Wang and Forssberg et al., 2006). However, an 
investigation on the effect of process parameters for the preparation of drug nanopart icles 
having sub-100 nm has not been attempted so far. Table 1 shows the list of drugs milled 
in WSMM with their initial drug load, initial particle size, batch volume and the final 
particle size. To the best of our knowledge, only using smaller initial drug particle size 
and at low batch volume, the drug nanoparticles with a typical median size of 136 nm and 
above have been produced via WSMM. It is to be noted that the preparation of drug 
particles with < 100 nm size is a challenging task, especially if the mill is desired to 
operate with the large initial drug particle size, high batch volume (> 200 ml at the bench 
scale), and high drug load > 10 % (w/w).  
Although the preparation sub-100 nm drug particle at a shorter milling time with 
reduced energy consumption is of great interest, the drug product contamination 
introduced by bead wear at intense process conditions is also not known. All of these 
aspects can be understood by investigating the impact of mill operating parameters on 
particle breakage rate and the energy dissipation rate during the deformation of the 
particles. This can be elucidated by studying the fluctuating motion of beads in sheared 
suspensions i.e., microhydrodynamics. Eskin et al., (2005a,b) developed a comprehensive 
microhydrodynamic model describing the dynamics of the milling beads and their 
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interactions with the particles in a dense slurry flow. Recently, Bilgili and Afolabi (2012) 
modified this model to understand the viscous dampening effect caused by the use of 
polymeric stabilizers in WSMM. The model consists of several intrinsic bead parameters 
and the magnitude of change in parameter values at different mill operating conditions 
enable us to select right process parameters.  
 
The preceding Chapters 3 and 4 sheds more light on the impact of formulation 
and processing parameters on drug nanoparticle suspension produced via WSMM. A 
minimum stabilizer-to-drug ratio was attained and individual process parameter was 
optimized. The major objective of this chapter is to elucidate a combined experimental 
and theoretical approach to achieve faster production of sub-100 nm BCS class II drugs 
having reduced specific energy consumption with minimal bead wear contamination. In 
the experiments, the effects of media (bead) size on the energy consumption, bear wear 
and breakage kinetics of two model poorly water-soluble drugs, griseofulvin (GF) and 
naproxen (NAP) were studied. Then, this baseline process conditions with the optimal 
bead size was intensified by increasing the rotor tip speed, bead load, and suspension 
flow rate systematically, as guided by a microhydrodynamic model of the process. The 
intensified process led to the production of sub-100 nm particles within 30 min of milling 
with significant reduction in bead wear. Similarly, milling of NAP also led to sub-100 nm 
particles within 30 min. The use of small beads has enabled us to intensify the process, 
increase the particle breakage rate (shorter cycle time), and reduce the energy 
consumption with minimal bead wear contamination.  
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5.2 Experimental 
 
5.2.1 Materials 
GF, (EP/BP grade) was purchased from Letco Medical (Decatur, AL, USA). Naproxen, 
NAP, (USP grade, solubility in water: 15.9 mg/l) was purchased from Medisca 
(Plattsburgh, NY, USA). The d10 (10% passing size), d50 (median or 50% passing size) 
and d90 (90% passing size ) values of as-received GF and NAP particles measured by 
laser diffraction device (LS 13-320, Coulter Beckman, Brea, CA) were 5.0 µm, 21.85 
µm, 57.77 µm, and 6.93 µm, 16.60 µm, 77.12 µm respectively. Hydroxypropyl methyl 
cellulose (HPMC, Methocel- E3), a neutral polymeric stabilizer, was purchased from 
Dow Chemical (Midland, MI, USA). Sodium dodecyl sulfate (SDS), an anionic 
stabilizer, and nitric acid was purchased from Sigma Aldrich (Bellefonte, PA, USA). 
Wear resistant yttrium- stabilized zirconia milling  media (YSZ) with a nominal size of 
100, 200, 400 and 800 µm was purchased from Saint Gobain ZirPro (Zirmil Y, 
Mountainside, NJ, USA), were used as milling media. The reported density of milling 
media was 6000 kg/m3, consists of 93 % ZrO2 and 5 % Y2O3 . De-ionized water was used 
in all experiments.  
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Table 5.1 Literature Summary of Drug Particles Prepared via Wet Stirred Media Milling with Median Particle Size < 200 nm 
Drug Initial median 
particle size 
(m) 
Drug 
loading 
(% w/w) 
Batch 
volume 
(ml) 
Process 
time 
Final median 
drug particle 
size (nm) 
Reference 
       
Etravirine 11 20 300 60 min 140 Cerdeira et al., 2011 
Fenofibrate 
 
16 
 
10 
 
200 
 
120 min 
 
150 
 
Knieke et al., 2013 
 
Griseofulvin 22 10 200  64 min 161 Bhakay et. al. 2013 
Itraconazole 20 20 300 60 min 136 Cerdeira et al., 2013 
 
Miconazole 20 20 300 60 min 140 Cerdeira et al., 2013 
Naproxen 13 
 
10 490 64 min 143 Monteiro et al., 2013 
Undisclosed 15-20 5 NM 6 h 200 Bose et al., 2012 
NM: not mentioned       
 
 
1
0
5
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5.2.2 Methods  
 
5.2.2.1 Wet Stirred Media Milling. The milling procedure followed in the present work 
is the same as reported in Chapter 3 and Chapter 4. The schematic of the mill can be seen 
in Figure 3.1. The mill chamber has a volume (Vm) of 80 ml lined with zirconia, 
connected to a rotating shaft (diameter, D = 7 cm). A stainless steel screen (Netzsch, 
Exton, PA, USA) was used to restrict the flow of milling media (beads) out of the 
chamber. Screens having different opening (pore) size was used for varying bead size, 
and a ratio of 1:2 screen opening size to bead size was maintained in all experiments. 200 
ml of aqueous suspension containing 10 % w/w (with respect to water) drug along with 
stabilizers was initially added to the holding tank (500 ml) of mill, and the recirculation 
of suspension between holding tank and milling chamber was achieved at a controlled 
flow rate with use of peristaltic pump. A paddle mixer connected to the holding tank was 
operated continuously at 800 RPM to ensure the suspension homogeneity in the holding 
tank. The suspensions at several milling time points (4, 8, 16, 32, 64, 120, 180, 240, 300 
and 360 min) were collected from the outlet of milling chamber, and used for particle size 
and morphology analysis. The final milled suspensions were stored in a refrigerator at 8 
oC. Table 5.2 shows different milling conditions (Runs 1–9) followed in the present work, 
with respect to change in mill operating parameters such as bead size db, mill tip speed u, 
bead volumetric concentration c, and suspension flow rate Q. 
Prior to milling, the as received drugs were prepared in the form of suspensions 
along with stabilizers with use of low shear laboratory stirrer [Fisher Scientific (Catalog 
no. 14–503), Pittsburgh, PA, USA]. The procedure was followed as reported in Chapter 3 
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and Chapter 4. Stabilizer solution was prepared by initially adding 0.4 g of SDS to 200 
ml de- ionized water, followed by gradual addition of 5 g of HPMC-E3 within 30 min 
under stirring (300 rpm). 
Table 5.2 Processing Conditions used in the Wet Milling Experiments (Runs 1–9) 
 at Drug Load: 10%a, Batch Size: 200 Mlb and HPMC/SDS Concentration: 2.5%/0.2% 
 
Run 
No. 
 
Drug 
 
 
Bead Size 
(µm) 
 
Stirrer Speed 
(rpm, m/s) 
 
Bead Load, 
Concentration 
(gm), (c) 
 
Suspension 
Flow rate 
 (mL/min) 
 
1 GF 800 3200, 11.7 195.7, 0.408 126 
2 GF 400 3200, 11.7 195.7, 0.408 126 
3 GF 200 3200, 11.7 195.7, 0.408 126 
4 GF 100 3200, 11.7 195.7, 0.408 126 
5 GF 100 4000, 14.7 195.7, 0.408 126 
6 GF 100 4000, 14.7 260.7, 0.543 126 
7 GF 100 4000, 14.7 260.7, 0.543 343 
8 NAP 100 3200, 11.7 195.7, 0.408 126 
9 NAP 100 4000, 14.7 260.7, 0.543 343 
a 
% w/w with respect to de-ionized water.
  
 b 
 de-ionized water.
 
 
The resultant solution was further stirred for 10 min and left at rest until a clear 
solution was obtained. To this stabilizer solution, 20 g of as received drug particles was 
added gradually within 30 min of stirring, and kept in refrigerator (8 oC) for 90 min. The 
prepared final suspension has 10 % w/w drug, 2.5% w/w HPMC, and 0.2% w/w SDS (all 
with respect to water). The particle size of drug in pre-suspension form was measured, 
and referred as 0th minute particle size. At the end of milling process, the cumulative 
energy consumption (E) of the slurry (beads, drug, stabilizer and solvent) was directly 
recorded from the mill control panel. From this, the average stirrer power applied per unit 
volume of slurry Pw was calculated as  
Pw=E/ΔtVm                                                                                                       (5.1) 
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where, Δt is the cumulative milling time i.e., final time point of milling process. The 
specific energy consumption, E*, which is the energy spent per unit mass of drug in mill 
chamber was also calculated from E, and is given as  
* sE E m                                                                                                   (5.2)  
where ms is the mass of the drug in the mill chamber.  
Recall the energy dissipation rate Π (see Chapter 2.4) can be decompose into a 
material-dependent factor  and a process-dependent factor, F, which is referred to as the 
milling intensity factor, defined as follows:  

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Where F represent the milling intensity factor with the use of the same drug, same bead 
material, but different bead sizes. Upon a change in each process parameter, a possible 
increase/decrease in F corresponds to a proportional increase/decrease in Π in some time- 
and space-averaged sense because well-mixedness and average power consumption 
during the milling are considered, and  is taken as a constant for a given pair of drug–
bead materials. One can then refer to either F or Π while reporting the impact of the 
process parameters. All microhydrodynamic parameters calculated are presented in Table 
5.3.  
5.2.2.2 Characterization Techniques. Laser diffraction (LD) was used to 
determine the particle size of milled suspensions with median particle size d50 above 200 
nm. The measurements were performed in LS 13-320 Beckman Coulter instrument (Brea, 
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CA) as reported in Chapter 3 and Chapter 4. A refractive index (RI) of 1.65, 1.41 and 
1.33 were used for GF, NAP and water (measurement medium) respectively. All the 
measurements were performed at 25 °C, and the particle size was measured at least thrice 
and the average values were reported. Milled suspensions with d50 less than 200 nm were 
investigated by dynamic light scattering (DLS) using Delsa Nano C Particle analyzer 
(Beckman coulter, Brea, CA). The milled suspension was diluted with de- ionized water, 
and the median particle size, d50 based on intensity weighted distribution was recorded 
along with polydispersity index (PI). All the measurements were performed at 25 °C, and 
the particle size was measured at least thrice and the average values were reported.  The 
combined use of LD and DLS to analyze the particle size data have been previously 
reported by Knieke et al. (2009) and Schubert et al. (2006) and similar procedure is 
followed. 
Particle size and morphology of the as-received and milled drug particles were 
examined using LEO 1530 SVMP (Carl Zeiss, Inc., Peabody, MA, USA) scanning 
electron microscopy (SEM). For this analysis, 0.5 ml of the milled suspension was 
diluted with 30 ml de- ionized water, and a drop was placed on a silicon chip (Ted Pella, 
Inc., Redding, CA, USA). The chip was mounted on a carbon specimen holder, followed 
by drying in dessicator for 2 h. All the samples were then sputter coated with carbon and 
observed in SEM. X-ray Powder Diffraction (P-XRD) technique was used to analyze the 
crystallinity of the as-received and milled GF particles. The suspension sample was dried 
at 40 ºC for overnight in a convective drier (Gallenkamp, Netherlands), and the particles 
were finely grounded with the help of a mortar and pestle. As-received drug powder was 
directly used for analysis. The dry powder was packed in an aluminum holder and 
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mounted on a Empyrean series 2 X-ray diffractometer (PANalytical, Westborough, MA, 
USA), provided with Cu Kradiation ( = 1.5406 Å). The samples were scanned for 2θ 
ranging from 5o to 40o at a scan rate of 0.165 s–1.  
 
The apparent shear viscosities L of the milled suspensions were measured at 25 ± 
0.5 oC using R/S plus Brookfield rheometer (Brookfield Engineering, Middleboro, MA, 
USA) as reported in Chapter 3 and Chapter 4. The density of the milled suspension was 
performed as reported in Chapter 3 and Chapter 4. Bead wear contaminants (zirconium 
and yttrium) levels in the final milled suspensions were analyzed by inductive coupled 
plasma mass spectrometry (ICP-MS) according to European Pharmacopeia 6.0 §2.2.58 
with a limit of quantification of 0.1 µg/g. For this, the milled suspension sample was 
dried at 40 ºC for 24 h in a convective drier, and the dried particles were finely grounded 
with the help of a mortar and pestle. Then, 1 g of dried powder was added to 40 ml of 
water, followed by addition of 40 ml of 65 % nitric acid. The mixture was then heated up 
until a clear solution was observed. The resultant clear solution was cooled down to room 
temperature and diluted further with water for ICP-MS analysis. The measurements were 
performed thrice and the average value was reported.  
 
5.3 Results and Discussion 
 
5.3.1 Effect of Bead Size on the Temporal Evolution of GF Particles  
Proper selection of bead size can help to improve the efficiency of wet media milling 
operation by producing fine size nanoparticles with low energy consumption. In this 
chapter, the effect of bead size on the preparation of GF particles was first studied by 
milling the as-received GF particles with varying bead size of 800, 400, 200 and 100 µm 
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(refer Table 5.2, Runs 1–4). Yttrium stabilized zirconia (YSZ) bead were selected for this 
study as they tend to exhibit low level contamination of the final drug product due to its 
high hardness of 19 GPa and a reduced modulus of about 218 GPa (Lian et al., 2007). 
The mill tip speed u, bead volumetric concentration c, and suspension flow rate Q were 
kept constant at 11.7 m/s, 0.4 and 126 ml/min, respectively (baseline process condition). 
Figure 5.1 shows the temporal evolution of the median size d50 of the GF particles. The 
median size d50 decreased exponentially and slowly approached an asymptote near 360 
min of milling, illustrating that the size reduction slowed down during milling 
monotonically. After 360 min milling, the median sizes attained with 800, 400, 200 and 
100 µm beads were 176, 140, 124 and 98 nm, respectively. The corresponding d10 and d90 
values are given in Table 5.3. The poly dispersity index, PI of all the measured particles 
was less than 0.2. Thus, the use of smallest beads (100 µm) resulted in 98 nm median 
size, implying that sub-100 nm particles can be produced with use of small beads in wet 
stirred media milling provided the process can be intensified (see Section 5.3.2). 
To establish the reproducibility of the milling process, repeat experiments of Runs 
1–4 were performed. The d50 and d90 sizes attained with 800, 400, 200 and 100 µm beads 
were 174 and 295 nm, 144 and 261 nm, 121 and 245 nm, and 99 and 210 nm, 
respectively. The (absolute) percent deviations from the d50 and d90 values were 
negligibly small: 1.14 and 0.34%, 2.86 and 1.56%, 2.42 and 0.81%, and 1.02 and 1.87%, 
respectively. Hence, milling process and the particle size measurements were fairly 
reproducible. Good reproducibility has also been established in our recent work on wet 
stirred media milling of several other poorly water-soluble drugs such as 
azodicarbonamide, fenofibrate, griseofulvin, and naproxen with HPC (hydroxypropyl 
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cellulose) or HPMC in the presence of SDS (Bhakay et al., 2013; Bilgili and Afolabi, 
2012; Knieke et al., 2013; Monteiro et al., 2013; Sievens-Figueroa et al., 2012).  
 
Figure 5.1 Temporal evolution of the median size d50 of GF particles for Runs 1–4. Runs 
1, 2, 3 and 4 refer to milling of GF with 800, 400, 200 and 100 µm YSZ beads 
respectively, at baseline mill conditions of mill tip speed u = 11.7 m/s, bead volumetric 
concentration c = 0.4 and suspension flow rate Q = 126 ml/min. At t = 0 min, the GF 
particles have d50 = 21.85 ± 1.25 m and d90 = 57.77 ± 4.35 m. 
 
Table 5.3 Particle Size Statistics of the Suspensions for Runs 1–9 after Milling  
and After 7 Day Storage 
Run 
No. 
Milling 
Time 
(min) 
After Milling  
d10 (nm), d50 (nm), d90 (nm) 
7 day storage 
d10 (µm), d50 (nm), d90 (nm) 
1 360 110, 176, 294 NMa 
2 360 84, 140, 257 NMa 
3 360 72, 124, 247 NMa 
4 360 57, 98, 214 60, 101, 298 
5 120 57, 95, 209 NMa 
6 120 41, 85, 180 NMa 
7 120 38, 83, 164 41, 90, 214 
8 360 35, 87, 154 NMa 
  9 120 26, 82, 139 32, 95, 165 
a
NM: not measured. 
 
 
 
  113 
 
Before delving into analyzing the results presented above, it is of utmost 
importance to establish the aggregation state of the milled suspension. In the present 
work, HPMC and SDS stabilizer combination was used for stabilization of GF particles 
based on a previous formulation optimization study, which showed an excellent 
stabilization for several BCS II drugs such as fenofibrate, naproxen, ibuprofen etc (Bilgili 
and Afolabi, 2012; Knieke et al., 2013; Monteiro, et al., 2013). Figure 5.2 shows the 
SEM images of 4, 32, 120, 240, and 360 min milled GF particles with 100 µm beads 
(Run 4), capturing the evolution of the particle size and morphology. GF particles got 
smaller and more spherical as milling progressed. The calculated average size for the 360 
min milled particles (Figure 5.2f) from SEM was 90 nm, which is very close to the 
median particle size obtained from light scattering measurements technique. Image J 
software was used to count and compute the particle size from SEM image, and a total of 
1450 particles were used for the particle size analysis. These findings suggest that even 
the suspension with the smallest particles (Run 4) is not significantly aggregated at the 
time scale of the milling process, and the electrosteric stabilization mechanism imparted 
by the HPMC–SDS combination was quite effective (Run 4).  
Short term physical stability of Run 4, Run 7 and Run 9 milled suspensions were 
performed for a period of 7 days at 8 °C. Table 5.3 shows the particle size statistics of 7 
day storage of the milled suspension. After 7 day storage, d50 and d90 of the milled 
suspensions did not change significantly; the suspensions were physically stable and 
remained colloidal mainly due to the synergistic stabilizing action of the HPMC–SDS 
combination. Long term physical stability of these suspensions was not investigated in 
the present study. 
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Figure 5.2 SEM images showing the evolution of GF particle size for Run 4: (a) as 
received, (b) 4 min, (c) 32 min, (d) 120 min, (e) 240 min, (f) 360 min of milling. Run 4 
refers to the use of 100 µm YSZ beads at the baseline mill conditions (u = 11.7 m/s, c = 
0.4 and Q = 126 ml/min). At t = 0 min, the GF particles have d50 = 21.85 ± 1.25 m and 
d90 = 57.77 ± 4.35 m. 
In general, the observed slow-down of the size reduction during the milling (see 
Figure 5.1) may be explained mainly by particle breakage and aggregation mechanisms. 
Of course, as milling progressed long enough, aggregation ra te may have increased upon 
production of finer (colloidal) drug particles, which could be a reason for the equilibrium 
(plateau), approached near 360 min. As the drug particle size decreases, number 
concentration in the suspension increases and the interparticle distance decreases, leading 
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to more frequent collisions and potentially higher aggregation rate (Bhakay et al., 2011; 
Sommer et al., 2006). The similarity of the primary particle sizes from the SEM image 
and the particle size measured by DLS suggests that particle breakage was the dominant 
mechanism and aggregation of the particles occurred at a smaller rate than the breakage 
in the presence of stabilizers during most of the milling process.  
On the other hand, as milling progressed, finer particles were produced, which 
have a much lower specific breakage rate (breakage probability) than the coarser particles 
and thus are harder to break (Bilgili et al., 2004, 2006, 2008). In addition, smaller 
particles are more difficult to capture between the beads during the bead–bead collisions, 
further reducing the specific breakage rate. In fact, population balance models without 
any aggregation terms (Bilgili et al., 2007; Bilgili and Capece, 2011) were able to capture 
the sharp decrease in breakage rate even during the breakage of large microparticles. 
Considering that nanoparticles are even less likely to break than microparticles (Bilgili et 
al., 2004, 2006) a claim can be made that the approach to or attainment of a plateau size 
observed in Figure 5.1 is mainly explained by extremely the low breakage probability of 
nanoparticles and the lower capture efficiency of such particles, and, to a minor extent, 
by the aggregation of the produced nanoparticles in the presence of HPMC-SDS.  
Figure 5.3 shows the XRD patterns of as-received and 360 min milled GF (Run 4). The 
peak positions of both patterns are identical, which confirms that the crystallinity of GF 
was not altered even after long hours of milling.  
5.3.1.1 Quantification of Wear from Different Size Beads. Generation of wear 
from beads during milling leads to undesirable contamination of the milled drug product. 
To investigate the effect of bead size on bead wear contaminants levels [zirconium (Zr) 
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and yttrium (Y)], GF particles milled with use of 800 and 100 m beads were analyzed 
using ICP-MS. 
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Figure 5.3 XRD patterns of as-received and 6 h milled GF particles (Run 4). Run 4 refers 
to the use of 100 µm YSZ beads at the baseline mill conditions (u = 11.7 m/s, c = 0.4 and 
Q = 126 ml/min). 
 
As-received GF and stabilizers (HPMC and SDS) showed no elemental levels of Zr and 
Y. The elemental Zr and Y levels [mass of contaminant/mass of milled drug in dry form] 
of 6 h milled GF with 800 µm beads (Run1) and 100 µm beads (Run 4) were 607 ± 35 
µg/g Zr, 32 ± 2 µg/g Y and 357 ± 7 µg/g Zr, 20 µg/g Y respectively. Approximately, 1.7 
times reduction in both Zr and Y were observed by using 100 µm beads. Similarly, 
Juhnke et al., (2012) also observed reduced contaminant levels with use of sma ller size 
beads. Hence, the use of smallest beads (100 µm) helps in achieving final drug product 
with low level contamination compared to the use of larger bead sizes.  
5.3.1.2 Effects of Bead Size on Specific Energy Consumption and Applied Power.  
Figure 5.4 shows the specific  energy consumption E* and the average power applied per 
unit volume of slurry Pw for varying bead sizes up to 360 min of milling. Both E* and Pw 
were low for 100 µm beads and increases with increasing bead sizes. With this low 
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specific energy consumption, 100 µm beads were effective in producing the smallest GF 
particle size (refer to Figure 5.1), suggesting high grinding efficiency from an energetic 
perspective. From literature, it is understood that the specific energy consumption is 
proportional to the particle fineness (Breitung-Faes and Kwade, 2013). However, the 
particle size observed at higher specific energies is large (for 800 µm beads) as compared 
to small size particles obtained using 100 µm beads, accounting only low specific energy. 
Hence, a conclusion can be made that specific energy consumption is not a direct 
measure of particle fineness during wet media milling because only a small fraction of 
the specific energy is actually spent on deforming/breaking the drug particles, which is 
largely controlled by the microhydrodynamics.  
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Figure 5.4 Specific energy consumption (E*) and power applied by the mill stirrer per 
unit volume (Pw) for various bead sizes during 360 min of milling at the baseline mill 
conditions (u = 11.7 m/s, c = 0.4 and Q = 126 ml/min). 
 
5.3.1.3 Microhydrodynamic Analysis of Beads. To develop a fundamental 
understanding of the bead size effect on the observed smallest GF particle size, reduced 
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energy consumption and reduced contaminant levels (bead wear), the 
microhydrodynamic parameters ,, ub, b
max, F, and a were calculated and plotted as a 
function of bead size (see Figures 5.5a and 5.b). At constant mill tip speed, bead load and 
suspension flow rate, the fluctuating motion of beads () becomes less vigorous with a 
decrease in bead size. This low fluctuating velocity led to low impact force and low 
compressive stresses (b
max) i.e., a low stress intensity, for smaller beads (refer Figure 
5.5b). On the other hand, the frequency of bead oscillations,  (number of stressing 
events) and the average frequency of drug particle compression, a is seen higher with a 
decreasing bead size (Figure 5.5b). Smaller size beads constitute more in number causing 
a dramatic increase in the bead–bead collisions (increasing ) which also allowed 
capturing of more drug particles (increasing a) due to less inter-bead distances. Thus, 
increase in v led to faster breakage rate and increase in a helped in achieving sub-100 nm 
particles with the use of 100 µm smallest bead size. Also, a decrease in Pw is observed 
(see Figure 5.5b and Table 5.3) with decreasing bead size which is due to low ub and 
This resulted in reduced specific energy consumption for decreasing bead sizes. The 
observed reduced contaminants levels with the use smallest bead size (100 µm) can be 
explained in terms of compressive stresses (b
max). Smaller beads undergo less impactful 
collision (lower b
max) and results in less bead wear. On comparing the b
max for 800 µm 
(Run 1) and 100 µm (Run 4) beads (Table 5.3), a 1.6 times reduction in b
max was 
observed with use of 100 µm beads, yielding low levels of contamination. To better 
understand the impact of particle breakage rate of different size beads, the milling 
intensity factor F, which is proportional to the energy spent during the deformation of the 
drug particles per unit volume, was calculated using Eq.5.4. The milling intensity factor 
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F captures all of the above effects on the number and intensity of stressing events in a 
single parameter (Afolabi et al., 2013).   
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Figure 5.5 Effect of bead size on microhydrodynamic parameters: (a) granular 
temperature, average bead oscillation velocity ub and frequency of single bead 
oscillation . (b) Maximum contact pressure b
max, milling intensity factor F, and average 
frequency of drug particle compressions a. Milling conditions: u = 11.7 m/s, c = 0.4 and 
Q = 126 ml/min.  
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In Figure 5.5b, an increase in F is seen for decreasing bead sizes which implicates that 
smaller bead size possess faster breakage rate due to more number of stressing events. 
Thus, microhydrodynamic analysis justifies or rationalizes the use of smaller beads for 
finer particle preparation, and so 100 µm beads were further used in experiments.  
In the planned experiments, an attempt to use less than 100 µm bead size resulted 
in inefficient operation of the mill. For example, when 50 µm beads were used for milling 
by having screen with pore size of 25 µm (recommended), the presence of large initial 
GF particle size (d90 = 57.77 µm) resulted in clogging of screen pores and the suspension 
was not even allowed to flow out of the milling chamber. Very small size beads are 
generally not employed for milling due to their difficulty in handling, high cost, and 
problems associated with separation of beads from the suspension (Haskell, 2003). 
Hence, due to practical limitation of the mill, 100 µm beads were used as the least size in 
this study. 
 
5.3.2 An Intensified Process with 100 µm Beads 
From the bead optimization study, it can be seen that 100 µm beads are effective in 
producing < 100 nm particles. However, the mill operating conditions employed in the 
bead optimization study took almost 360 min (6 h) to obtain GF particles with a median 
size of 98 nm (Run 4). The microhydrodynamics analysis suggests that the breakage rate 
of the GF particles was higher resulting in faster production of fine nanoparticles, when 
the milling intensity factor F was higher. Equation (5.4) suggests that F depends on 
parameters andc besides Rb, which can be directly increased by increasing the rotor 
(mill stirrer) tip speed and bead load, respectively (Afolabi et al., 2013). In addition to the 
above, it is also reported that an increase in suspension flow rate also leads to increased 
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breakage rate as high suspension flow rate results in tighter residence time distribution 
(RTD) (no back-mixing) of suspension in mill chamber (Monteiro, et al., 2013; Stehr, 
1984). Hence, the combination of higher mill tip speed, higher bead load, and higher 
suspension flow rate may allow for the development of an intensified process.  
Developing such an intensified process is important as it helps to increase the 
particle breakage rate, thereby achieving faster production of fine nanoparticles with 
reduced bead wear contamination level. Figure 5.6 shows the schematic of the 
methodology followed in development of an intensified process with 100 µm beads to 
produce sub-100 nm particles, with the objective of reducing the milling time and bear 
wear contamination level.  
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Figure 5.6 Schematic of the methodology followed for the development of an intensified 
wet stirred media milling process with the use of 100 µm YSZ beads for the faster 
production of sub-100 nm drug particles. 
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The effect of each process parameter on the reduction of milling time and particle size 
was studied by varying one process parameter at a time. From a specific parameter 
variation study, the intensified mill parameter was selected and subsequently used for 
other parameter intensification studies.  
5.3.2.1 Effect of High Mill Tip Speed. To investigate the effect of mill tip speed on 
reduction in particle size and milling time, the mill tip speed u was increased to 14.7 m/s. 
It is to be noted that the maximum tip speed allowed per mill design is 15.4 m/s, and to 
avoid reaching the limitation of the mill, a mill tip speed of 14.7 m/s was used as 
maximum in this study. Figure 5.7a shows the temporal evolution of GF median particle 
size, milled at u = 14.7 m/s at c = 0.4, and Q = 126 ml/min (Table 5.2, Run 5). For the 
sake of comparison, experimental result of lower mill tip speed (Run 4, u = 11.7 m/s) is 
also plotted in Figure 5.7a. With an increase in mill tip speed (Run 5), a faster particle 
breakage rate is observed and a dynamic equilibrium was achieved from 120 min of 
milling (plateau not shown). The d50 particle size obtained at 120 min was 95 nm, and 
further size reduction was not observed even up to 6 h of milling (refer to Table 5.3 for 
the particle size statistics). Reduction in only milling time by increasing the mill tip speed 
was also observed by Afolabi et al., 2013; Fadhel and Frances, (2001). Therefore, a 
higher mill tip speed of 14.7 m/s was used in the further process intensification 
experiments. 
5.3.2.2 Effect of High Bead Load at High Mill Tip Speed. Increasing the bead 
load (amount of grinding beads) reduces the volume of empty spaces between the 
colliding beads, and helps to increase the frequency of particle capture during bead-bead 
collisions. Better grinding performances were achieved especially at higher media fillings 
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as in Afolabi et al., (2013), Persson and Forssberg (1994), and Sadler et al. (1975). 
Therefore, the effect of bead load on reduction in particle size and milling time was 
investigated by increasing the bead load to c = 0.543, which corresponds to 90% of the 
total mill volume. 
 
 
Figure 5.7 (a) Temporal evolution of the median size d50 of GF particles for the Runs 4–
7 with the use of 100 µm YSZ beads, (b) SEM of GF nanoparticles prepared using 
intensified process conditions (Run 7: u = 14.7 m/s, c = 0.543 and Q = 343 ml/min). Inset 
SEM shows magnified GF nanoparticles. At t = 0 min, the GF particles have d50 = 21.85 
± 1.25 m and d90 = 57.77 ± 4.35 m.   
(a) 
(b) 
 
 
 
  124 
 
Bead load above 90 % resulted in pressure build-up, and hence a maximum bead load of 
c = 0.543 was used in this study. Other operating process parameters, mill tip speed and 
suspension flow rate were kept at u = 14.7 m/s and Q = 126 ml/min (Table 5.2, Run 6) 
respectively. In Figure 5.7a, Run 6 shows a much faster breakage rate compared to Run 5 
and a least size of 85 nm were produced within 60 min of milling (Table 5.3 shows the 
particle size statistics).. Hence, the intensified process with combined effect of higher 
bead load and higher mill tip speed was used in further studies.   
5.3.2.3 Effect of High Suspension Flow Rate at High Bead Load and Tip Speed. 
In an attempt to further reduce the milling time, the suspension flow rate Q was increased 
from 126 ml/min to a maximum of 343 ml/min at c = 0.543, u = 14.7 m/s (Table 5.2, Run 
7). From Figure 5.7a, higher suspension flow rate (Run 7) resulted in much faster 
breakage rate compared to lower suspension flow rate (Run 6), and a particle size of 83 
nm was achieved within 32 min of milling (Table 5.3 shows the particle size statistics). 
Further reduction in particle size was not observed even after prolong milling. SEM of 
the GF particles prepared with this condition (Figure 5.7b) shows the primary GF 
particles (refer inset of Figure 5.7b), with an average particle size of 74 nm. Higher 
suspension flow rate leads to reduction in cycle time (i.e., faster breakage rate) due to 
plug flow like behavior of the suspension in mill chamber resulting in tighter RTD (no 
back-mixing). Detailed study on the reduction in cycle time by increasing the suspension 
flow rate in terms of increasing Péclet number is given in Monteiro, et al. (2013) and 
Stehr (1984). Hence, the milling process was further intensified which resulted in a final 
GF nanoparticle size of 83 nm attained within 32 min of milling.  
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5.3.2.4 Reduction in Cycle Time, Specific Energy Consumption, and Bead Wear.  
Considering some potential end points in industrial scale milling operations, the milling 
time required to produce GF median particle size of 100 nm was predicted by 
interpolating (Hermite interpolation) the experimental data of Runs 4–7. The predicted 
cycle time to achieve 100 nm GF particles for the Runs 4–7 were 300 min, 98 min, 41 
min, and 22 min respectively. The cycle time was greatly reduced upon intensifying the 
mill process, and a comparative analysis of cycle time of the intensified process having 
high rotor speed at high bead load and suspension flow rate (Run 7) with the base line 
process (Run 4) show a 13.6 times reduction in cycle time. Thus the cycle time was 
largely reduced with the help of intensified process conditions compared to the baseline 
process conditions to get median GF size of 100 nm. Similarly, the specific energy 
consumption E* up to the predicted time for all the Runs was also calculated. The E* 
values for Runs 4–7 were 6.69 MJ/kg, 6.56 MJ/kg, 6.47 MJ/kg, and 3.81 MJ/kg 
respectively. It is to be noted that upon intensifying the process conditions, the power 
(Pw) spent on the slurry (Table 5.3) was higher. However, a steady decrease in specific 
energy consumption values was seen due to the reduction in cycle time. On comparing 
the Run 7 and Run 4, for a 13.6 time reduction in cycle time, the specific energy 
consumption was reduced to 1.6 times and is proportional to 43 % energy savings.  
Scant information is available on the bead wear contaminant level in terms of 
cycle time, and varying process conditions (Hennart et al., 2010; Juhnke et al., 2012; 
Stein, et al., 2010). Figure 5.8 shows elemental level of zirconium and yttrium for Runs 
4–7, milled with the use of 100 µm beads up to the predicted time to achieve GF median 
particle size of 100 nm. Recall that the predicted cycle time to achieve 100 nm GF 
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particles for Runs 4–7 were 300 min, 98 min, 41 min, and 22 min respectively. In Figure 
5.8, the elemental zirconium (Zr) and yttrium (Y) levels contaminations for Runs 4–7 
were 298 ± 4 µg/g Zr, 20 µg/g Y, 132 ± 6 µg/g Zr, 12 µg/g Y, 71 ± 4 µg/g Zr, 5 µg/g Y, 
and 40 ± 2.3 µg/g Zr, 3 µg/g Y respectively. From Figure 5.8, about 86.5% reduction in 
Zirconium level can be observed with the use of the intensified process (Run 7) compared 
to the baseline process condition (Run 4). Decrease in contaminants levels (from Runs 4–
7) with respect to decrease in the cycle time to reach 100 nm GF particles, suggests that 
contaminant level is proportional to the milling time irrespective of the process 
conditions. It is also to be noted that if the milling time is kept constant for both baseline 
and intensified process conditions; an increase in contaminant levels with the intensified 
process conditions can be observed. 
To prove this, we have also milled GF with the baseline process condition (u = 
14.7 m/s at c = 0.53, and Q = 343 ml/min) and the intensified process condition (u = 14.7 
m/s at c = 0.53, and Q = 343 ml/min) for a constant mill time up to 2 h with the use of 
100 m beads. The contaminants levels for baseline and intensified process conditions 
were 33 ± 5 µg/g Zr, 8 µg/g Y and 147 ± 18 µg/g Zr, 10 µg/g Y respectively. Compared 
to the baseline process, an increase in contaminant levels up to 4.5 times was observed 
with the intense process conditions for a constant mill time of 2 h. However, it is not 
required to run the intensified process for a long time, as the process leads to fine particle 
size at a much shorter time with reduced contamination levels. Hence, the assessment on 
cycle time and specific energy consumption suggests that one can use the intensified 
process conditions to achieve faster production of small size drug nanoparticles with 
significant energy savings and reduced product contamination by the beads. It is to be 
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mentioned that shortening of cycle time with reduced energy consumption and bead wear 
with the intensified process is mainly due to faster breakage rate of particles which is a 
resultant of increased bead-bead collisions (see Section 5.3.2.5). 
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Figure 5.8 Elemental level (g/g) of zirconium and yttrium from YSZ beads determined 
by induced couple plasma mass spectroscopy (ICP-MS) along with the time required to 
reach a median size of 100 nm at different mill process conditions for Runs 4–7. Run 4 at 
the baseline conditions (u = 11.7 m/s, c = 0.4 and Q = 126 ml/min); Run 5 (u = 14.7 m/s, 
c = 0.4 and Q = 126 ml/min); Run 6 (u = 14.7 m/s, c = 0.543 and Q = 126 ml/min); Run 7 
(u = 14.7 m/s, c = 0.543 and Q = 343 ml/min). 100 µm YSZ beads were used for all the 
Runs from 4–7. 
 
5.3.2.5 Microhydrodynamic Analysis of the Intensified Process. Table 5.4 shows the 
calculated MHD parameters for the baseline and intensified process conditions (see Runs 
4–7). At higher tip speed (Run 5), all calculated MHD parameters (, , ub, b
max, F, and 
a) show higher values as compared to Run 4, and especially one order of magnitude 
increase in the milling intensity factor F is seen. At higher rotor tip speed, more 
mechanical energy was imparted on the slurry, which led to more impactful bead 
collisions (higher and higher compressive stresses (higher b
max), i.e., a greater stress 
 
 
 
  128 
 
intensity. This effect led to a reduction in milling time (i.e., reduced bead wear) and 
reduced specific energy consumption. At combined conditions of both high tip speed and 
high bead load, a counteracting effect was observed:  , ub,, b
max  were smaller, whereas  
,  a, and F were greater (Run 6, Table 5.4) as compared to Run 5. In other words, the 
amount of stress intensity decreased, but the number of stressing events dramatically 
increased due to higher bead load. This led to small clearance between the beads causing 
a dramatic increase in the bead–bead collisions and the average number of drug particle 
compressions per unit time ( and a), i.e. higher particle capture efficiency than Run 5. 
The increase in the capture efficiency led to a further reduction in cycle time, specific 
energy consumption, and bead wear. Finally with the above intensified process, when the 
suspension flow (Run 7) rate was increased, the overall breakage rate was further 
increased due to tighter RTD and plug-flow like behavior of the suspension in the mill 
chamber. The increase in the suspension flow rate influenced the input MHD parameters: 
an increase in the rotor power and the decrease in the suspension viscosity (Table 5.4). 
This was due to the higher number of inelastic bead–bead collisions and liquid-film 
squeezing events coupled with an increase in the effective drag coefficient Rdiss which led 
to greater energy dissipation. It is worth-mentioning that the increase in the energy 
dissipation further led to an increase in both MHD parameters and the overall breakage of 
the drug particles. Overall, 8.7 times increase in F can be observed with intensified 
condition (Run 7) compared to the baseline condition (Run 4) which led to a 13.6 times 
reduction in cycle time as compared to the predicted baseline mill time of 300 min with 
energy savings up to 43%, and 86.5% less zirconium wear from the beads.  It is to be 
noted that the use of 100 m beads enabled us to reduce the cycle and particle size due to 
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relatively higher particle capture frequency compared to other larger size beads. Though 
the compressive stresses (b
max) of 800, 400, 200 m beads are higher compared to 100 
m beads, the mill intensity factor (grinding efficiency) is higher for 100 m beads. 
Therefore, an effective intensification of the mill process can be achieved only by using 
smaller size beads. 
 
5.3.3 Milling of Naproxen with Intensified Process 
It is important to demonstrate our intensified process with other drug, so as to confirm 
that the methodology developed results in fine nanoparticles at a shorter milling time. For 
this, we have selected naproxen (NAP), milled with baseline (Table 5.2, Run 8) and 
intensified process Table 2, Run 9) conditions.  Naproxen loading of 10 % (w/w) and a 
combined stabilizer having 2.5% (w/w) HPMC, and 0.2% (w/w) SDS were used. Figure 
10 shows the temporal evolution of Naproxen median particle size, milled with use 100 
µm beads at the baseline conditions (Run8: u = 11.7 m/s, c = 0.408, and Q = 126 ml/min) 
and intensified process conditions (Run 9: u = 14.7 m/s, c = 0.543, and Q = 343 ml/min). 
Similar to GF milling, NAP also resulted in sub-100 nm range for both Run 8 and Run 9. 
In this case too, the baseline process condition (Run 8) took almost 6 h (data shown till 
mill time of 120 min) to reach 87 nm whereas, intensified condition (Run 9) resulted in 
82 nm within 32 min of milling. XRD analysis also confirmed that crysta llinity of milled 
NAP was not altered (Figure not shown).  
Upon assessing the cycle time, specific energy consumption, and bead wear 
between Runs 8 and 9, the predicted cycle time to achieve 100 nm NAP particles were 
194 min and 18 min respectively. Reduction in cycle time about 10.7 times was achieved 
upon intensifying the process, and the calculated energy savings and reduced zirconium 
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bead wear at this reduced cycle time were up to 21% and 76%, respectively. This 
observation is similar to the milling of GF particles as shown in Section 5.3.2.4, thus 
proving that the methodology followed in the intensified process works well for other 
drugs. Table 5.4 shows the calculated MHD parameters for Runs 8 and 9. Similar to GF, 
the intensified process conditions (Run 9) shows 8 times high F compared to the baseline 
process condition (Run 8). Overall most of the MHD parameters values were high for the 
intensified process which led to an increase in F (i.e. faster breakage of NAP particles).  
 
Figure 5.9 Temporal evolution of the median size d50 of the naproxen (NAP) particles 
milled with the use of 100 µm YSZ beads. Run 8 at the baseline conditions (u = 11.7 m/s, 
c = 0.4 and Q = 126 ml/min) and Run 9 at the intensified process conditions (u = 14.7 
m/s, c = 0.543 and Q = 343 ml/min). At t = 0 min, the NAP particles have d50 = 16.60 ± 
1.27 m and d90 = 77.12 ± 2.10 m. 
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Table 5.4 Power Applied per Unit Volume of Slurry (Pw), Measured Viscosity (µL) and Density (L) of the Milled Drug  
Suspensions, and the Calculated Microhydrodynamic Parameters ( , ub,, b
max, a, and F ) for Different Runs 
                                                             
 
 
                                         
Run 
No. 
Pw  
(W/m3) 
µL  
(cP) 
ρL  
(kg/m3) 
  
(m2/s2) 
ub  
(m/s) 
ν  
(KHz) 
b
max  
(GPa) 
a  
(mHz) 
F 
(m0.6/s2.6) 
1 3.13105 5.97 1034 2.2510–2 2.4010–1 3.98 2.19 1.2410–1 5.261012 
2 2.92105 5.73 1026 1.2410–2 1.7810–1 5.47 1.95 1.9910–1 2.871013 
3 2.71105 5.51 1028 5.3010–3 1.1610–1 7.17 1.64 3.2810–1 1.531014 
4 2.29105 5.63 1040 2.0610–3 7.2410–2 7.58 1.36 3.2210–1 3.701014 
5 6.88105 5.04 1036 5.9010–3 1.2210–1 12.8 1.68 8.9910–1 1.461015 
6 1.25106 4.83 1038 3.7010–3 9.7610–2 27.1 1.53 2.10 2.811015 
 7 1.38106 4.56 1037 4.2010–3 1.0310–1 28.7 1.57 2.45 3.311015 
 8 2.08105 4.93 1008 2.0910–3 7.2910–2 7.63 1.36 3.7510–1 3.771014 
 9 1.38106 4.78 1007 4.1010–3 1.0210–1 28.4 1.56 2.30 3.211015 
 
 
 
1
3
1
 
 
 
 
 
 
  132 
 
5.4 Summary and Conclusions 
Wet stirred media milling is considered as the robust process for the production of poorly 
water-soluble drug nanoparticle suspensions. Besides its advantage in large scale 
production, the process is limited by long hour of operation, intense energy consumption 
and bead wear. In the present work, an intensification process methodology for WSSM 
has been developed with the objective of producing sub-100 nm particles at a reduced 
mill time, energy consumption, and bead wear. Two model poorly water- soluble drugs, 
Griseofulvin (GF) and Naproxen (NAP) were selected for this study, milled at a bench 
scale process having 200 ml batch volume with 10 wt% drug loading. The use of smallest 
beads (100 µm) in our base line process conditions enabled us to produce stable 
suspensions containing sub-100 nm (98 nm) GF particles after 6 h of milling with 
reduced energy consumption and reduced bead wear. Microhydrodynamic theory of 
beads clearly explains the following within the context of 100 µm beads (i) fastest 
particle breakage rate due to more number of stress events (ii) production of sub-100 nm 
particle due to high particle capture frequency (iii) reduced energy consumption due to 
low fluctuating motion of beads and (iv) reduced bead wear contamination due to low 
compressive stress between the beads. A milling intensity factor, which is proportional to 
the energy dissipation rate during deformation of the drug particles, explained the overall 
positive effects of the smaller beads. Further, an increased mill intensity factor was 
achieved by increasing the particle breakage rate via combined use of intense mill 
parameters such as rotor tip speed, bead load, and feed flow rate, which finally led to the 
production of 83 nm GF particles within 30 min of milling. Further reduction in both 
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particle size and milling time was not achieved due to the practical limitation of our mill 
such as maximum stirrer speed and difficulty to use/separate less than 100 µm beads.  
A comparative analysis between the baseline and intensified process conditions to 
produce GF particle size of 100 nm showed a 13.6 times reduction in cycle time with 
energy savings up to 43% with use of intensified process conditions. Bead wear 
contamination levels of zirconium and yttrium in the milled drug particles was found to 
be proportional to the milling time, and 86.5% less bead wear (zirconium) contamination 
was observed with the reduced milling time. S imilarly, milling of NAP with intensified 
process conditions also led to the faster preparation of sub-100 nm particles with reduced 
specific energy consumption and bead wear. Thus, the intensified process methodology 
developed in this Chapter presents an opportunity for formulators/engineers to design an 
intensified wet-milling process for faster production of sub-100 nm drug particles with 
energy savings and reduced bead wear contamination of final drug product.  
 
 
 
 
  134 
 
CHAPTER 6 
CONTINUOUS PRODUCTION OF DRUG NANOPARTICLE SUSPENSIONS 
VIA WET STIRRED MEDIA MILLING: A FRESH LOOK AT THE 
REHBINDER EFFECT  
 
6.1 Introduction 
Fast and efficient development of pharmaceutical formulations containing poorly water-
soluble drug particles is of great interest to the pharmaceutical industry (Date and 
Patravale, 2004). By some estimates, 60% of drug candidates currently under 
investigation can be classified as Biopharmaceutical Classification System (BCS) Class 
II, for which the bioavailability is limited by solubility rate. Recent advances in 
combinatorial chemistry aided the discovery of new drug molecules with such low 
solubility characteristics (Muller and Peters, 1998; Niwa et al., 2011). Production of 
nanoparticles and microparticles of poorly water-soluble drugs can enhance the 
dissolution rate through the significant increase of the surface area (see e.g. the Noyes–
Whitney equation (Noyes and Whitney, 1897)). Such small particles can be produced 
either by the so-called top-down approach, which includes jet milling (Chan et al., 2002), 
high pressure homogenization (Kamiya et al., 2009), and stirred media milling (Bilgili et 
al., 2004, 2006); or by the bottom-up approach (Anais et al., 2009; Chiou et al., 2008; 
Date and Patravale, 2004) which involves building up particles by precipitation of 
dissolved molecules. Both approaches have been widely used to produce 
microsuspensions (suspensions with particles having a mean or median size in the range 
1–10 μm) and nanosuspensions (suspensions with particles having a mean or median size 
less than 1 μm) (Ain-Ai et al., 2008; Basa et al., 2008; Hu et al., 2004; Kesisoglou et al., 
2007; Liversidge et al., 1995; Park et al., 2009; Tanaka et al., 2009). 
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A thorough search of pharmaceutical literature for the wet media milling of BCS 
Class II drugs shows that a great majority of the experimental data was obtained with the 
batch/recirculation operation mode. In batch operations, the mill is operated either 
vertically or horizontally, where agitation of the milling media (beads) is performed by a 
main rotating shaft, with the possibility of sub-shafts branching off. Batch mills are not 
widely used in large scale production due to scale-up issues; however, nanomilling of 
pharmaceuticals in small-scale batch operations has been documented (Bhakay et al., 
2011; Lee et al., 2008; Sepassi et al., 2007). Recirculation mode uses a  small milling 
chamber, recirculation pump, holding tank, and milling media containment screen to 
facilitate particle breakage. Similar to standard batch milling, particle breakage originates 
from the intense agitation of the beads and product suspension. A pump is employed to 
circulate the suspension from the holding tank, through the mill, and back into the 
holding tank (see Figure 6.1a). Elan’s Nanocrystal Technology™ makes use of 
recirculation media milling to produce drug nanosuspensions in marketed products like: 
Rapamune (Wyeth), Emend (Merck), Tricor (Abbott), and Megace (Par Pharmaceutical) 
(Bruno et al., 1996), with a couple of review papers (Merisko-Liversidge et al., 2002; 
Merisko-Liversidge and Liversidge 2011) thoroughly discussing the recirculation milling 
process. Several research groups (Cerdeira et al., 2011; Ghosh et al., 2011; Singh et al., 
2011) have recently used the recirculation milling mode to produce drug nanosuspensions 
in small batch sizes; however, a comparison to other milling modes was not performed. A 
comparison study of standard batch mode and recirculation mode of milling of drug 
nanosuspensions was performed using a planetary mill (Juhnke et al., 2010); however, no 
comparison or discussion of multi-pass (or cascade continuous mode) was presented.  
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Some researchers (Adjei et al., 1995; Annapragada et al., 1996; Verhoff et al., 
2003; Czekai and Seaman, 1996, 1998) refer to the recirculation operation mode as a 
continuous milling process. Although the milling is performed ‘continuously’ in a milling 
chamber, no product is withdrawn continuously from the mill as 100% of mill output is 
circulated back to a holding tank, which allows the production of a fixed batch size as 
determined by the capacity of the holding tank (Figure 6.1a). The milling dynamics is 
partly coupled to the mixing dynamics in the holding tank that is usually assumed well-
mixed. Figure 6.1b depicts a multi-pass continuous milling process:  unmilled suspension 
is loaded into the holding tank, pumped to pass through the mill, and collected into the 
receiving tank. Using this milling mode, multiple passes can be performed by repeating 
the said procedure. It is possible to automate the multi-pass mode using two separate 
holding tanks with interconnected valves and pumps by which the suspension can be 
processed from one tank to the other in a swing or pendulum motion. Figure 6.1c depicts 
a true (cascade) continuous milling process where unmilled suspension is loaded into the 
holding tank and allowed to pass through n number of mills in series before being 
collected in the receiving tank. The multi-pass mode (Figure 6.1b) is intended to simulate 
the operation of true (cascade) continuous milling (Figure 6.1c). Since it is expensive to 
acquire n (usually 6–12) number of mills for research/development purposes at the lab-
scale, the investigation of continuous milling was carried out using the multi-pass mode 
in this chapter. 
In all major chemical industries, continuous processing is widely used for large-
scale production. There is a growing interest in moving all pharmaceutical unit operations 
in drug product manufacture from batch processes to continuous processes. Recent 
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publications on continuous mixing have made the case for the feasibility of continuous 
drug product manufacture (see e.g. Berthiaux et al., 2008; Vanarase et al., 2010a, 2010b). 
This manufacturing strategy could bring the pharmaceutical industry advantages such as 
consistent and improved product quality, reduced waste, lower inventory and equipment 
costs, easy scale-up, flexibility, and short cycle times. Pharmaceutical unit operations 
such as tabletting, roller compaction, and capsule filling are already performed semi-
continuously; whereas mixing, wet milling, most granulations, drying, and tablet coating 
are usually performed in the batch/recirculation mode.  Although ample experimental 
studies of batch and recirculation mode of wet media milling exist in literature, little 
effort has been devoted to the cascade or multi-pass continuous modes. In the area of 
continuous wet stirred media milling of drugs, there are only a couple of patents available 
(Holland et al., 2006; Verhoff et al., 2003). Initial discussion on the feasibility of 
nanomilling Fenofibrate using a wet stirred media mill operating in single-pass mode was 
presented (Holland et al., 2006); however, the figures and examples provided only 
described recirculation milling. Another patent (Holland et al., 2006) presents what is 
believed to be the first documentation of cascade continuous mode of wet media milling 
of drugs, where Nabumetone nanoparticles were produced using five media mills in 
series. In both cases, only the final median particle size was provided; procedural details 
were missing, and the breakage dynamics was not studied.  
Wet stirred media milling of poorly water-soluble drugs has been commonly 
performed in recirculation/batch mode (see preceding chapters) to understand the impact 
of formulation and processing parameters, and scant information is available on the 
continuous mode of operation. 
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Figure 6.1 Schematic of recirculation, multi-pass continuous, and cascade continuous 
modes of wet media milling. ‘P’ represents pressure gauge and ‘T’ represents 
thermometer. (a) Recirculation – Suspension recirculates through the mill. (b) Multi-Pass 
Continuous – Suspension flows from holding tank, through mill, and into receiving tank. 
(c) Cascade Continuous - Suspension flows from holding tank, through mills in series, 
and into receiving tank (coolant flow for cascade continuous mode is not shown for 
clarity).Figures are not drawn to scale.  
 
An objective of the current chapter is the continuous production of nanosuspensions of 
two BCS Class II drugs, i.e. Griseofulvin (GF) and Naproxen (NAP), using a single wet 
stirred media mill (Netzsch Microcer) in the multi-pass mode. Evolution of the particle 
size distribution (PSD) during recirculation and multi-pass continuous modes of 
operation was studied to describe the breakage dynamics along with the effects of a 
reduced suspension flow rate. Another objective of the present chapter is the elucidation 
of the so-called Rehbinder effect on fine milling. The Rehbinder effect is described as the 
facilitation of crystal cleavage and decrease in hardness of crystals caused by surface-
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active agents. Adsorption of the surface-active agents can weaken the bonds in the crystal 
surface layer and lower the specific surface free energy (Butyagin, 1999; Rehbinder, 
1958; Rehbinder and Shchukin, 1972; Shchukin, 2006). When GF particles were milled 
in the presence of hydroxypropyl methyl cellulose (HPMC) as the only stabilizer in a 
Micros batch mill, limited analysis (Bhakay et al., 2011) did not reveal a significant 
Rehbinder effect. Here, GF and NAP particles were milled in the presence/absence of a 
stabilizer combination, i.e., a polymer (hydroxypropyl cellulose, HPC) and an anionic 
surfactant (sodium lauryl sulfate, SLS), toward elucidating the Rehbinder effect. Laser 
diffraction, BET nitrogen adsorption, SEM imaging, and a microhydrodynamic analysis 
were used as tools to investigate the roles of the stabilizers. Milling the drugs in the 
absence of stabilizers produced primary nanoparticles and their aggregates, while milling 
in the presence of stabilizers produced smaller primary nanoparticles with minimal 
aggregation. This is the first study in pharmaceuticals literature that provides sufficient 
evidence for the existence of the Rehbinder effect. Not only do the stabilizers allow 
proper stabilization/dispersion of the milled suspensions, but they also do facilitate the 
breakage of the drug particles.  
 
6.2 Experimental 
 
6.2.1 Materials 
GF (BP/EP micronized grade) and NAP (USP grade), were used for all wet media milling 
as reported in Chapter 5. SEM images of as-received drug particles are shown in Figure 
6.2. An anionic surfactant, sodium lauryl sulfate (SLS), and a neutral polymer, 
hydroxypropyl cellulose (HPC, SL grade), were used as stabilizers.  
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Figure 6.2 SEM images of BCS Class II drugs as received from the manufacturer: (a) 
Griseofulvin (GF) at 2 kX, (b) Naproxen (NAP) at 1 kX. 
 
6.2.2 Methods  
6.2.2.1 Preparation of Feed Suspensions. Feed drug suspensions were prepared by 
first weighing de- ionized water (Di-H2O) inside a clean beaker. SLS was weighed and 
added to the water gradually for 15 min while mixing. HPC was then weighed and added 
gradually for 30 min while mixing. The HPC/SLS solution was then mixed for an 
additional 15 min to ensure that the HPC and SLS particles were properly dissolved. SLS 
and/or HPC addition steps were skipped for runs that do not use the stabilizer(s) (see 
Table 6.1). The drug particles were then weighed and added gradually for 40 min while 
mixing. Two samples (1 mL) were taken after 40 min of mixing for PSD analysis, 
corresponding to the 0th turnover or pass sample in the dynamic study (see below). All 
mixing was performed using the low shear laboratory stirrer. To defoam and pre-cool the 
suspension, feed suspensions were kept in a refrigerator at about 8 oC for 1 h prior to 
milling. 
Table 6.1 shows the formulations used for the wet media milling experiments. 
The drug loading was 10% for all runs performed. Unless otherwise specified, all weight 
percentages are with respect to water.  
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Table 6.1 Operating Conditions and Formulations of the Wet Media Milling Experiments  
Run  
No. 
 Drug 
 
Flow 
Rate 
(mL/min) 
Milling  
Mode 
Di-H2O 
(mL) 
Drug 
Loading 
(% w/w)a 
HPC 
Concentration 
(% w/w)a 
SLS 
Concentration 
(% w/w)a 
1 GF 110 Recirculation 400 10 2.5 0.5 
2 GF 110 Multi-Pass 445 10 2.5 0.5 
3 GF 55 Recirculation 400 10 2.5 0.5 
4 GF 55 Multi-Pass 445 10 2.5 0.5 
5 GF 110 Multi-Pass 457 10 — — 
6 NAP 110 Recirculation 400 10 2.5  0.5 
7 NAP 110 Multi-Pass 445 10 2.5  0.5 
8 NAP 55 Recirculation 400 10 2.5  0.5 
9 NAP 55 Multi-Pass 445 10 2.5  0.5 
10 NAP 110 Multi-Pass 454.5 10 — 0.0825 
a
% w/w with respect to Di-H2O (de-ionized water). 
 
 
 
1
4
1
 
 
 
 
 
  142 
 
A suspension of 440 mL was used when operating in the recirculation mode. About 50 
mL residual suspension must be retained within the milling chamber during each pass of 
the multi-pass mode of operation because running the mill empty could cause serious 
damage. Therefore, the suspension volume was increased to 490 mL when milling in 
multi-pass continuous mode to account for the 50 mL residual suspension. In the first part 
of this Chapter (Runs 1–4 and 6–9), HPC and SLS loading were 2.5% and 0.5%, 
respectively. Experiments were performed with both 110 and 55 mL/min flow rate. After 
milling, samples from Runs 1, 2, 6, and 7 were refrigerated at about 8 oC for 7 days. The 
refrigerated samples were analyzed using laser diffraction to assess the short-term 
physical stability of the suspensions. Stability studies were not performed for the other 
runs with identical formulations despite the difference in the suspension flow rate.  
In the second part of this chapter, Runs 5 and 10 were designed to elucidate the 
effect of stabilizers on particle breakage by milling the drugs in the absence of stabilizers. 
No processing issue was encountered during GF milling and subsequent characterization. 
On the other hand, a thick foam was formed while attempting to prepare the NAP 
suspension without HPC/SLS (Run 10). Since the foam could not be milled as prepared, 
small batch size experiments were performed to determine the minimum amount of SLS 
required to properly wet the particles and to facilitate milling. It was determined that at 
0.0825% SLS, the foam was reduced to such a level and consistency that milling could be 
performed. Such a small addition of SLS was not expected to significantly affect the 
analysis since the amount of SLS added was substantially less than the critical micelle 
concentration (CMC) of SLS (2.36 g/L CMC vs. 0.825 g/L SLS added). However, a 
 
 
 
  143 
 
confounding effect cannot be completely ruled out due to this small SLS amount in NAP 
milling. 
6.2.2.2 Milling Procedure. The mill was set up to operate either in recirculation mode 
(Figure 6.1a) or in multi-pass continuous mode (Figure 6.1b) by choice. In recirculation 
milling, the unmilled feed suspension was loaded into the 500 mL holding tank. The 
suspension then circulates continuously from the holding tank, through the mill, and back 
into the holding tank by a peristaltic pump. A complete passage of the bulk volume from 
the holding tank, through the mill, and back into the holding tank is referred to as a 
‘turnover’. The amount of time required to perform a single turnover was calculated by 
dividing the batch volume in the holding tank by the suspension flow rate. The number of 
turnovers performed during a milling experiment is given by the ratio of the total milling 
time to the turnover time. A total milling time of 64 min was used for all milling 
experiments performed in this study.  
In multi-pass continuous milling, the unmilled suspension was loaded into the 
holding tank and pumped through the mill by the peristaltic pump and collected in the 
receiving tank; with each trip referred to as a ‘pass’. When the MicroCer mill was 
operated in the multi-pass continuous mode, additional mixing and recirculation time had 
to be introduced to deal with the 50 mL residual suspension that must remain inside the 
milling chamber in between passes. The procedure was as follows: After the first pass of 
milling, the receiving tank suspension was poured back into the holding tank and mixed 
for 3 min with the paddle mixer set at 1000 rpm. A 1 mL sample was taken after 3 min.  
The suspension was then circulated for 8 min with the mill rotor off while the 
paddle in the holding tank was rotated at 1000 rpm. This was performed to allow the 
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milled suspension and 50 mL unmilled residual suspension to mix completely. After 8 
min, the well-mixed suspension was ready to pass through the mill and to be collected in 
the receiving tank once again (the second pass). The procedure mentioned above was 
repeated for all the remaining passes.  
In both modes of milling, the mill rotor was rotated at 3600 rpm (tip speed of 13.2 
m/s), with the suspension in the holding tank mixed at 400 rpm during milling. For runs 
operating with a flow rate of 110 mL/min, 1 mL samples were taken after the 1st, 2nd, 3rd, 
4th, 7th, 8th, 12th, and 16th turnover or pass (64 min total, 4 min per turnover or pass). 
When switching to runs operating at a flow rate of 55 mL/min, samples were taken after 
the 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, and 8th turnover or pass (64 min total, 8 min per turnover 
or pass). Multi-pass mode with a flow rate of 55 mL/min required 16 min of additional 
mixing/recirculating of the 50 mL residual suspensions with the produced suspension in-
between the passes. Particle size analysis was performed on all samples (see Particle Size 
Analysis below). 
Establishment of a steady-state operation in terms of particle size is important in 
continuous milling. The rotor reaches the set speed usually within few seconds, the 
peristaltic pump recirculates the suspension at a constant flow rate with small variability, 
and the intensive cooling of the milling chamber allows maintenance of low temperature 
in the suspension during milling. Therefore, in multi-pass continuous milling, it is 
theoretically expected that the process will reach a steady-state in each pass within a short 
period of time, as compared with the duration of the whole pass. Each pass (1st, 2nd, and 
so on) corresponds to a different steady-state condition, which will emulate responses 
from different mills in series in a large-scale cascade operation. To prove that the steady-
 
 
 
  145 
 
state was achieved relatively fast, samples were taken at the outlet of the mill at 15, 30, 
60, 120, and 240 s during the 2nd pass of a GF suspension (110 mL/min flow rate), as 
opposed to the usual sampling done on the whole milled suspension obtained from the 2nd 
pass. The median particle sizes of the samples were measured by laser diffraction (see 
below) to be 684, 494, 498, 497, and 472 nm, respectively, with an average value of 529 
nm (490  13 nm excluding the 15 s sample). The 2nd pass sample collected cumulatively 
in the beaker (usual sampling) had a median size of 525 nm. These findings suggest that a 
steady-state was established within 15–30 s during the 2nd pass of the GF suspension. 
Considering the fact that the total duration of the 2nd pass was 4 min, the steady-state was 
indeed established fast. In addition, there was no need to discard the milled product 
obtained during the early 0–30 s period because the amount of suspension produced was 
small compared with the whole milled product during the 2nd pass. This approach was 
justified by the similarity between the averaged median size of the multiple time samples 
(490 nm, excluding the 15 s sample) and that from the whole sample accumulated in the  
beaker during the 2nd pass (525 nm). Of course, process engineers will opt to divert the 
product stream until a steady-state is established during cascade-continuous operation in 
manufacturing. Formulation and processing parameters may affect the attainme nt of 
steady-state and steady-state particle size, which is of practical importance; however, this 
aspect will not be treated here extensively.  
6.2.2.3 Particle Size Analysis and SEM. Particle size analysis of the milled 
suspensions was performed by laser diffraction using a Coulter Beckmann LS 13-320 
(Brea, CA, USA) as reported in previous chapters. Samples were taken during milling 
after the various turnovers or passes mentioned above and were diluted with 10 mL of the 
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relevant solution: HPC/SLS solution (Runs 1–4 and 6–9), de- ionized water (Run 5), and 
SLS solution (Run 10) prior to particle size measurements. To measure the particle size 
of the refrigerated samples after 7 days of storage, content of the sample vials was gently 
mixed by a stir bar to redisperse and homogenize the samples. All given sizes are 
volume-weighted values. Besides the usual 50% and 90% passing sizes (d50 and d90), a 
Sauter-Mean Diameter (SMD) was also calculated from the size distribution, which was 
compared with the SMD calculated from the BET analysis. SEM imaging was performed 
as reported in Chapter 3 and Chapter 4. 
6.2.2.4 Differential Scanning Calorimetry (DSC). A Mettler-Toledo Polymer Analyzer 
DSC (Model: PolyDSC) (Columbus, OH, USA) was used to obtain the onset melting 
temperature, peak melting temperature, and heat of melting of GF and NAP as received 
and after milling (Runs 5 and 10) as reported in Chapter 3.  
6.2.2.5 Raman Spectroscopy and X-ray Powder Diffraction (PXRD). In order to 
verify the findings from the DSC analysis and elucidate any changes to the GF 
crystallinity upon milling, as-received and milled/dried GF samples were subjected to 
Raman Spectroscopy and X-ray Powder Diffraction (PXRD). Raman spectra were 
collected using a Mesophotonics SE 1000 Raman spectrometer (Chilworth Science Park, 
Southampton Hampshire, UK), which was calibrated to 2 cm–1 with a 250 mW near-
infrared laser operating at 785 nm with a 130 µm diameter spot size. Data acquired with 
the Raman spectrometer represent an average of five scans, for a total of 50 seconds. All 
Raman data were as-recorded by the instrument. During the spectra acquisition, powder 
samples were placed on glass substrates. In PXRD, as-received and milled/dried GF 
particles were analyzed using a wide-angle Philips X’pert MRD Diffractometer (7609 
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RG, Almelo, Netherlands) with Cu Kradiation ( =1.5406Å). The tube voltage and 
amperage were set to 45 kV and 40 mA, respectively. The samples were scanned for 2θ 
ranging from 5o to 40o at a speed of ~0.01 2θ/s. Data were collected using Philips X’Pert 
DataCollector and analyzed using X’Pert Data Viewer.  
6.2.2.6 BET Nitrogen Adsorption. Powder samples for the BET experiments were 
obtained from the suspension samples following the same drying procedure as that used 
for the preparation of the DSC samples. The dried samples were then degassed under 
vacuum at 80 oC for 24 h to remove atmospheric moisture bound to the particle surface 
prior to nitrogen adsorption. The powder specific surface area (SSA) of Runs 5 and 10 
samples were determined from an 11-point nitrogen adsorption isotherm using a Nova 
3200 BET analyzer (Quantachrome Instruments, Boynton Beach, Florida, USA). 
Assuming spherical primary particles, the Sauter-Mean Diameter (SMD) was calculated 
using SMD = 6/(×SSA), where  is the true density of the drug (1.4 g/cm3 for GF and 
1.2 g/cm3 for NAP). 
6.2.2.7 Viscosity and Density of the Milled GF Suspensions. To be able to perform 
a microhydrodynamic analysis, the apparent shear viscosity of some of the milled GF 
suspensions (Runs 2 and 5) was determined using an R/S plus Rheometer (Brookfield 
Engineering, Middleboro, MA, USA) as reported in Chapter 3 and Chapter 4. 
Measurements were performed in duplicate to check for reproducibility. Density of the 
above suspensions (L) was determined as reported in Chapter 3 and chaprter 4. 
Measurements were performed in triplicate to check for reproducibility and the average 
was calculated.  
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6.3 Results and Discussion 
 
6.3.1 Recirculation vs. Multi-Pass Continuous Operation 
6.3.1.1 Characteristics of the Final GF and NAP Suspensions. GF and NAP particles 
were separately milled in the recirculation mode for 16 turnovers (Runs 1 and 6). They 
were also milled in the multi-pass continuous mode for 16 passes (Runs 2 and 7), while 
keeping formulation and process conditions the same (Table 6.1). For all these different 
runs, the total milling time was 64 min and the suspension flow rate was 110 mL/min. 
Irrespective of the milling mode, nanoparticles were obtained, and the final median 
particle size after 16 turnovers or passes were similar for these runs (Table 6.2). The flow 
rate was then reduced by half to 55 mL/min while leaving total milling time unchanged, 
i.e., 64 min (Runs 3, 4, 8, and 9). GF and NAP were milled in recirculation mode (Runs 3 
and 8), with the turnover time increased from 4 to 8 min to account for the decreased 
flow rate. They were also milled in multi-pass continuous mode (Runs 4 and 9) while 
keeping formulation and process conditions the same. Table 6.2 shows that even after 
reducing the flow rate by half, nanoparticles with similar median sizes were obtained 
using both modes of milling after the completion of 8 turnovers or passes.  
Overall, these results suggest that given sufficient total milling time (64 min), 
both the recirculation and multi-pass continuous modes led to similar particle sizes, 
irrespective of the suspension flow rate used. To gauge the reproducibility of the wet 
media milling process, GF runs (Runs 1 and 2) were repeated. It was observed that a 
repeat of Run 1 produced a final median particle size of 0.157 µm, yielding a 1.3 % 
difference when compared to the data shown in Table 6.2.  Similarly, a repeat of Run 2 
produced a final median particle size of 0.159 µm (a 0.6 % difference).  
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Table 6.2 Particle Size Statistics of the Suspensions Before and After Milling As Well 
As After 7-Day Storage 
Run 
No. 
Before Milling 
d50 (µm), d90 (µm) 
After Milling 
d50 (µm), d90 (µm) 
After 7-Day Storage 
d50 (µm), d90 (µm) 
1 18.8, 54.8 0.159, 0.223 0.157, 0.224 
2 16.3, 46.0 0.160, 0.229 0.157, 0.233 
3 18.3, 53.3 0.157, 0.228 — 
4 13.9, 34.9 0.154, 0.238 — 
5 15.4, 31.4 6.04, 8.76 5.33, 8.80 
6 12.9, 34.2 0.143, 0.238 0.137, 0.269 
7 10.4, 29.0 0.147, 0.253 0.145, 0.286 
8 15.7, 51.0 0.138, 0.229 — 
9 14.6, 33.8 0.146, 0.327 — 
10 17.8, 39.0 5.78, 15.3 14.5, 29.6 
Note: 7 day stability testing was not performed on Runs 3, 4, 8, and 9.  
Good reproducibility of the particle size of final drug suspensions has also been 
established in earlier work (Bhakay et al., 2013; Bilgili and Afolabi, 2012; Sievens-
Figueroa et al. 2012), regardless of the variability in the initial as-received drug particle 
size provided that the suspensions had a wetting agent (e.g. SLS) and some stabilizers 
(e.g. HPC and SLS). A short-term physical stability study of several suspensions (Runs 1, 
2, 5, 6, 7, and 10) was performed by analyzing particle size after seven days of storage 
(Table 6.2). Results indicate the amount of polymer and surfactant used was sufficient to 
stabilize the suspensions against both aggregation and ripening, as deduced from a 
comparison of the d50 and d90 values after milling and 7-day storage (similar particle 
sizes). 
To develop a more fundamental understanding of the HPC–SLS synergy and the 
interactions with the specific drugs considered here, HPC–SLS adsorption on the 
respective drug surfaces must be studied (see Chapter 3). In the absence of stabilizers 
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(Run 5) or with minimal amount of surfactant (Run 10), aggregates of smaller particles 
formed during milling, rendering the suspensions unstable. A stability study was not 
performed on runs operating at the reduced flow rate as the formulation remained 
unchanged. In addition, a long-term stability was not performed as the suspensions were 
intended to be dried shortly after media milling in various drying applications (as in 
Bhakay et al., 2013; Sievens-Figueroa et al., 2012). Readers are referred to Bhakay et al., 
(2013) and Sievens-Figueroa et al., (2012) for the effects of drying of the drug 
nanosuspensions on the reconstitution of the nanoparticles. In aqueous dispersion of the 
dried products (coated microparticles and films), the formulations used in this study led 
to stable, well-dispersed suspensions with effective recovery of the drug nanoparticles.  
A DSC study was performed on various samples to investigate the effect of 
milling on the drug crystallinity. DSC thermograms (Figure 6.3) exhibited sharp 
endothermic peaks associated with the melting of the crystalline drugs; no other thermal 
event was encountered. It should be noted that milling, especially dry milling and 
cryomilling, can induce defects in crystals as well as amorphous regions, which can lead 
to appearance of exothermic response like recrystallization and glass transition (see e.g. 
Feng et al., 2008; Sharma et al., 2009; Zarow et al., 2011). If crystal defects accumulate 
to a significant extent and/or amorphous content becomes appreciable, the melting 
temperature and the heat of melting can be reduced significantly (Feng et al., 2008). 
Polymorphic changes can also lead to such changes.  
As presented in Table 6.3 for GF and NAP, both the onset and peak melting 
temperatures of the as-received samples remained the same after milling of GF (Run 5) 
and NAP (Run 10). No broadening of the melting point range was observed. Only a slight 
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decrease (5.4%) in the heat of melting (fusion) was observed for GF, whereas a 5.1% 
increase was observed for NAP.  
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Figure 6.3 DSC thermograms of (a) as-received GF and milled/dried GF w/o stabilizers 
(Run 5), (b) as-received NAP and milled/dried NAP w/o HPC/0.08% SLS (Run 10).  
 
Table 6.3 Melting Points and Heat of Melting of As-Received and Milled GF and NAP 
Sample Onset Melting Point 
(oC) 
Peak Melting Point 
(oC) 
ΔHm 
(J/g) 
As-received GF  218.0 220.1 111.1 
Milled GF, w/o HPC/SLSa 217.3 219.2 105.1 
As-received NAP 155.0 158.6 136.0 
Milled NAP, w/o HPC/0.08% SLSb 153.9 157.9 142.9 
aRun 5 
bRun 10   
 
These small deviations in the heat of melting could be attributed to experimental errors 
(sample weight, bulk density, and particle size differences in the samples as well as 
presence of SLS in NAP sample, etc.). Overall, the DSC results suggest that the 
crystalline nature of GF and NAP was largely preserved after milling and no polymorphic 
form change has occurred during milling; a cautionary note that small amount of 
amorphous content may not be accurately determined using the DSC.  
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Figure 6.4 Raman spectra of as-received and milled/dried GF w/o HPC/SLS (Run 5): (a) 
the 0 to 3500 cm-1 region, (b) expanded view of the 0 to 1000 cm-1 region. 
 
In order to support the findings from the DSC analysis, an extensive 
characterization was performed on as-received and milled/dried GF samples using Raman 
spectroscopy and PXRD. The Raman spectra of the as-received and milled/dried samples 
of GF were very similar, with characteristic peaks occurring at similar frequencies 
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(Figure 6.4). The occurrence of a doublet peak in the ~640 cm–1 region is attributed to the 
C–Cl stretching mode in the GF molecule (Feng et al., 2008; Zarow et al., 2011). Only a 
single peak would appear at this frequency if the samples were amorphous. More 
importantly, the ~820 cm–1 line, attributed to the cyclohexanone ring stretching vibration, 
is well-known to disappear upon a decrease in GF crystallinity (Zarow et al., 2011), while 
a sharp peak is still visible after milling in the milled sample.  
The PXRD pattern of the milled/dried sample was similar to that of the as-
received GF sample (Figure 6.5), with some reduction in peak heights. The peak 
positions were very similar to the published experimental and computed PXRD patterns 
of pure, crystalline GF in the literature (Feng et al., 2008; Zarow et al., 2011).  Therefore, 
Raman spectra and PXRD patterns appear to support the findings from the DSC analysis 
in that wet media milling did not significantly change the crystalline nature of GF within 
the detection limits of the respective equipment. The reduction in PXRD peak heights 
could be attributed to small amount of defects formed at the particle surfaces and 
nanocrystalline nature of the particles produced by the wet media milling (Feng et al., 
2008; Zarow et al., 2011). In the absence of water, cryomilling of GF and indomethacin 
led to significant reduction in crystallinity: transformation to amorphous form and crystal 
defects (Feng et al., 2008; Sharma et al., 2009; Zarow et al., 2011). Interestingly, in the 
presence of water, cryogrinding did not produce amorphous phase for indomethacin 
(Sharma et al., 2009). Plasticizing action of water on the newly formed amorphous 
content and ensuing rapid recrystallization could be one mechanism (Sharma et al., 
2009). In wet media milling, besides having a plasticizing effect, water allows fast and 
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effective cooling during particle breakage, which can minimize formation of local hot 
spots on particle surfaces and thus reduce the extent of surface amorphization.    
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Figure 6.5 PXRD patterns of the as-received GF and milled/dried GF w/o HPC/SLS 
(Run 5). 
 
6.3.1.2 Evolution of Particle Size during Milling: Effects of Operation Mode.  
Samples were periodically taken from the holding tank at various turnovers or passes 
corresponding to different processing times. Note that the processing time is typically 
much larger than the total mean residence time, which is equal to the mean residence time 
during a single pass multiplied by the number of passes in the multi-pass mode 
(excluding the remixing time associated with the 50 mL residual suspension). The 
samples were analyzed using laser diffraction to study the evolution of the PSD. Since 
the analysis and discussion of the wet stirred media milling dynamics of drugs is scarce 
(see Bhakay et al., 2011), a thorough analysis will be given here. Figure 6.6 presents the 
d50 and d90 evolution during recirculation and multi-pass continuous milling of GF (Runs 
1 and 2) and NAP (Runs 6 and 7) at a flow rate of 110 mL/min. For both GF and NAP 
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cases with either operation mode, upon an increase in processing time, the particle size 
was reduced almost monotonically and no apparent size increase was observed while an 
equilibrium (plateau or limiting) particle size was approached or attained after a high 
number of turnovers or passes (about 8 for GF and 12 for NAP). A size increase may 
occur in poorly stabilized suspensions during milling if the aggregation rate of produced 
fine particles exceeds the rate at which large particles and aggregates break (Bhakay et 
al., 2011). In view of this, the results suggest that particle breakage was the dominant 
mechanism and aggregation of the particles occurred at a smaller rate than the breakage 
in the presence of stabilizers during most of the milling process. Of course, as milling 
progressed long enough, aggregation rate increased upon production of finer (colloidal) 
drug particles, which could be a reason for the equilibrium (plateau) approached at the 
high number of turnovers/passes (Knieke et al., 2008, 2009). As the drug particle size 
decreases, number concentration in the suspension increases and the interparticle distance 
decreases, leading to more frequent collisions and potentially higher aggregation rate 
(Bhakay et al., 2011; Sommer et al., 2006). On the other hand, the drastic decrease in 
breakage rate and observed approach to a plateau size in Figure 6.6 can be partly 
explained by another factor: as milling progressed, finer particles were produced, which 
have a much lower specific breakage rate (breakage probability) than the coarser particles 
and thus are harder to break (Bilgili et al., 2004, 2006, 2008). Population balance models 
without any aggregation terms (Bilgili, 2007; Bilgili and Capece, 2011) were able to 
capture the sharp decrease in breakage rate even during the breakage of large 
microparticles. Considering that nanoparticles are even less likely to break than 
microparticles (Bilgili et al., 2004, 2006), it can be argued that the approach to or 
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attainment of a plateau size observed in Figure 6.6 is not solely explained by the 
aggregation of fine particles (especially nanoparticles), but also by the extremely low 
breakage probability of such particles.  
Recirculation and multi-pass operation modes of GF milling seem to result in a 
similar evolution of the particle size at 110 mL/min (Figure 6.6). In the case of NAP, the 
recirculation mode had a slightly faster breakage rate than the multi-pass continuous 
mode after the first few turnovers/passes. Initially, larger particle size observed in the 
recirculation mode prior to milling (due to as-received PSD variability) caused a larger 
particle size in this mode as compared with the multi-pass mode during the first turnovers 
or passes. In general, at this high flow rate, the evolution of the PSD and final pa rticle 
size after 16 turnovers or passes were very similar. Figure 6.7 illustrates the particle size 
evolution during GF (Runs 3 and 4) and NAP (Runs 8 and 9) milling at a reduced flow 
rate of 55 mL/min. Again, after the first or second turnover/pass, recirculation mode had 
a greater breakage rate than the multi-pass mode. The impact of the initial size difference 
seems to disappear after the second turnover/pass.  
 A cursory look at Figures 6.6 and 6.7 suggests that a larger disparity between the 
milling modes occurred when milling was performed at a reduced flow rate. This could 
be partly explained by the presence of 50 mL residual (unmilled) suspension (about 10% 
of the total suspension) that had to be left unprocessed in the milling chamber and tubing 
during each pass of the multi-pass mode. This residual suspension was mixed later on 
with the milled suspension in the receiving tank (see Figure 6.1b), and the mixed 
suspension was then used as the feed to the subsequent pass.  
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Figure 6.6 Evolution of d50 and d90 during recirculation and multi-pass continuous modes 
of wet media milling with 110 mL/min suspension flow rate: (a) Griseofulvin (GF) (Runs 
1 and 2), (b) Naproxen (NAP) (Runs 6 and 7).  
 
# of Turnovers or Passes
0 2 4 6 8
P
a
rt
ic
le
 S
iz
e
 (

m
)
0.1
1
10
100
(b)
d
50:NAP-Rec.
d
50:NAP-Cont.
d
90:NAP-Rec.
d
90:NAP-Cont.
# of Turnovers or Passes
0 2 4 6 8
P
a
rt
ic
le
 S
iz
e
 (

m
)
0.1
1
10
100
d50: GF-Rec.
d50: GF-Cont.
d90: GF-Rec.
d90: GF-Cont.
(a)
 
Figure 6.7 Evolution of d50 and d90 during recirculation and multi-pass continuous modes 
of wet media milling with 55 mL/min suspension flow rate: (a) Griseofulvin (GF) (Runs 
3 and 4), (b) Naproxen (NAP) (Runs 8 and 9).   
 
 
 
 
  158 
 
Hence, some 10% of the particles were subjected to no milling action in a given pass 
during the multi-pass mode, which may have contributed to the observed smaller 
breakage rate for both GF and NAP. This may also explain the larger d90 for NAP even 
after 8 turnovers in the multi-pass mode as compared with that in the recirculation mode 
(see Runs 8 and 9 in Table 6.2). This effect of the residual suspension is expected to 
disappear as the number of passes increases because further mixing of the residual 
suspension and the milled suspension takes place. There were 8 passes associated with 55 
mL/min flow rate as opposed to 16 passes at 110 mL/min, leading to a reduction of the 
number of times the residual suspension in the milling chamber was mixed with the 
milled product in the holding tank and subsequently milled for the former case. It should 
be noted that the effect of the residual suspension will completely disappear as the ratio 
of residual suspension to total suspension volume decreases (larger scales and/or larger 
product volumes).  
6.3.1.3 Effects of the Suspension Flow Rate. To analyze the milling dynamics 
more quantitatively, the median particle size (d50) data presented in Figures 6.6 and 6.7 
were fitted by the following two-parameter empirical model shown in Eq. (2.7) (See 
Chapter 2.3).Table 6.4 presents the values of the parameters dlim and τp as well as some 
fitting statistics. The coefficient of determination (R2) and the sum of squared-residuals 
(SSR) gauge the accuracy with which the model explains the deviations from the 
experimental data. An R2 value approaching 1 and small SSR values reflect good 
accuracy. Table 6.4 shows an acceptable fit of the data (R2 values greater than or equal to 
0.92). COV% is defined as the ratio of the standard deviation to the mean of the 
estimated parameter, where a lower value makes the parameter more precise and more 
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certainly non-zero. In addition, p-values less than 0.05 indicate that the parameters are 
non-zero and statistically significant. All p-values (not shown in table) for the parameters 
shown in Table 6.4 were found to be less than 0.006, signifying the statistical 
significance of the model parameters.  
The estimated dlim values (Table 6.4) are almost identical to the experimental 
median particle sizes obtained after total milling time of 64 min (Table 6.2), except for 
Runs 4 and 8, thus giving some credence to the purely empirical model (Eq. (2.7)). Even 
for Runs 4 and 8, the experimental median size was within two standard deviation of the 
estimated dlim.  
Table 6.4 Parameter Estimates from the Empirical Model Fit (Eq. (2.7)) to the  
Milling Data with Statistical Analysis 
Run 
No.a 
dlim, COV% 
(µm), (–) 
τp, COV% 
(min), (–) 
R2 
(–) 
SSR 
(–) 
1 0.159 (5.98) 5.59 (8.93) 0.980 1.32×10-2 
2 0.156 (6.37) 6.06 (8.93) 0.980 1.39×10-2 
3 0.155 (4.75) 6.45 (9.25) 0.983 9.76×10-3 
4 0.128 (12.8) 16.3 (12.1) 0.978 9.66×10-3 
6 0.148 (8.84) 4.67 (10.8) 0.969 3.16×10-2 
7 0.179 (12.0) 5.88 (17.8) 0.920 5.09×10-2 
8 0.136 (3.40) 5.78 (7.29) 0.990 5.50×10-3 
9 0.145 (18.5) 12.5 (17.7) 0.925 4.20×10-2 
a
Note: Data for Runs 5 and 10 were not fitted as the suspensions were not physically stable.  
 
The main interest lies in the time constant (τp). Comparing τp values of different milling 
modes at a flow rate of 110 mL/min (Runs 1 vs. 2 for GF and Runs 6 vs. 7 for NAP), 
analysis from the model fit illustrate that the breakage in the recirculation mode of 
milling was slightly faster than the breakage in the multi-pass continuous mode. 
Comparing the same processes at a reduced flow rate (Runs 3 vs. 4 and Runs 8 vs. 9) led 
to confirm this finding. Moreover, an additional evidence for the increased disparity 
between the recirculation and multi-pass continuous modes of milling at the lower 
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suspension flow rate (55 mL/min) can be observed. This was partly ascribed to the 50 mL 
residual suspension in the multi-pass mode, but it could also be related to the degree of 
back-mixing taking place in the milling chamber (see below). 
A comparison of the empirical model fit parameters from Runs 1 vs. 3, Runs 2 vs. 
4, Runs 6 vs. 8, and Runs 7 vs. 9 in Table 6.4 shows that the runs with a suspension flow 
rate of 55 mL/min had a larger characteristic time constant than the runs with a 
suspension flow rate of 110 mL/min. This suggests a slower overall breakage rate at the 
lower suspension flow rate. Comparing Figures 6.6 and 6.7 suggests a wider PSD at the 
reduced flow rate. Since a study of the residence time distribution (RTD) of particles in 
the mill is beyond the scope of this chapter, few limited studies will be mentioned from 
the literature to discuss the effects of the suspension flow rate from the RTD perspective. 
During wet media (bead) milling of various materials, an increase in the suspension flow 
rate caused a tightening of the RTD (Deutsche Keramische Gesellschaft, 2009; Kula and 
Schütte, 1987; Stehr, 1982) (less back-mixing) or that a decrease led to widening of the 
RTD (Stehr and Schwedes, 1983). Within the context of the convection–dispersion model 
(Schwedes and Bunge, 1993; Stehr, 1984), the RTD in a wet stirred media mill may be 
described by a single dimensionless number called Péclet (Pe) number: Pe = VL/D. Here, 
V is the average axial velocity of the suspension, L is the length of the horizontal mill 
chamber, and D is the axial dispersion coefficient. A Pe value of 0 describes an ideal, 
perfectly well-mixed vessel (perfect back-mixing), whereas a Pe value of ∞ describes 
ideal, plug-flow vessel (no back-mixing). Obviously, real systems operate somewhere in 
between these two extreme, idealized back-mixing scenarios: Pe for stirred bead mills 
usually varies from 0.6 to 5 depending on the operational conditions  (Schwedes and 
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Bunge, 1993). This suggests that the mixing condition in stirred media mills is closer to 
that of a perfectly well-mixed vessel (Folger, 1999). From the definition of Péclet (Pe) 
number, one can see that an increase in the suspension flow rate leads to a larger Pe 
(tighter RTD) through a proportional increase in V (with negligibly small increase in D), 
which in turn leads to a tighter and usually finer PSD during milling (Deutsche 
Keramische Gesellschaft, 2009; Schwedes and Bunge, 1993; Stehr, 1982, 1984; Stehr 
and Schwedes, 1983). Population balance modeling of continuous mills demonstrated 
that the PSD is tighter and finer for a mill with no back-mixing (plug-flow) than that with 
perfect mixing (Bilgili and Scarlett, 2005), thus suggesting a higher overall breakage rate 
for the plug-flow case. In summary, the wider PSD and reduced overall breakage rate 
associated with the decrease in the suspension flow rate could be explained by a decrease 
in the Péclet (Pe) number (widening of the RTD).     
 
6.3.2 Role of Stabilizers in Wet Media Milling 
During wet media milling of materials, stabilizers such as polymers and surfactants, also 
known as grinding aids, can affect or play a major role in three phenomena: stabilization 
of the suspension and proper dispersion of the product particles, microhydrodynamics 
during media milling as affected by suspension rheology, and particle strength (El-Shall 
and Somasundaran, 1984; Klimpel, 1999). In a suspension, electrically neutral polymers 
like HPC stabilize particles by steric forces that are created by protruding large chains 
after polymer adsorption onto the particle surfaces (steric mechanism); whereas anionic 
surfactants like SLS can render the particles negatively charged after adsorption, which 
increases the electrostatic repulsion among adjacent particles and thereby preventing 
particle aggregation (electrostatic mechanisms) (El-Shall and Somasundaran, 1984; 
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Klimpel, 1999). Combination of polymers (like HPC) and surfactants (like SLS) is 
known to have synergistic stabilizing effects (Basa et al., 2008; Ryde and Ruddy, 2002). 
It is interesting to note that most pharmaceuticals literature on wet media milling focused 
on the first phenomena, i.e., stabilization and proper dispersion of the particles (e.g. 
Bruno et al., 1996; Ghosh et al., 2011; Lee et al., 2008; Singh et.al., 2011), thus largely 
neglecting the impact of the stabilizers on the microhydrodynamics and the particle 
strength (associated with the Rehbinder effect). The so-called Rehbinder effect 
(Rehbinder, 1958) is defined as the reduction in surface energy and surface structure 
change upon adsorption of surface-active agents, which leads to an increase in ductility, 
reduced hardness, and enhanced crack propagation in various materials (Butyagin, 1999; 
Karpenko, 1974; Rehbinder and Shchukin, 1972; Shchukin, 2006), thus potentially 
enhancing the breakage of particles during wet milling operations (Butyagin, 1999; 
Rehbinder, 1958; El-Shall and Somasundaran, 1984). Unfortunately, up to now, 
sufficient experimental data are not available to prove or disprove the Rehbinder effect 
during milling processes (Kissa, 1999; Tadros, 1994) perhaps due to the aforementioned 
confounding effects of the stabilizers.  
6.3.2.1 Stabilization and Rehbinder Effect. Milling experiments were carried out 
under identical conditions (same set points for the process variables) in the presence and 
absence of stabilizers (HPC/SLS) toward elucidating the roles of stabilizers. To this end, 
particle sizing via laser diffraction (LD), SEM imaging, and BET nitrogen adsorption 
were used. The Sauter-Mean Diameter (SMD) was calculated separately from the LD 
particle size distribution data on milled suspension samples and the specific surface area 
(SSA) (BET adsorption on dried suspension samples). No BET adsorption was performed 
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on samples with the stabilizers as the particle surfaces were covered by excessive 
amounts of the stabilizers, which could prevent accurate measurement of the SSA 
without yielding a good estimate of the primary particle size. Table 6.5 summarizes the 
calculated SMD values. A suspension of GF without the stabilizers (HPC/SLS) was 
prepared and milled in the multi-pass continuous mode (Run 5). The PSD was obtained 
and compared to that of the milled GF in the presence of the stabilizers (Run 2).  
Table 6.5 Sauter-Mean Diameter (SMD) of the Milled GF and NAP 
Run 
No. 
Drug Stabilizers Added 
Before Milling 
Stabilizers Added 
After Milling 
Measurement 
Methoda 
SMD 
(µm) 
2 GF 2.5% HPC/0.5% SLS — LD 0.153 
5 GF — — LD 1.48 
5 GF — — BET 0.522 
5 GF — 2.5% HPC/0.5% SLS  LD 0.479 
7 
10 
10 
NAP 
NAP 
NAP 
2.5% HPC/0.5% SLS 
0% HPC/0.08% SLS 
0% HPC/0.08% SLS 
— 
— 
— 
LD 
LD 
BET 
0.130 
0.563 
1.12 
aLD (laser diffraction) was performed on wet suspension samples, whereas BET nitrogen  
adsorption was performed on oven-dried suspensions after degassing.  
 
Figure 6.8 illustrates that in the absence of the stabilizers, GF suspension exhibits a 
bimodal PSD, possibly indicating the presence of primary nanoparticles and their 
aggregates of various sizes (to be confirmed with SEM imaging and BET adsorption 
analysis). On the other hand, the PSD of GF suspension milled with the stabilizers shows 
a tight, unimodal distribution of particle sizes in the range of about 100–200 nm. Figure 
6.9 presents the SEM images of the dried samples from Runs 2 and 5. Figure 6.9a shows 
GF milled in the absence of the stabilizers (Run 5) at low magnification, with mostly 
aggregated particles sized between 1 and 20 µm in size. Further magnification of these 
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particles (Figure 6.9b) shows the existence of primary nanoparticles with a size range of 
150–600 nm.  To compare these results, SEM images of the GF milled in the presence of 
the stabilizers in both recirculation and multi-pass continuous modes (Runs 1 and 2) 
(Figure 6.9c and 6.9d) are shown, where primary particles sized between 100–200 nm 
can be observed. 
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Figure 6.8.Effect of polymer/surfactant (HPC/SLS) on the particle size  distribution of 
milled GF (Runs 2 and 5). 
 
The SEM imaging appears to corroborate the laser diffraction results: Run 5 suspension, 
being unstable in the absence of the stabilizers, consists of some nanoparticles and their 
aggregates (primary particle sizes in the size range of 150–600 nm), whereas Run 2 
suspension, being stable in the presence of the stabilizers, consists of primary 
nanoparticles in the size range of 100–200 nm (see both Figure 6.9d and Figure 6.8) with 
minimal amount of aggregates. This suspension was also physically stable over 7-day 
storage (see Table 6.2). 
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Figure 6.9 SEM images of milled Griseofulvin (GF): (a) milled in multi-pass continuous 
mode for 16 passes w/o HPC/SLS at 1.5 kX (Run 5), (b) milled in multi-pass continuous 
mode for 16 passes w/o HPC/SLS at 100 kX (Run 5), (c) milled in recirculation mode for 
16 turnovers w/ HPC/SLS at 137 kX (Run 1), (d) milled in multi-pass continuous mode 
for 16 passes w/ HPC/SLS at 137 kX (Run 2).  
 
In the absence of the stabilizers (HPC/SLS), the  nanoparticles formed by the 
breakage of GF particles in Run 5 aggregated extensively in the suspension due to their 
large surface area, high number concentration, and strong attractive interparticle forces 
(van der Waals and hydrophobic interactions (El-Shall and Somasundaran, 1984; Kissa, 
1999). On the other hand, due to the synergistic stabilizing action of adsorbed HPC/SLS  
(Basa et al., 2008; Ryde and Ruddy, 2002), the nanoparticles were protected against 
aggregation during the milling and storage, and thus a stable suspension formed in Run 2. 
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Besides its interaction with HPC, SLS helps wetting the particles and aggregates that may 
have formed instantaneously during the milling. SLS also helps fluid penetration into 
aggregate pores, which may in turn facilitate the deaggregation of these aggregates into 
primary particles during the milling (Kissa, 1999). 
All of these aspects that relate to the stabilization/dispersion phenomena are 
widely recognized within the pharmaceuticals field. Polymers and surfactants have a 
major role in wet media milling: they stabilize particles against aggregation and ensure 
the production of a stable, properly dispersed suspension. On the other hand, a more 
important conclusion can be drawn from the aforementioned SEM images: the primary 
GF nanoparticles formed in the presence of the stabilizers (Run 2, 100–200 nm) appear to 
be smaller than those formed in the absence of the stabilizers (Run 5, 150–600 nm). In 
other words, the stabilizers facilitated the particle breakage and caused the formation of 
smaller primary particles during the milling. This is the first piece of evidence for the 
Rehbinder effect of HPC/SLS during the wet milling of GF particles. To gather additional 
evidence, Sauter-Mean Diameter (SMD) values calculated from LD and BET analysis 
were compared (see Table 6.5). The SMD values obtained from the LD data were 1.48 
µm for Run 5 sample (no stabilizers) and 0.153 µm for Run 2 sample (with the 
stabilizers). From the BET analysis, SSA and SMD values were 8.21 m2/g and 0.522 µm 
for Run 5 sample. The SMD calculated from SSA (BET nitrogen adsorption) is a good 
measure of the true primary particle size in a powder with aggregates (Vital et al., 2008). 
For Run 5 (without stabilizers), the SMD value of 0.522 µm (BET) vs. 1.48 µm (LD) 
confirms that Run 5 particles in the suspension consist of nanoparticles and their 
aggregates. More importantly, while noting the difference in the respective measurement 
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techniques, with the SMD value of 0.522 µm (BET) and the observed primary particle 
size range of 150–600 nm (SEM), it can be confirmed that Run 5 (no stabilizers) primary 
particles are indeed larger than those of Run 2 (with stabilizers), thus giving credence to 
the existence of the Rehbinder effect.  
It is argued that stabilizers can be added to a milled drug suspension (without 
stabilizers) at the end of the milling process, which may result in a similar PSD to that 
obtained with initial addition of the stabilizers (standard procedure). If this were the case, 
the Rehbinder effect could be refuted because the stabilizers would not appear to 
facilitate the particle breakage (Bhakay et al., 2011). Toward testing this hypothesis, 
HPC/SLS was dissolved in 50 mL Run 5 sample by mixing for 15 min (GF suspension 
obtained from the 16 passes of the multi-pass continuous milling in the absence of the 
stabilizers) to prepare a suspension with 2.5% HPC and 0.5% SLS while keeping GF 
loading at 10%. This sample was then sonicated for 35 min to facilitate the efficient 
deaggregation of the aggregates in Run 5 based on the learning from a comprehensive 
redispersion study on drug nanoparticle deaggregation (Bhakay et al., 2013). PSD data 
obtained from laser diffraction of Run 5 sample after HPC/SLS addition shows an SMD 
of 0.479 µm (Table 6.5), which was much larger than the SMD value for the Run 2 
sample (0.153 µm) with the stabilizers added at the beginning of the milling.  Similar 
information can be gained from a comparison of the SEM images in Figure 6.9d (Run 2) 
and 10 (Run 5, after HPC/SLS addition): the primary particles appear to be smaller when 
the stabilizers were added at the beginning of the milling (Figure 6.9d) as opposed to the 
case where the stabilizers were added at the end of milling (Figure 6.10). Hence, the 
Rehbinder effect cannot be refuted. 
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Similar to the analysis performed on GF, the PSD of NAP milled with no 
HPC/0.08% SLS (Run 10) was obtained and is shown in Figure 6.11, along with NAP 
milled in the presence of HPC/SLS (Run 7). Figure 6.11 suggests that NAP milled with 
no HPC/0.08% SLS produced a bimodal distribution, which indicates the presence of 
primary nanoparticles and their aggregates (see also Figure 6.12), while the PSD of NAP 
milled with stabilizers shows a tight, unimodal distribution with particle sizes in the range  
of 50–250 nm. The LD analysis yielded SMD values of 0.130 µm and 0.563 µm for Runs 
7 and 10 respectively (Table 6.5). BET adsorption analysis yielded an SMD value of 1.12 
µm (SSA = 4.45 m2/g). SEM image of Run 10 viewed under low magnification is 
provided in Figure 6.12a: aggregated particles can be seen. Further magnification of these 
aggregated particles (Figure 6.12b) shows evidence of primary particles with a size range 
of about 200–1000 nm. Figures 6.12c and 6.12d (Runs 6 and 7) show primary 
nanoparticles sized mostly between 100–200 nm when HPC/SLS combination was used 
during the milling. The above results from SMD data and SEM imaging confirms the 
presence of larger primary particles in the case of no HPC/0.08% SLS than in the case of 
2.5% HPC/0.5% SLS, and that the suspension was not properly stabilized in the former 
case. These findings provide evidence for the Rehbinder effect in NAP milling; however, 
a cautionary note that the presence 0.08% SLS (albeit much smaller than the CMC of 
SLS) may confound some of the above findings in NAP case. However, it was not 
feasible to process NAP particles consistently and reproducibly due to poor wetting of 
NAP in the absence of the surfactant. 
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Figure 6.10 SEM image (magnification at 75 kX) of Griseofulvin (GF) particles after 
milling in multi-pass continuous mode for 16 passes in the absence of HPC/SLS (Run 5) 
followed by addition of 2.5% HPC and 0.5% SLS with sonication for 35 min.  
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Figure 6.11 Effect of polymer/surfactant (HPC/SLS) on the particle size distribution of 
milled Naproxen (NAP) (Runs 7 and 10).  
 
6.3.2.2 Suspension Rheology and Microhydrodynamics. One may argue that the 
aforementioned positive effects of the presence of stabilizers in the production of finer 
primary drug particles and stable nanosuspensions could have resulted from the 
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stabilizers’ impact on the suspension rheology and microhydrodynamics in the mill.  
Toward testing this hypothesis, the apparent shear viscosity of the milled GF suspensions 
(Runs 2 and 5) as a function of shear rate was measured (see Figure 6.13).  
 
Figure 6.12 SEM images of milled Naproxen (NAP): (a) milled in multi-pass continuous 
mode for 16 passes w/o HPC and with 0.08% SLS at 1.0 kX (Run 10), (b) milled in 
multi-pass continuous mode for 16 passes w/o HPC and with 0.08% SLS at 75 kX (Run 
10), (c) milled in recirculation mode for 16 turnovers w/ HPC/SLS at 137 kX (Run 6),  
(d) milled in multi-pass continuous mode for 16 passes w/ HPC/SLS at 130 kX (Run 7).  
 
The stabilized GF suspension with minimal aggregation (Run 2, with HPC/SLS) exhibits 
a Newtonian fluid behavior above a shear rate of 150 1/s, whereas the unstable GF 
suspension with aggregates (Run 5, without HPC/SLS) exhibits a strong shear-thinning 
behavior due to extensive deaggregation of the aggregates with increasing shear rate. The 
apparent viscosity of Run 5 suspension tends to plateau as the shear rate approaches 1000 
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1/s. These observations are in line with other suspension rheology studies (Barthelmes et 
al., 2010; Bernhardt et al., 2010; Vital et al., 2008). Although the shear rate in media 
mills usually exceeds 1000 1/s, most earlier work considered 1000 1/s as a representative 
value for the high shear rate in their analysis (Barthelmes et al., 2010; Bernhardt et al., 
2010; Knieke et al., 2010; Vital et al., 2008). As can be seen from Figure 6.13, for both 
suspensions, the apparent shear viscosities approach a constant value near 1000 1/s; 
hence, taking the viscosity value at a shear rate of 1000 1/s does not cause a serious flaw 
within the context of the microhydrodynamic analysis presented below.  
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Figure 6.13 Variation of the apparent shear viscosity as a function of the shear rate at 25 
oC for the milled Griseofulvin (GF) suspensions: with stabilizers (Run 2) and without 
stabilizers (Run5). 
 
A microhydrodynamic analysis of wet stirred media mills has been recently 
developed to simulate the impact of mill rotor speed and bead type/size on the bead–bead 
collisions and to relate the responses from these simulations to some general observations 
from wet media milling experiments (Eskin et al., 2005a, 2005b). The 
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microhydrodynamic analysis have been used to explain the experimentally observed 
“viscous dampening” phenomenon (see Chapter 3) during the wet media milling of high 
drug–polymer loaded suspensions (Bilgili and Afolabi, 2012). According to this 
theoretical approach, the specific power applied to the mill rotor (Pw) dissipates through 
the fluctuating motions of the beads at the micro-scale, which is mathematically 
expressed in Chapter 2.4. Table 6.6 presents the measured parameters Pw, L, and µL and 
calculated values of, ub, and ν. Milling in the absence of the stabilizers (Run 5) led to 
slightly higher , ub, and ν values than milling in the presence of the stabilizers (Run 2).  
Table 6.6 Measured Parameters (Pw, L, and µL) and Calculated Microhydrodynamic 
Parameters ( , , and ub) for Milling of GF  
Run 
No. 
Pw 
(W/m3) 
L 
(kg/m3) 
µL 
(cP) 

(m2/s2) 
  
(1/s) 
ub 
(m/s) 
2 1.24×106 1037 31.0 2.28×10-2 6.47×103 2.41×10-1 
5 7.89×105 1008 10.4 2.61×10-2 6.92×103 2.58×10-1 
 
The microhydrodynamic analysis suggests that slightly faster particle breakage and finer 
primary particles should have been observed in the absence of the stabilizers because the 
higher values of , ub, and ν mean more intense and frequent bead–particle collisions in 
the mill. However, the experimental findings presented earlier suggest otherwise. 
Therefore, the aforementioned positive effects associated with the use of the stabilizers 
(proper stabilization/dispersion and facilitation of the particle breakage or Rehbinder 
effect) did occur despite the less favorable microhydrodynamics in the mill.   
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6.4 Summary and Conclusions 
Two poorly water-soluble drugs, Griseofulvin and Naproxen, were milled in a wet stirred 
media vessel using the recirculation mode and the multi-pass continuous mode at two 
different suspension flow rates. Breakage dynamics was assessed using an empirical 
model fit of the median particle size. The roles of stabilizers (HPC and SLS) have been 
elucidated by performing experiments in the presence/absence of stabilizers and 
characterizing the milled suspensions and dried suspensions via laser diffraction, BET 
nitrogen adsorption, and SEM imaging. Based on characterization with DSC (on both GF 
and NAP), PXRD (on GF), and Raman spectroscopy (on GF), the crystallinity of the 
drugs has been largely preserved after wet media milling. Continuous production of drug 
nanoparticles and stable nanosuspensions has been successfully demonstrated in the 
multi-pass continuous mode, which in general yielded similar PSDs to those obtained 
from the recirculation mode especially at the high flow rate. The deviations observed 
between the two operation modes is attributed to the 50 mL residual suspension in each 
pass during the multi-pass operation mode. The observed decrease in the breakage rate 
during the milling and approach to a plateau size upon prolonged milling were explained 
thoroughly in view of the lower specific breakage rate (breakage probability) of produced 
finer particles and the equilibrium between breakage and aggregation. When the flow rate 
was halved keeping the same total milling time (half number of passes), the overall 
breakage rate decreased and PSD widened because of a decrease in the Péclet number 
(widening of the residence time distribution). This also led to more disparity between the  
two modes of operation. The implications of the findings from a formulation/process 
development perspective are  
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a) Formulation development with nanosuspension formulations, even those intended for 
continuous manufacturing, can be performed in the batch or recirculation mode. The 
formulation, stabilization, and processing knowledge generated can be transferred to 
continuous operations without major difficulty.  
b) Multi-pass mode can be automated to allow passes between two holding tanks in a 
swing/pendulum fashion, which will reduce development time significantly toward 
predicting the number of mills required for true (cascade) continuous milling 
operation. 
c)  In a true continuous milling process, a cascade of 6–12 media mills in series can lead 
to production of drug nanosuspensions. The exact number depends on the drug 
properties, formulation, and specific milling equipment as well as the desired/target 
drug particle size.  
Through a comparative analysis of laser diffraction data, SEM images, and BET-
based Sauter-Mean Diameter, this study has provided sufficient evidence for the 
existence of the Rehbinder effect during the milling of poorly water-soluble drugs. Not 
only do polymers/surfactants allow proper stabilization/dispersion of the nanoparticles in 
the suspensions (major effect), but they also facilitate drug particle breakage (minor–
moderate effect). These positive effects of the stabilizers did occur despite the less 
favorable microhydrodynamics in the mill. In a future study, polymers and surfactants 
with a wide concentration range will be separately studied to elucidate their individual 
roles in the Rehbinder effect.  
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CHAPTER 7 
OVERALL SUMMARY AND CONCLUSIONS 
 
In the preceding chapters, a comprehensive investigation of the production of 
Griseofulvin nanosuspensions in a wet stirred media mill operating in both the 
recirculation and continuous modes has been carried out. From a process engineering 
perspective, many important conclusions can be drawn. The findings in the preceding 
chapters suggest that physically stable nanosuspensions of BCS Class II drugs can be 
produced via wet stirred media milling (WSMM) with a judicious and synergistic use of 
cellulosic polymers and surfactants. This solvent- free process appears to be robust, 
yielding reproducible suspensions with high drug loading and minimal media 
contamination. It can be carried out in batch, recirculation, and multi-pass continuous 
modes successfully. The as-received and milled particles of two BCS class II drugs 
namely Griseofulvin (GF) and Naproxen (NAP) were characterized to investigate the 
crystalline state of the particles. Characterization with DSC (on both GF and NAP), 
PXRD (on GF), and Raman spectroscopy (on GF), suggests that the crystallinity of the 
drugs has been largely preserved after wet media milling.  
The dissertation work also contributed to the fundamental understanding of the 
preparation of stable drug nanoparticles suspensions; specifically it (1) indicated the need 
for a minimum polymeric stabilizer-to-drug ratio for proper stabilization of drug 
nanosuspensions as dictated by polymer adsorption and synergistic interactions between a 
polymeric stabilizer and a surfactant, (2) demonstrated the existence of an optimum 
polymer concentration from a breakage rate perspective in the presence of a surfactant, 
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which results from the competing effects of viscous dampening and enhanced steric 
stabilization at higher polymer concentration, (3) developed fundamental understanding 
of the breakage dynamics–processing–formulation relationships and rationalized 
preparation of a single highly drug- loaded batch (20% or higher) instead of multiple 
dilute batches, (4) developed an intensified process for faster preparation of sub-100 nm 
particles with reduced specific energy consumption and media wear (i.e. minimal drug 
contamination), and (5) provided evidence for the proof of the Rehbinder effect during 
the milling of drugs. Not only do the polymers and surfactants allow proper physical 
stabilization of the nanoparticles in the suspensions, but they also do facilitate drug 
particle breakage.  
To understand the governing mechanism(s) during particle formation, a detailed 
the roles of stabilizers, i.e., cellulosic polymers and surfactants, were investigated in 
Chapter 3. Although polymers and surfactants are commonly used as stabilizers to impart 
physical stability to the suspensions produced by WSMM of poorly-water soluble drugs, 
scant information is available in pharmaceutical literature regarding their impact on the 
breakage kinetics. A combined microhydrodynamics–polymer adsorption analysis was 
implemented in Chapter 3 to elucidate the roles of stabilizers with a focus on the kinetics. 
Griseofulvin (GF) was milled at various concentrations of hydroxypropyl cellulose 
(HPC) in the presence–absence of sodium dodecyl sulfate (SDS). Particle sizing, 
scanning electron microscopy, thermal analysis, and rheometry were used to determine 
the breakage kinetics, adsorption isotherm, and apparent viscosity, which were then used 
to analyze the aggregation state of the milled suspensions and the microhydrodynamics. 
In the absence of SDS, an increase in HPC concentration slowed the particle aggregation 
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leading to faster apparent breakage. On the other hand, due to a synergistic stabilizing 
action of HPC with SDS, lower HPC concentration was needed to stabilize the 
suspensions, and an optimum HPC concentration for the fastest apparent breakage was 
identified. The microhydrodynamic analysis quantified, for the first time, the viscous 
dampening effect of polymers, while only the combined analysis could explain the 
observed optimum.          
As the WSMM process is expensive and energy- intensive, it was important to 
study the breakage kinetics, which determines the cycle time and production rate for a 
desired fineness. To this end, the impact of stirrer speed, bead concentration, and drug 
loading on the breakage kinetics was explored via a microhydrodynamic model for the 
bead–bead collisions. Suspensions of GF were prepared in the presence of two 
stabilizers: HPC and SDS. Laser diffraction, scanning electron microscopy, and 
rheometry were used to characterize them. Various microhydrodynamic parameters 
including a newly defined milling intensity factor was calculated. An increase in either 
the stirrer speed or the bead concentration led to an increase in the specific energy and the 
milling intensity factor, consequently faster breakage. On the other hand, an increase in 
the drug loading led to a decrease in these parameters and consequently slower breakage. 
While all microhydrodynamic parameters provided significant physical insight, only the 
milling intensity factor was capable of explaining the influence of all parameters directly 
through its strong correlation with the process time constant. Besides guiding process 
optimization, the analysis rationalizes the preparation of a single highly drug- loaded 
batch (20% or higher) instead of multiple dilute batches.  
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Chapter 5 presents the design of an intensified WSMM process for the production 
of truly nanosized drug particles (1-100 nm) with acceptable physical stability and 
minimal bead wear. In pharmacutical literature, 100–300 nm particles were prepared by 
several hours to days of milling with relatively high energy consumption. A combined 
experimental and theoretical approach (microhydrodynamic model) was adopted with the 
ultimate objective of achieving faster production of sub-100 nm BCS class II drug 
particles with reduced energy consumption. The impact of media (bead) size on the 
energy consumption and breakage kinetics GF and naproxen (NAP) were elucidated. The 
baseline process with the optimal bead size was intensified by increasing the stirrer tip 
speed, bead loading, and suspension flow rate systematically, as guided by the 
microhydrodynamic model of the process. In all milling experiments, the suspensions 
were physically stabilized using a low molecular weight neutral polymer -hydroxypropyl 
methyl cellulose (HPMC-E3) and SDS. Static light scattering, dynamic light scattering, 
scanning electron microscopy, and powder X-ray diffraction were used to characterize 
the milled drug particles. Experimental and microhydrodynamic analysis of the milling 
beads showed that the smallest beads were effective in achieving sub-100 nm median size 
particles at the end of 6 h, with reduced specific energy consumption due to their relative 
high energy dissipation rate during the deformation of the particles (mill intensity factor). 
As guided by the microhydrodynamic model, the mill intensity factor was further 
increased by the combined use of intense mill parameters, which led to a GF particle size 
of 83 nm within 30 min of milling. Experimental investigation to produce GF particle 
size of 100 nm (ball-park size) with use of intensified process showed a 13.6 times 
reduction in cycle time compared to the baseline process with energy savings up to 43%. 
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This also led to 86.5% less bead wear (zirconium) contamination in the GF drug 
suspension as measured by inductive coupled plasma mass spectrometry analysis. 
Similarly, milling of NAP with intensified process conditions also led to the faster 
preparation of sub-100 nm particles with reduced specific energy consumption and bead 
wear. The use of small beads (100 m) has enabled the intensification of the process, 
increase the breakage rate, and reduce the energy consumption without causing gross 
contamination of the drug product with worn-out beads. The intensified process 
methodology developed in Chapter 5 presents an opportunity for formulators/engineers to 
design an intensified wet-milling process for production of sub-100 nm drug particles 
with reduced cycle time and acceptable media contamination and/or to optimize existing 
wet-milling processes. 
In Chapters 3–5, nanoparticles of BCS Class II drugs were produced during 
WSMM operating in recirculation mode. Scant information is available in the 
pharmaceutical literature regarding the continuous production of drug nanoparticles via 
wet media milling. GF and NAP were milled in both recirculation mode and multi-pass 
continuous mode to study the breakage dynamics and to determine the effects of 
suspension flow rate (Chapter 6). The evolution of the median particle size was measured 
and described by an empirical breakage model. The results in Chapter 6 indicate that the 
two operation modes could produce drug nanosuspensions with similar particle size 
distributions (PSDs). A reduced suspension flow rate slowed the breakage rate and led to 
a wider PSD and more differentiation between the two operation modes. The latter part of 
Chapter 6 focused on the roles of stabilizers (HPC and SDS) and elucidation of the so-
called Rehbinder effect (reduction in particle strength due to adsorbed stabilizers such as 
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polymers and surfactants). Milling the drugs in the absence of the stabilizers produced 
primary nanoparticles and their aggregates, while milling with the stabilizers produced 
smaller primary nanoparticles with minimal aggregation. Using laser diffraction, BET 
nitrogen adsorption, SEM imaging, and a microhydrodynamic analysis of milling, this 
study, for the first time, provides sufficient evidence for the existence of the Rehbinder 
effect during the milling of drugs. Not only do the polymers and surfactants allow proper 
stabilization of the nanoparticles in the suspensions, but they also do facilitate drug 
particle breakage.  
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CHAPTER 8 
FUTURE WORK 
 
8.1 Develop a Multi-Scale Modeling Approach for WSMM 
To gain a fundamental insight into the kinetics of particle breakage and aggregation as 
well as the stabilization behavior, a multi-scale modeling approach can be employed. In 
this approach, the combined use of the population balance model (PBM) (process or 
macro-scale) along with the microhydrodynamic model (micro-scale) will be 
investigated. The multi-scale modeling approach will be adopted for a recirculation mill 
so as to model the temporal evolution of the particle size distribution during milling. In 
Chapters 3 and 4, the impacts of processing/formulation parameters on the 
microhydrodynamics have been investigated. However, fitting and prediction of the 
particle size distribution at the macro-scale via the population balance model has not been 
investigated (see e.g. Bilgili and Scarlett 2005; Bilgili et al. 2006a, 2006b; Sommer et al. 
2006 for population balance equation). Birth and death terms for particle aggregation will 
be introduced. As a major novelty, the specific breakage rate k will be correlated to 
granular temperature , thus enabling a first connection between the micro–macro scales. 
PBM should also be used to elucidate diferrent breakage and aggregation mechanism. 
 
8.2 Process Intensification for Formation of Sub-100 Nm Particles 
 with Multiple Drugs: Surfactant-Free Suspensions for Sterile  
Filtration (Along with Process Intensification) 
In Chapter 5, an intensified wet media milling process for faster p roduction of dense, 
stable drug suspensions with sub-100 nm particles was investigated. The synergistic 
combination of a polymer anda surfactant was employed, and small milling beads were 
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used along with intensified process conditions: a high flow rate, high mill tip speed, and a 
high bead concentration. The short-term physical stability of the drug suspensions was 
also investigated and the suspensions were stable. The use of surfactants have been 
identified to be the most effective class of dispersants improving the wettability and 
redispersibility as compared with soluble polymers and sugars ( Bhakay et al., 2012). 
However, the use of surfactants can affect the long term stability of the suspension upon 
storage due to Ostwald ripening (Verma 2011; Ghosh, 2011). Other issues such as 
toxicity of the surfactants due to excess use are a concern in most formulations 
(Liversidge and Cundy 1995). For inhalation applications, the use of surfactant is either 
prohibited or utilized at extremely low concentrations due to the toxicity (Suzuki et al. 
2000). Future work will focus on the use of multiple drugs along with acceptable 
polymers/surfactants. Future work should also explore the long term stability of such 
drug suspensions. 
 
8.3 Formulation Doe for Multiple Drugs and Relate Milling  
Performance to Physicochemical, Mechanical,  
and Surface Properties of the Drugs 
The task aims at producing stable nanosuspensions of five BCS Class II drugs namely 
griseofulvin, naproxen, fenofibrate, azodicarbonamide, and phenylbutazone using a 
combination of HPC and SDS and superdisintegrants. Impact of wet-milled 
superdisintegrants, as novel dispersants, on the physical stability of the drug suspensions 
will also be investigated. Few systematic studies related the milling performance to the 
physicochemical and surface properties of the drugs. Lee et al. (2005; 2008) studied the 
effect of hydrophobicity of copolymers; Choi et al. (2005) studied the surface energy of 
polymers on drug stabilization; Choi et al. (2008) and Sepassi et al. (2007) studied the 
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effect of polymer molecular weight; George and Ghosh (2013) investigated the material 
property variables (drug and stabilizer) that control the critical quality attributes (CQA) 
defining a nanosuspension formulation; Cerdeira et al. (2011) investigated the role of 
milling parameters and particle stabilization of drug materials with similar mechanical 
properties. The Young’s modulus of the drug crystal was measured using in house 
software and the Hertzian calculation model. Their result suggests that similar 
mechanical properties of drugs exhibited similar milling behavior. Future work will 
investigate how milling performance of multiple drugs relate to their physicochemical, 
mechanical, and surface properties. The physical stability of the suspension should be 
assessed. Elucidate the structure and the state of the polymer (mono- layer vs. multi- layer 
coverage) on the surface of drug by experiments and models.  
 
8.4 Is the Adsorbed Polymer or Surfactant Responsible for the Rehbinder Effect? 
Chapter 6 sheds light on the role of the combination of polymer and surfactant on the 
particle strength (Rehbinder effect) and suggests that either stabilizer could have affected 
the strength of the drug particles. A systematic study with each type of stabilizer (i.e. 
polymer or surfactant) alone can elucidate whether the observed Rehbinder effect 
originated from either one of the stabilizers or both.  
 
8.5 Effect of Temperature during WSMM 
The effect of temperature during WSMM should be investigated along with different 
degrees of cooling should be considered.  
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8.6 Influence of Different Bead Materials along with Bead Mixtures of Various Sizes 
on the Millng Performance of Multiple Drugs 
The task aims at investigating the influence of various bead materials (i.e. density of 
grinding beads) along with the mixtures of the beads for the milling of multiple drugs. 
Crosslinked polystyrene beads and yttrium stabilized zirconia bead is currently used for 
the production of nanosuspension in the literature. Scant information exists on the impact 
of bead mixtures on the milling performance of multiple drugs. Future work will involve 
a systematic design of experiment to investigate the impact of bead mixtures on the 
milling performance of multiple drugs. The impact of the ratio of drug particle size to the 
bead size should be further examined using the microhydrodynamic model.  
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APPENDIX A 
 SUPPLEMENTARY MATERIAL 
 
Figures A.1 to A.6 shows supplementary material used in the text.  
 
 
 
Figure A.1 Electrical double layer. 
 
 
Figure A.2 Zeta potential. 
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Figure A.3 Schematic representation of two coated nanoparticles of diameters d1 and d2 
separated by surface to surface distance (s) and center to center distance (r). 
 
 
 
 
Figure A.4 Possibilities for stabilization. 
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Figure A.5 Typical energy versus distance profiles of DLVO theory.  
 
 
  
Figure A.6 Bead–bead interaction. 
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APPENDIX B 
TYPICAL FLOW BEHAVIOR OF SUSPENSIONS 
 
 
 
Figure B.1 Various types of common flow behavior (Edited from source: Schramm, G., 
2000. “A practical approach to rheology and rheometry”. Gebrueder HAAKE GmbH, 
Karlsruhe, Dieselstrasse, Germany, pp. 20–25) 
Newtonian behavior (curve 1) is observed in dilute stable dispersion of spherical 
particles. For Newtonian fluids, the apparent viscosity stays relatively constant with shear 
rate. The flow curve (1) is known to be ideal. All other liquids not exhibiting this “ideal” 
flow behavior are called “Non-Newtonian liquids”. Liquids which show pseudoplastic 
flow behavior under certain conditions of stress and shear rates – often just called 
“pseudoplastic liquids” or shear thinning liquids. The structures formed by the drug 
particles either due to aggregation are destroyed or deaggregated with increasing shear 
rates thereby leading to a lower viscosities. For most liquid materials the shear-thinning 
effect is reversible – often with some time lag – i.e. the liquids regain their original high 
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viscosity when the shearing is slowed down or is even terminated: the chain-type 
molecules return to their natural state of non-orientation, deformed droplets return to ball 
shape and the aggregates reform due to Brownian motion (Schramm, 2000). Dilatant 
liquid or shear thickening occurs when an increase in the shear rate increases the 
viscosity. Shear thickening mostly occurs at high solid loadings and high shear rates due 
to densely packed particles. Pseudoplastic liquids or shear thinning liquids with a yield 
point is known to exhibit plasticity (Schramm, 2000). Schramm (2000) describes the 
plastic fluid as dispersions which at rest can build up an intermolecular /interparticle 
network of binding forces (polar forces, van der Waals forces, etc.). These forces restrict 
positional change of volume elements and give the substance a solid character with an 
infinitely high viscosity. The shear thickening behavior and the plastic fluid behavior was 
not investigated in this work. 
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